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 SYNTHETIC STUDIES ON NECIC ACIDS OF
 
PYRROLIZIDINE ALKALOIDS
 
CHAPTER I 
GENERAL INTRODUCTION 
(+)-Nemorensine (1)1 and (-)-swazine (2)2 belong to the broadly 
distributed family of pyrrolizidine alkaloids that have been shown to possess 
powerful hepatotoxic and carcinogenic properties.3-8 These alkaloids are 
widespread in nature and it is estimated that the potential number of alkaloid-
containing species are as high as 6000, or 3% of the world's flowering plants.9 
To date, there are at least 100-150 pyrrolizidine alkaloids that have been 
identified  in over 150 plant species and nearly 70 genera.3,6,9  The 
hepatotoxicity of these alkaloids has caused large-scale death in grazing cattle 
and presents a potentially serious human health problem.3-8 Due to the toxicity 
of pyrrolizidine alkaloids and their consequent environmental health hazard, 
much attention has been drawn to this area. 
0 
(+)-Nemorensine (1)  (-)-Swazine (2) 2 
Human poisoning by pyrrolizidine alkaloids has been documented in 
Europe, Africa, Central Asia, and the U.S.3,4 One of most severe outbreaks of 
pyrrolizidine alkaloid poisoning occurred in Afghanistan in 1974. Around 35,000 
people in 98 villages in a remote area of northwest Afghanistan were affected by 
consumption of bread made from wheat contaminated with pyrrolizidine 
alkaloids.10,11  There are two main sources of human exposure to toxic 
pyrrolizidine alkaloids.3,4 The most important of these is consumption of cereal 
grains, such as wheat and millet, contaminated with the seed or other parts of 
plants containing these alkaloids.  A second source is the consumption for 
medicinal or dietary purposes of herbs containing the alkaloids, either as the 
plant itself or as an infusion.  It has also been found that pyrrolizidine alkaloids 
can enter the food chain through milkl 2 from cattle that graze on tansy and 
through honey13 acquired by bees from pyrrolizidine containing plants. 
Many pyrrolizidine alkaloids are lactones or esters derived from amino 
alcohols such as supinidine (3), retronecine (4) and crotanecine (5) by 
esterification with a variety of branched chain, usually hydroxylated aliphatic 
acids.  The alkaloids themselves may be monoesters, diesters, or cyclic 
dilactones. A large number of pyrrolizidine alkaloids have been isolated as 
macrocyclic dilactones, in which a pyrrolizidine diol (necine base) is esterified 
with a dicarboxylic acid (necic acid) to produce an eleven-to-fourteen membered 
ring.3 Examples include merenskine N-oxide (6),14 madurensine (7),15,16 and 
jacobine (8).17,18 
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A structural feature that is required for toxicity in pyrrolizidine alkaloids is 
unsaturation in the 1,2-position as shown in 9, and at least one of the hydroxyl 
groups must be esterified. The endocyclic C-1,2 olefin functionality is essential 
for the toxic effects of the alkaloids.19-22 
9 
The toxicity of pyrrolizidine alkaloids can be classified according to their 
structures.  In general, monoesters, such as heliotrine (10),23,24 are least toxic. 
Non-cyclic diesters, such as lasiocarpine (11),23,24 are of intermediate toxicity. 
The most toxic alkaloids are usually the cyclic dilactones such as retrorsine 
(12)25 and monocrotaline (13).26  In alkaloids such as senkirkine (14),27 the 
ketonic character of the eight-membered ring is diminished through interaction of 
the carbonyl group with the lone pair of electrons on the nitrogen atom. This 
alkaloid is about one-seventh as toxic as retrorsine (12).28 Alkaloids that have 4 
no double bond in the pyrrolizidine subunit, such as platyphylline (15),29 are not 
toxic.22 
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The toxic effects of pyrrolizidine alkaloids are due to metabolites of the 
alkaloids and not the alkaloids themselves.3,4 There are several possible 
pathways by which the alkaloids are metabolized (Figure 1.1).34  In vivo 
hydrolysis of pyrrolizidine alkaloids leads to the formation of their necic acid and 
necine base moieties both of which are non-hepatotoxic.20,30-31 The oxidation 
of pyrrolizidine alkaloids to their N-oxides is induced by hepatic microsomal 
enzymes.4 The water soluble N-oxide metabolites are rapidly excreted in the 
urine.32 The N-oxides themselves are much less toxic than the parent alkaloid, 
and can be regarded as detoxification products.32-34 Finally, toxic pyrrolizidine 
alkaloids can be metabolized to pyrrolic derivatives (dehydroalkaloids) by a 5 
hepatic P-450 monooxygenase.33-34 These pyrrolic metabolites are believed to 
be responsible for the major toxic effects of pyrrolizidine alkaloids.22 
R'CO2  CH2O2R"  R'CO2  CH2O2R"
hydrolysis 
(enz)  -2H (enz) 
NECINE  PYRROLIZIDINE  DEHYDROALKALOID 
non-hepatotoxic  ALKALOID  primary toxic metabolite 
[0] 
(enz) 
ITCO2  CH2O2R" 
0 
PYRROLIZIDINE N-OXIDE 
detoxification pathway 
Figure 1.1. Major metabolic pathways of unsaturated pyrrolizidine alkaloids.4 
As toxic primary metabolites, the pyrrolic derivatives of pyrrolizidine 
alkaloids  are  constitutionally  dehydropyrrolizidine  esters.  These 
dehydropyrrolizidine esters are highly reactive compounds, in which the acyloxy 
substituents are activated by the pyrrole ring and become leaving groups. When 
an ester group is lost it leaves a positively charged dehydropyrrolizidine moiety 
which can react with nucleophilic species such as amines or thiols to form 
relatively stable alkylation products. Thus the dehydroalkaloids act effectively as 
bis alkylating agents (Figure 1.2).22,32 6 
R 
cs,L
H-9 .,0 
R 
N
.:i 
0 
0 
+ 
Nu-, 
Nu-2  H+ 
Figure 1.2. Mechanism of bisalkylation of pyrrolic derivatives of pyrrolizidine 
alkaloids.32 
It is known that  pyrrolizidine alkaloids are metabolized primarily in the 
liver, although small amounts of pyrrolic metabolites have been found in the 
lungs and kidneys. The hypothetical fate of a reactive pyrrolic metabolite in the 
liver is illustrated in Figure 1.3.22 Some of the pyrrolic metabolites may be 
hydrolyzed while others might alkylate soluble thiols or amines, such as 
glutathione or amino acids. These relatively stable, soluble products will then be 
eliminated from the body. Some of these reactive pyrrolic metabolites may bind 
proteins or nucleic acids within the cell, and remain for a much longer time as 
"bound pyrroles". These "bound pyrroles" are believed to be responsible for toxic 7 
effects in the cell.  Some of the metabolites may survive long enough to be 
transported by the bloodstream to other organs such as the heart and lungs.22 
Highly reactive
 
Dehydropyrrolizidine ester
 
Liver 
Alkaloid 
..­
soluble thiols,  c? o

amines, etc.  Liver
 
H2O
  tissue 
/--- slower 
HO  CH2OH 
Bound pyrrole 
Soluble pyrroles to urine 
Figure 1.3. Hypothetical fate of a reactive pyrrolic metabolite 
(dehydropyrrolizidine ester) in the liver of a rat.22 
In addition to their toxicity, certain pyrrolizidine alkaloids, such as heliotrine 
(10), lasiocarpine (11), monocrotaline (13), and indicine N-oxide (16) have been 
found to have antitumor activity.36,37  Indicine N-oxide (16) was tested in 
phase II clinical trials for the treatment of leukemia and solid tumors,38-45 but its 
hepatotoxicity was found to be too high for its further development as an 
anticancer agent. 8 
Indicine N-oxide (16) 
Organic chemists have long been fascinated by the complex structural and 
synthetic puzzles posed by natural products and, like many natural products, 
pyrrolizidine alkaloids have presented challenging targets for synthesis. 
Synthetic routes have been devised for making necine bases and necic acids,3 
and a few of these have been extended to total synthesis of the ester 
alkaloids.46-59 These syntheses not only have been valuable for establishing 
the precise structure and stereochemistry of many pyrrolizidine alkaloids, but also 
have been a valuable source of modified alkaloids or analogs with which to test 
structure-activity relationships and to study their metabolism and toxicity.3 
Nemorensine (1) was isolated from three varieties of Senecio nemorensis 
L. including ssp. Jacquinianus, ssp. fuchsii, and var. subdecurrens GRISEB. by 
Klasek and coworkers in 1972.1  Its structure was initially assigned as 17, when 
another pyrrolizidine alkaloid retroisosenine (18) was isolated in 1975 from 
Senecio nemorensis L., var. bulgaricus (VEL.) STOP. et STEF.60 The configuration 
at C-3 in these two alkaloids was left unspecified. 9 
0
 
17  18 
Alkaline hydrolysis of 17 and 18 gave necic acids 19 and 21 respectively. 
Although the structural features of necic acid 21 derived from 18 resemble those 
of the necic acid 19 from 17, the actual values of chemical shifts in their 1H NMR 
spectra are different. The necic acids 19 and 21 were converted to their dimethyl 
esters 20 and 22, respectively, and the relative stereochemistry of the esters was 
assigned by assuming a deshielding effect by the methoxycarbonyl group at C-2 
on the cis methyl protons at C-5. Since a downfield shift was observed for the 
methyl signal of the necic ester (20) derived from nemorensine relative to the 
corresponding signal in the necic ester (22) of retroisosenine, "nemorensic acid" 
was assigned as 19. The structure of nemorensine was therefore represented by 
17. The necic acid from retroisosenine was assigned as 21 and the structure of 
the parent alkaloid was represented by 18.1,60 
..,.. 
)40
I  CO2R 
1  0 CO2R 
RO2C  RO2C 
19 R = H  21 R = H 
20 R = Me  22 R = Me 10 
Subsequently, the structure of nemorensine was revised without 
explanation to the stereoisomeric (2R,5R)-disubstituted tetrahydrofuran 23 when 
oxonemorensine (24), the N-oxide of 23, was isolated in 1979.61  Again, the 
configuration at C-3 was not specified in this structure. 
0 
23  24 
In related studies by Nghia60 and Kirfel,62 the necic acid 25 was shown to 
be present among the degradation products of both (-)-bulgarsenine (26) and (+)­
doronenine (27). Thus, hydrolysis of (-)-bulgarsenine (26), isolated from Senecio 
nemorensis L., var. bulgaricus (VEL.) STOP. et STEF., under both basic and acidic 
conditions, gave 25 resulting from cyclization of the intermediate 6-hydroxy a,13­
unsaturated dicarboxylic acid (Scheme 1).60 
KOH, Me0H or 
H2SO4, reflux  I" 
HO2C 
0 'CO2H 
25 
(-)-Bulgarsenine (26) 
Scheme 1 11 
The absolute configuration of (+)-doronenine (27) was determined by X-
ray crystallographic analysis.63 After basic hydrolysis, (+)-doronenine (27) was 
found to give the same necic acid 25 as obtained from bulgarsenine (26) 
(Scheme 2). The stereochemistry of this necic acid was determined by X-ray 
crystallographic analysis.64 
Ba(OH)2, Et20 
25 
(+)-Doronenine (27) 
Scheme 2 
An open-chain form of nemorensic acid (35), isolated from the acidic 
fraction of an ethereal extract of Senecio nemorensis L., was first synthesized by 
Roder as a racemate in 1979.65 The synthesis started from commercially 
available 3,3-dimethylacrylic acid (28).  Esterification of 28 gave 29, which was 
reacted with N-bromosuccinimide (NBS) to afford a mixture of cis- and trans 
bromo esters 30 in a 1:1 ratio. The mixture 30 was alkylated with ethyl a­
methylacetoacetate (31) in the presence of dibenzo-18-crown-6 as catalyst to 
yield keto ester 32 as the coupled product.  Saponification of 32 with sodium 
hydroxide was followed by spontaneous decarboxylation of the 13 keto acid to 
furnish keto acid 33. After formation of the cyanohydrin 34, the latter was treated 
with concentrated hydrochloric acid at high temperature to produce a dicarboxylic 
acid 35 presumably as a mixture of stereoisomers (Scheme 3).65 12 
EtOH, p -TsOH,  NBS, AIBN, P205, 
CCI4, reflux  CCI4, reflux
HO2C  EtO2C  EtO2C"Br 
89%  64%
28  29 
30 
0 
Et02C.,..A.,  O 
31 
EtO2C 
5% NaOH 
HO2C 
cat. dibenzo-18-crown-6,  80% 
NaOH, C6H6  32  33 
48% 
Conc. HCI, 0 °C, HO\  I)K)
35% H2SO4,  then 100 °C HO2CrWCN  HO2C '- CO2H 
NaCN, 0 °C  6% (from 33) 
34  35 
Scheme 3 
In 1985, Klein reported the first synthesis of (±)-25, which he claimed to be 
the racemate of the necic acid of retroisosenine (18).66 This claim was later 
proved to be incorrect, and Klein's product was shown to be the necic acid of 
nemorensine by an asymmetric synthesis of (+)-25 from this laboratory.67 In 
Klein's synthesis, an intramolecular Diels-Alder reaction of furfuryl ally! sulfide 42 
was the key step used for the construction of the tetrahydrofuran ring system. 
The Klein synthesis of 25 began from commercially available methyl 2­
methy1-3-furancarboxylate (36), which was reduced to its corresponding alcohol 
37 with lithium aluminum hydride. Subsequent benzylation of the primary alcohol 
gave benzyl ether 38. Vilsmeier formylation of 38 occurred exclusively at the C-5 
position to produce 39, which was treated with ammonium hydrogen sulfide to 
yield the crude furfuryl disulfide 40.  Without purification, this disulfide was 
immediately reduced with lithium aluminum hydride to the mercaptan 41, which 
was directly reacted with allyl bromide to afford allyl sulfide 42. With this key 13 
intermediate in hand, an intramolecular Diels -Alder reaction was effected in 
refluxing toluene to produce the desired cycloadduct 43 in 48% yield along with 
40-45% of recovered starting material. This cycloaddition was shown to be an 
equilibrium process since the same ratio was obtained when either isolated 
product 43 or starting material 42 was resubmitted to the reaction conditions 
(Scheme 4).66 
NaH, PhCH2Br CO2Me  OH LiAIH4, THE  THE -DMF (4:1)  OCH2Ph / \ 
0  74% (2 steps)  0\ 
37 36  38 
POCI3,  OCH2Ph NH4SH, Me0H  PhCH2O 
OHC 0  0 DMF  rt. 5 h
 
39
  40 
LiAIH4, Et20  OCH2Ph  NaH, CH2=CHCH2Br
 
HSH2C  0
 reflux, 1 h  50-70% (4 steps)
 
41
 
OCH2Ph 
PhCH3, reflux, 24 h 
0  48% (40-45% SM) 
42 
43 
Scheme 4 
Ozonolysis of 43, followed by a reductive workup using sodium 
borohydride, yielded the tetrahydrofuran 44 (Scheme 5).  This dihydroxy 
sulfoxide was produced as a mixture of diastereomers, which was used in 
subsequent reactions without separation.  The primary alcohol of 44 was 14 
selectively silylated in the presence of the secondary alcohol with tert­
butyldimethylsilyl chloride (TBSCI) in pyridine at elevated temperature to afford 
45, which was treated with Raney nickel in refluxing ethanol.  This served to 
reduce the sulfoxide and desulfurize the resultant cyclic sulfide to yield the 
trimethyl substituted tetrahydrofuran 46. Removal of the secondary hydroxyl 
group of 46 proceeded cleanly using Barton's two-step method, in which the 
crude xanthates 47 were reduced with tri-n-butyltin hydride in refluxing toluene. 
The benzyl protecting group of 48 was removed with lithium in ammonia, and the 
resultant alcohol 49 upon oxidation with Jones' reagent directly afforded ( ±)­
25.66 
OCH2Ph  03, EtOH;  TBSCI, py. 
HO NaBH4  70 °C, 2h 
43  PhCH2O  44 
;-(3	  Raney nickel  NaH, 
EtOH, reflux  CS2, Mel HO,. 
68% (3 steps) OTBS	  OTBS
PhCH20-'- PhCH20
 
45
  46 
Bu3SnH, Ph Me 
reflux  Li, NH3-THF
MeS(S)C0  0	  ( 0
80% (2 steps)
OTBS  OTBS O
PhCH20  PhCH2O
 
47  48
 
H2Cr04, Me2C0
 
r'ss 0
  0 ---b02H 
l 60% (2 steps) 
s's 
HO.) 
OTBS  CO2H
 
49  (±)-25
 
Scheme 5 15 
In Klein's (±)-25, the methyl groups at C-2 and C-5 are in a cis orientation, 
which agrees with the assignment made to the necic acid of retroisosenine 
(18).60  It was therefore presumed that (±)-25 is the necic acid of retroisosenine 
(18).  However, the first asymmetric synthesis of (+)-25 accomplished in this 
laboratory has shown that this dicarboxylic acid is not the necic acid of 
retroisosenine, but rather is the necic acid of nemorensine (1).67 In addition, the 
synthesis of (+)-25 has necessitated revision of the stereochemistry of 
nemorensine and has established the absolute configuration of the necic acid of 
this alkaloid.67 
(-)-Swazine (2) was isolated from an extract of  Senecio swaziensis 
Compton obtained in Swaziland, South Africa.2 Swazine was found to be one of 
the more complex structures among the dilactone pyrrolizidine alkaloids, 
consisting of a fully functionalized dicarboxylic acid derivative 50 (swazinecic 
acid) which bridges the C-7 and C-9 hydroxyl groups of retronecine to form a 
twelve-membered dilactone. 
0 
HO2C 
(-)-Swazine (2)  Swazinecic acid (50) 
Neither acidic nor careful basic hydrolysis of 2 has permitted isolation of 
swazinecic acid (50).268  Instead, the constitution of this necic acid was inferred 
from the spirodilactone 51 obtained upon treatment of (-)-swazine (2) with hot, 3N 16 
sulfuric acid (Scheme 6).  The structure of 51 was established by X-ray 
crystallographic analysis of its p-bromobenzoate 52.2 
3N H2SO4,  0  OH  HO H 
,OH 
THF, reflux  0 
+ 
N 
51  Retronecine (53) 
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Scheme 6 
Initially, swazine was formulated as the dilactone isomeric with 2, in which 
swazinecic acid (50) was connected to retronecine in the reverse orientation.2 
This assignment was subsequently revised, and the revision was accepted after 
a more complete degradative and spectroscopic investigation of the 
alkaloid.68,69 The latter study also led to the absolute configuration for ( -)­
swazine represented by 2. Although evidence for this stereostructure seemed 
persuasive, we nevertheless felt that before attempting a synthesis of 2, it was 
prudent to verify the assignment made to swazinecic acid, particularly in view of 
the harsh conditions under which the relationship between stereocenters in 50 
and its derived spirodilactone 51 had been deduced. 17 
Gordon-Gray and Whiteley had previously attempted to synthesize 
spirodilactone 51.  Synthesis of the intermediate dicarboxylic acid 65 was 
accomplished by either condensation of diethyl malonate with 58, or a coupling 
reaction of 62 with cuprate 63. The first synthesis started with the Darzens 
condensation of a-bromo ester 54 with acetone to afford glycidic ester 55, which 
underwent elimination to allylic hydroxy ester 56.  Resolution of 56 was 
attempted in order to accomplish an absolute stereoselective synthesis of 
spirodilactone 51 but was unsuccessful. The synthesis, continued in racemic 
form, next involved allylic bromination of 56 to give bromo ester 57 (Scheme 
7).70 
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The tertiary alcohol of 57 was protected as its O-ethoxycarbonyl derivative 
58, and the latter was condensed with diethyl malonate to furnish 59. Hydrolysis 
of 59 produced the triacid 60 which, after stirring with the Mannich reagent 
prepared from aqueous formaldehyde, diethylamine, and a buffered acetic acid 
solution gave the diacid 65 (Scheme 8).70 57 
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A more convergent at synthesis of 65 was accomplished by a coupling 
reaction of 62 with the cuprate 63 to provide diester 64, which on hydrolysis 
yielded the diacid 65 (Scheme 9).  Again, all attempts at resolution of  this 
dicarboxylic acid failed.70 
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Subsequently, an asymmetric synthesis of spirodilactone 51 was 
attempted by Whiteley.71  The commercially available oxazoline 66 was first 
converted into its methyl ether 67 which was then brominated to afford 68 as a 
mixture of diastereoisomeric bromides (Scheme 10). Deprotonation of 68 using 
lithium diisopropylamide as base afforded the lithiooxazoline with the halogen 
atom anti to the lithium cation as the presumed thermodynamically favored form. 
The a-anion, as expected, attacked the carbonyl group of acetone from the least 
hindered face; this was followed by spontaneous SN2 displacement of the 
halogen in 69 to form the desired epoxy oxazoline 70 with the required (R)­
configuration at the a-carbon. In the presence of excess p-toluenesulfonic acid, 
epoxide 70 was rearranged to allylic alcohol 71, which underwent subsequent 
hydrolysis to produce a-hydroxy ester 72. 
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The hydroxyl group of 72 was protected as its tert-butyldimethylsilyl (TBS) 
ether 73, and this was followed by a photolytic bromination using N­
bromosuccinimide to produce allylic bromide 74. Coupling of 74 with diethyl 
malonate anion gave the triester 75, from which the silyl group was removed with 
boron trifluoride etherate in dichloromethane to provide alcohol 76. Vanadium-
catalyzed epoxidation of allylic alcohol 76 with tert-butylhydroperoxide as the 
epoxidizing agent afforded the required erythro isomer 77 (Scheme 11).71 Basic 
hydrolysis of triester 77 with sodium hydroxide followed by refluxing in sulfuric 
acid afforded spirodilactone 78. Although work is reported to be in progress to 
convert 78 into spirodilactone 51,71 no synthesis of 51 has yet been disclosed. 
OH  OTBS  OTBS
 
NaH, TBSCI  NBS, hv, CCI4 
CO2Et  Br'''CO2Et 
54%  94% 
74 72  73 
EtO2CCH2CO2Et 
NaH, THE 
OTBS 
BF3.Et20, CH2Cl2 EtO2C 
OH 
CO2Et  CO2Et 
97%  EtO2C  93%  EtO2C 
75  76 
OH 
VO(acac)2, t -BuOOH  EtO2C  10% NaOH, rt.; 
CO2Et 
98%  5 M H2SO4, reflux EtO2C 
77  70% 
78 
Scheme 11 
51 
0 21 
As part of a program directed towards the synthesis of dilactone
 
pyrrolizidine alkaloids, a general approach to assembling the necic acid portion of 
these natural products from terpenoid precursors has been devised in this 
laboratory.47-49  The first two necic acids synthesized by this strategy, 
integerrinecic acid (79)46,47 and usaraminecic acid (80),48 led to the 
stereoselective synthesis of their parent alkaloids (-)-integerrimine (81) and (+)­
usaramine (82).49 
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OH 
HO  I HO s 
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Two routes to integerriminecic acid (79) were completed by White et al. 
The first, starting from methyl (R)-(-)-3-hydroxy-2-methylpropionate (83) led in 
nineteen steps to integerrinecic acid lactone (98) which was transformed to the 
necic acid derivative 100.46,49 A second, shorter synthesis of 98 was 
accomplished starting from (R)-(+)-citronellal (102).47,49 
In  the first  synthesis 'of 79,  initial  protection  of 83 with  [2­
(trimethylsily0ethoxy]methyl  (SEM)  chloride  in  the  presence  of 22 
diisopropylethylamine afforded the ether 84 (Scheme 12). The ester function in 
84 was reduced with lithium aluminum hydride, and the resultant alcohol was 
oxidized to aldehyde 85 under Swern's conditions.  Transformation of 85 to 
methyl ketone 86 was accomplished by treatment with methylmagnesium 
bromide, followed by Swern oxidation of the resultant alcohol. A chelation­
controlled addition of vinylmagnesium bromide to ketone of 86 yielded a 4:1 
mixture of the desired alcohol 87 and its diastereomer 88, respectively. Without 
separation, these diastereomers were converted to their cyclic carbonates 89 and 
90 by exposure to tetra-n-butylammonium fluoride in hexamethyiphosphoramide, 
followed by treatment of the resultant diols with carbonyldiimidazole.46,49 
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Scheme 12 
The major carbonate 89 was separated and was transformed to 
integerrinecic acid lactone 98 in nine steps (Scheme 13).  Thus, selective 23 
conversion of 89 to the primary tosylate and then to iodide 92, was followed by 
acetylation to furnish iodo acetate 93.  Intramolecular alkylation was 
accomplished by exposure of 93 to excess lithium diisopropylamide, and the 
resultant enolate 94 was immediately treated with acetaldehyde to provide the 
aldol product 95. Acetylation of this mixture of diastereomeric 13-hydroxy lactones 
gave a mixture of acetates 96, which was cleaved oxidatively with sodium 
periodate in the presence of a catalytic amount of ruthenium(III) chloride 
trihydrate, to yield a mixture of the corresponding carboxylic acids 97. The pair of 
acids 97 was smoothly converted into lactone 98 upon exposure to 1,8­
diazabicyclo[5.4.0]undec-7-ene (DBU). The carboxylic acid function in lactone 98 
was protected as its  (trimethylsilyl)ethyl ester 99 which was selectively 
hydrolyzed to the integerrinecic acid derivative 100.46,49 
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After completion of the synthesis of integerrimine (81), a search began for 
a general route to necic acids which could accommodate additional functional 
groups such as that present in usaramine (82). The initial goal therefore became 
a stereoselective pathway leading to both lactones 98 and 101 from a common 
intermediate.  Comparison of 98 and 101 suggested that the methyl and 
hydroxymethyl substituents of these 8-lactones could be installed by either 
hydride or alkoxide addition to a terminal epoxide, respectively. This strategy 
necessitated a change in the original synthetic plan departing from 83, whilst 
retaining the requirement for a progenitor from the chiral pool that would provide 
the (3R) methyl substituent of the necic acids. (R)-(+)-Citronellal (102) seemed 
ideally suited for this purpose, and all of the subsequent approaches to necic 
acids employed this monoterpene as the starting materia1.47,49 
OH 
(3° -"'CO2H  'CO2H 
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Alkylation of the lithium enolate derived from 102 with Eschenmoser's salt, 
followed by methylation of the resulting amine and treatment with aqueous 
sodium bicarbonate, gave the acrolein derivative 103.  Selective carbonyl 
reduction of the unsaturated aldehyde 103 occurred smoothly with sodium 
borohydride in the presence of cerium chloride and provided the allylic alcohol 
104.  It was expected that Katsuki-Sharpless catalytic asymmetric epoxidation of 
104 employing titanium(IV) isopropoxide and diisopropyl (-)-tartrate would afford 
the (R) epoxide 105 in high diastereomeric excess but in fact a 3:1 mixture of 105 
and the diastereomeric epoxide 106 was obtained. The preexisting asymmetric 
center in 104 apparently exerts a steric bias on the epoxidation which results in a 
substrate-catalyst mismatch and consequent poor stereoselectivity. Support for 
this postulate was obtained by epoxidation of 104 with the enantiomeric 
(matched) (+)-tartrate, which yielded diastereoisomers 105 and 106 in a ratio of 
4:96, respectively. The mixture of epoxy alcohols 105 and 106 were converted to 
their separable, crystalline 3,5-dinitrobenzoates 107 and 108 (Scheme 14).47,49 
LDA, Me2N=CH2 I;  NaBH4, Me0H 
CHO  Mel, Me0H;  CHO CeCI3.7H20 
102  NaHCO3, CH2Cl2 
103  95% 
78% 
OH 
C6H5C(CH3)200H, 
OH  + 
104  (-)-DIPT, Ti(0-i-PO4 
69%  105  106 
DMAP, pyridine 
98% 
107 
ODNB  + 
108 
ODNB 
R = (CH3)2C=CHCH2 
Scheme 14 26 
With pure 107 in hand, attention was turned to its conversion into lactone 
98 (Scheme 15). Reduction of 107 with lithium aluminum hydride afforded the 
diol 109, which was protected as its bis-3,5-dinitrobenzoate derivative 110. 
Oxidative scission of the isopropylidene group of 110 was accomplished with 
catalytic ruthenium trichloride and sodium metaperiodate.  Subsequent 
methanolysis of the 3,5-dinitrobenzoate esters, followed by acid-catalyzed 
lactonization, provided 111.  Oxidation of 111 with a catalytic amount of 
ruthenium(III) chloride and periodic acid, followed by esterification of the resulting 
crude carboxylic acid , gave methyl ester 112. The lithium enolate derived from 
112 was condensed with acetaldehyde, and the resultant aldol product was 
acetylated.  Elimination of acetic acid with DBU gave (E)-lactone 113 and 
subsequent hydrolysis with lithium hydroxide furnished (+)-98. Since synthesis of 
the integerrinecic acid derivative 100 had been accomplished previously (see 
Scheme 13), this route constitutes a second, enantioselective pathway to the 
necic acid.47,49 
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The synthetic route from (R)-(+)-citronellal to integerrinecic acid lactone 98 
described above is unfortunately marred by poor diastereoselectivity in the 
Katsuki-Sharpless epoxidation as compared to that observed in related 
systems.47,49 Recognizing that the stereochemical efficiency of this approach 
would be enhanced if epoxide 106, resulting from a matched substrate-catalyst 
reaction, were employed, a modification of the pathway was devised whereby 
111 could be accessed from this isomer (Scheme 16). Transformation of 106 to 
111 effectively required inversion of the quaternary center, a process which, in 
principle, could be accomplished by epoxide opening with attack by an internal 
carboxyl function.  The primary alcohol of 106 was protected as its tert­
butyldiphenylsilyl (TBDPS) ether 114 before oxidative cleavage of the olefin was 
carried out with ozone. Workup using Jones' reagent afforded a carboxylic acid 
which was esterified to give 115. Upon treatment of 115 with trifluoroacetic acid 
a single hydroxy lactone 116 was produced in which epoxide opening had 
occurred with inversion at the quaternary carbon center. The primary alcohol 116 
was converted to its iodide 117, which underwent reduction upon treatment with 
tri-n-butyltin hydride. Removal of the tert- butyldiphenylsilyl ether then yielded 
111,47,49 bringing this route into convergence with that shown in Scheme 15. 28 
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The structure of (+)-usaramine (82) differs from that of (-)-integerrimine 
(81) only in the presence of a hydroxymethyl substituent in place of the methyl 
group at C-12.  In planning an approach to the necic acid portion of 82, the 
objective was to employ the same epoxide(s) that had been used for the 
synthesis of 82.  In this case, however, hydrolytic rather than reductive opening 
of the epoxide function was required.48-49 
Epoxide 106, prepared in high diastereoselective excess via the 
epoxidation procedure described previously, was subjected to titanium 
isopropoxide-mediated ring opening in the presence of pivalic acid (Scheme 17). 
Nucleophilic attack occurred via 118 at the more accessible methylene carbon to 
afford pivalate 119. The diol function was protected as the acetonide 120, and 
reduction of the latter to 121 followed by oxidation with pyridinium dichromate 
(PDC), led to an unstable carboxylic acid which was isolated as its methyl ester 
122. Transesterification of 122 to the (trimethylsilyl)ethoxylmethyl (SEM) ester 29 
123 was achieved using titanium(IV) ethoxide as catalyst in a modification of the 
method reported by Seebach.72 Cleavage of the isopropylidene group of 123 
occurred cleanly upon ozonolysis to yield aldehyde 124, and oxidation of this 
material afforded the truncated carboxylic acid 125.48 -49 
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Hydrolysis of the acetonide 125 gave the dihydroxy acid 126, which was 
lactonized with Mukaiyama's reagent to provide 6-lactone 127. After protection of 
127 as its methoxymethyl (MOM) ether, condensation of the enolate derived from 
128 with acetaldehyde, followed by acetylation and elimination of acetic acid from 
the resulting 1- acetoxy lactone, gave the (E)-olefin 130. Hydrolysis of 130 to the 
usaraminecic acid derivative 130 was carried out, first with mineral acid to 
remove the MOM ether and then with basic peroxide to open the lactone of 132 
(Scheme 18).48'49 
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The foregoing studies provide a firm foundation on which to base further 
advances in the synthesis of necic acids. The chapters which follow describe two 
examples of the terpenoid route to necic acids which illustrate the power of this 
approach. The first example, an asymmetric synthesis of (+)-nemorensic acid, 
applies (R)-(+)-citronellal to the construction of a heavily substituted 
tetrahydrofuran, while the second, an approach to swazinecic acid, takes (S)-(-)­
citronellal towards one of the most highly functionalized necic acids found in 
pyrrolizidine alkaloids. 32 
CHAPTER II
 
ASYMMETRIC SYNTHESIS OF (+)-NEMORENSIC ACID
 
The successful exploitation of the relatively inexpensive monoterpene 
(R)-(+)-citronellal (102) as a starting material for synthesis of the necic acids of 
integerrimine46-47,49 and usaramine48-49 opens a broad approach to 
structurally diverse constituent acids of macrolactone pyrrolizidine alkaloids 
such as nemorensic acid and swazinecic acid.  Previous studies in these 
laboratories supported the concept that the same monoterpene would be a 
valuable starting material for a synthesis of (+)-nemorensic acid (25)46-49 
since the latter contains a secondary methyl group where the correct 
configuration can be acquired from 102. Moreover, 102 bears a functionalitic 
that can be easily amended for synthetic manipulation towards that of 25. 
An intramolecular conjugate addition of an alkoxide to the a,(3­
unsaturated ester in 150 was envisioned as the key step in our asymmetric 
approach to (+)-nemorensic acid (25) (Scheme 19). The anion 150 would be 
generated from desilylation of 142, which would be obtained by functional 
group manipulation of 137, including a regioselective opening of the epoxy 
function. The alkene 137 would be derived from methoxyselenylation of 134 
through a modification of the Toshimitsu reaction in which the trisubstituted 
olefin would undergo selective transposition in the presence of the disubstituted 
olefin.  The allylic alcohol 134 was to be synthesized from commercially 
available (R)-(+)-citronellal (102) by a-methylenation in this retrosynthetic 
analysis. 33 
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a-Methylenation73 of 102 was accomplished by treatment of its lithium 
enolate with Eschenmoser's salt, followed by methylation of the intermediate 
dimethylamine and elimination with aqueous sodium bicarbonate.  This 
protocol gave a,13-unsaturated aldehyde 133 in 94% overall yield.  The 
aldehyde 133 was reduced under Luche conditions74 with sodium 
borohydride in the presence of cerium(III) chloride heptahydrate to furnish 134 
in 93% yield. The more electron-rich trisubstituted olefin in diene 134 was then 
selectively transposed  in  a two-step procedure.  In  the  first  step, 
methoxyselenation of 134 under modified Toshimitsu conditions75 with 
phenylselenyl chloride and methyl alcohol as the nucleophile afforded 135. 
This was oxidized with hydrogen peroxide and the resultant selenoxide 34 
underwent in-situ elimination to give the allylic methyl ether 136 (Scheme 
20). 
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Sharp less  epoxidation76 of the allylic alcohol 136 with tert-butyl 
hydroperoxide using titanium tetraisopropoxide and (-)-diisopropyl tartrate 
(DIPT) as catalyst afforded the desired epoxide 137 accompanied by its C-2 
epimer (12:1 ratio as determined by 13C NMR spectroscopy). Epoxy alcohol 
137 underwent Swern oxidation77 to the corresponding aldehyde 138 in 
quantitative yield, and the aldehyde was further oxidized78 to carboxylic acid 
139.  The epoxy acid 139 without purification was treated with lithium 
aluminum hydride,49,79 resulting in selective reduction of the epoxide moiety to 
yield the a-hydroxy acid 140.  The latter was immediately converted to its 
methyl ester 141 in an overall yield of 45% based on 137.  Finally, silylation8O 35 
of the tertiary alcohol in 141 furnished the desired ether 142 in 82% yield 
(Scheme 21). 
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Cleavage of the alkene function of 142 and transformation to methyl 
ketone 145 was accomplished in three steps (Scheme 22). Thus, ozonolysis 
of 142, followed by reduction of the intermediate ozonide with dimethyl 
sulfide,81 afforded the aldehyde 143 in good yield.  Sequential treatment of 36 
143 with methylmagnesium bromide provided alcohol 144 as a mixture of two 
diastereomers. Without separation, these alcohols were oxidized under Swern 
conditions77 to give a single ketone 145 in quantitative yield. 
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Wadsworth-Emmons  olefination82 of keto ester 145 with triethyl 
phosphonoacetate produced a 5.6:1 mixture of (E)- and (Z)-socp-unsaturated 
esters, 146 and 147. When a mixture of the two isomers was exposed to tetra-
n-butylammonium fluoride (n-Bu4NF),83 the derived alkoxy anion underwent 
spontaneous cyclization to a mixture of tetrahydrofurandicarboxylic esters 148 
and 149 in a 1  : 4.5 ratio (Scheme 23). 
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The same ratio (1:4.5) of 148 and 149 was obtained by deprotection of 
pure (E)-isomer 146 with tetra-n-butylammonium fluoride83 followed by 
cyclization, thus proving that an equilibrium mixture of products had been 
reached (Scheme 24). 
EtO2C 
146 
n -Bu4NF  75% 
THF 
3 
l,, ,"  0  -"CO2Me  0  "CO2Me 
i 
EtO2C  EtO2C 
148  149 
1  :  4.5 
Scheme 24 
Stereoisomers 148 and 149 were separated by HPLC (250 X 4.6 mm 
silica column, 15:1  hexane-ethyl acetate, 3 mL /min), and the major 
stereoisomer 149 was shown to possess 2,5-trans configuration at the 38 
tetrahydrofuran by a nuclear Overhauser enhancement (nOe) experiment.  In 
this NMR experiment, Ha at C-4 was correlated with methyl protons at C-5, and 
Hp was correlated with methyl signals at C-2 and C-3 (Figure 2.1). 
1.94 ( Ha  4",, 
tO2Me 
EtO2C 
149 
Figure 2.1. Nuclear Overhauser Enhancement (nOe) Diagram of 149. 
The tetrahydrofuran 149 was presumed from the foregoing results to be 
the thermodynamically more stable product of cyclization of 146 and 147 
(Scheme 25).  When either the (E)- or (Z)-olefin is treated with tetra-n­
butylammonium fluoride, the resulting alkoxy anion 150 can in principle attack 
the conjugated double bond from either face to give both cyclic intermediates 
151 and 152.  However, under the reaction conditions, 151 and 152 must 
revert to alkoxy anion 150 in an equilibrium process, so that the major product 
from cyclization is the more stable tetrahydrofuran, i.e. 149. 39 
EtO2C 
+ Me3CMe2SiF 
EtO 
n -Bu4N F­
ess,( 0 ..--0O2Me  "CO2Me 
Et0  Et00 
151  152 
0  "CO2Me  0' tO2Me 
EtO2C  EtO2C
148  149 
Scheme 25 
The properties of synthetic (+)-25 obtained by saponification of 148, 
were in excellent agreement with those reported1 for the necic acid of (+)­
nemorensine, thus proving that nemorensic acid has 2R,3R,5S configuration. 
On the other hand, saponification of 149 afforded (+)-153 (5-epi-nemorensic 
acid) which exhibited spectroscopic properties clearly different from those 
recordedl for the hydrolysis product of (+)-nemorensine (Scheme 26). 0
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Finally, the structure of natural nemorensic acid was confirmed by a 
single crystal X-ray analysis of its parent alkaloid nemorensine (Figure 2.2) 
Figure 2.2. ORTEP Diagram from X-ray Crystallographic Analysis of 
(+)-Nemorensine (1). 42 
This determination conclusively established the structure of nemorensine 
as 1, in which the necic acid portion is shown to possess (2R,3R,5S) absolute 
configuration by virtue of its stereochemical relationship to the pyrrolizidine 
segment (-)-platynecine present as the necine base in the alkaloid.  The 
absolute configuration of (-)-platynecine (156) has previously been assigned 
on the basis of chemical studies84 as well as an enantioselective synthesis of 
this pyrrolizidine (156).85 
(+)-Nemorensine (1)  (-)-Platynecine (156) 
A comparison of the spectral properties of (+)-25 and (+)-153 with those 
reported for the necic acid derived from retroisosenine (18) indicates that 
neither of these substances corresponds to the necic acid of that alkaloid 
(18).60 Whether retroisosenine is a yet unidentified stereochemical variant 
based on 18 remains to be determined. 
In conclusion, the first asymmetric synthesis of (+)-nemorensic acid (25) 
which was accomplished during this research proved that the original 
stereochemical assignments made to nemorensine as 17 or 23 and to 
retroisosenine as 18 were incorrect.  The necic acid constituent of the 
pyrrolizidine alkaloid (+)-nemorensine  is now shown to possess the 
stereochemistry of (+)-25.  Furthermore, X-ray crystallographic analysis of 43 
nemorensine together with this synthetic work has established that the complete 
stereostructure of the natural alkaloid is correctly represented by 1. 44 
CHAPTER III 
ASYMMETRIC SYNTHESIS OF 2-epi-SWAZINECIC ACID
 
AND AN APPROACH TOWARDS
 
THE ASYMMETRIC SYNTHESIS OF SWAZINECIC ACID
 
Swazinecic acid (50), the constituent acid of the dilactone pyrrolizidine 
alkaloid swazine (2), presents a demanding test of the general strategy 
developed in these laboratories for the synthesis of necic acids, from a readily 
available monoterpene in the chiral pool.  Our approach, which employs (S)­
citronellal as the starting material, hinges upon oxidative truncation of an 
elaborated monoterpenoid system to generate a dicarboxylic acid having the 
requisite functionality and configuration of the necic acid.  The absolute 
configuration assigned to (-)-swazine (2) dictates that our point of departure 
towards 50 should be (S)-(-)-citronellal (157), the enantiomer of the starting 
material used for synthesis of nemorensic acid. Since our planned route to 50 
involved early introduction of a relatively sensitive epoxide, it was essential that 
later steps in the sequence avoid reagents which could destroy this function. 
0 
HO2C 
(-)-Swazine (2)  Swazinecic acid (50) 45 
Following the procedure employed in the enantiomeric series for 
asymmetric synthesis of (+)-nemorensic acid (25),67 a-methylenation73 of (S)­
(-)-citronellal (157) gave a,I3- unsaturated aldehyde 158. This was submitted to 
a Luche reduction74 with sodium borohydride and cerium trichloride to afford 
the allylic alcohol 159. The more electron-rich trisubstituted olefin in diene 159 
underwent selective methoxyselenylation using a modification of Toshimitsu's 
conditions,75 and after oxidation of the intermediate alkylselenide with 
hydrogen peroxide and in situ elimination of the selenoxide diene 160 was 
obtained.  Sharp less epoxidation76 of allylic alcohol 160 using (S,S)-(+)­
diisopropyl tartrate (DIPT) gave the desired epoxy alcohol 161 as the major 
stereoisomer accompanied by the C-2 epi epoxide.  The ratio of these 
stereoisomers was 13:1 as measured by 13C NMR spectroscopy (Scheme 
28). 
LDA, Me2N =CH2 I; 
Mel, Me0H;  CHO
 
NaHCO3, CH2Cl2
157  158 
94% 
NaBH4, Me0H,  PhSeCI, NaHCO3, Me0H; 
CeCI3.7H20  H202, NaHCO3, THE 
OH 
93%  84% 
159 
Ti(0-i-Pr)4, (+)-DIPT
 
MeO  MeO
 t- BuOOH, CH2Cl2 
OH 
87% 
160  161 
Scheme 28 46 
The primary alcohol 161 was oxidized to aldehyde 162 under Swern 
conditions,77 and 162 was reacted with methylmagnesium bromide at low 
temperature to afford alcohol 163 as a mixture of two diastereomers. The 
mixture was converted to ketone 164 as a single isomer upon oxidation with 
Dess-Martin periodinane86 (Scheme 29). 
(C00O2, WS() 
Et3N, CH2C12 
OH 
95% 
161 
Ac0 O 
, (M 0Ac 
MeMgBr, THE  so 
-78 °C to rt.  0 
79%  CH2Cl2 
MeO 
Scheme 29 
It was presumed that chelation-controlled Grignard addition to ketone 
164 would be directed by the epoxide and would therefore occur selectively at 
the si face of the carbonyl group to give (S) alcohol 165. In fact, when 164 was 
treated carefully with vinylmagnesium bromide at low temperature, a single 
alcohol was obtained in high yield (Scheme 30).  However the configuration 
of the tertiary alcohol in this product was subsequently found to be (R), the result 
of re face attack of Grignard reagent on ketone 164.  It is believed that chelation 47 
between the epoxide oxygen, ketone and vinylmagnesium bromide occurs as 
shown in 166, so that intramolecular delivery of the vinyl group to the carbonyl 
carbon takes place preferentially from the re face rather than the si face as had 
been expected.  The configuration of the tertiary alcohol in 167 was 
conclusively proved by X-ray crystallographic analysis of a later compound in 
this sequence. 
Si 
CH2=CHMgBr 
THF, -78 °C 
X 
CH2=CHMgBr 
THF, -78 °C 
84% (from 163) 
1 
MeO  OH ./ 
0= 
165 
1 
Scheme 30 
The tertiary alcohol 167 was protected as its tert-butyldimethylsilyl ether 
168,80 and an attempt was then made to cleave both olefins simultaneously to 48 
yield a dicarboxylic acid. Conventional ozonolysis, using an oxidative work-up, 
failed to produce a useful product from 168. On the other hand, ozonolytic 
cleavage of 168 as described by Schreiber87 gave the aldehyde ester 169 in 
excellent yield (Scheme 31).  This convenient protocol not only differentiated 
the termini of 169 by oxidation level, but did so in a highly selective manner. 
2,6-lutidine,
,OH MeO  TBSOTf, CH2Cl2 
84% 
03, NaHCO3, 
Me0H/CH2C12 (1:5); 
Me02C
 
Ac20, Et3N, DMAP
 
70%
 
Scheme 31 
Unfortunately, the inherent instability of 169 resulting from its propensity 
for intramolecular aldol condensation demanded immediate reduction of this 
aldehyde to its corresponding alcohol or oxidation to a carboxylic acid. 
Selective reduction of the aldehyde in 169 with sodium cyanoborohydride88 
was accomplished in high yield, and the resulting primary alcohol 170 was 
protected as its tert-butyldimethylsilyl (TBS) ether 17180 (Scheme 32). 
However, attempted  a-methylenation of ester 171 with Eschenmoser's salt 
was unsuccessful, and only the starting material 171 was recovered. 49 
Me02C 
,OTBS 
CHO 
NaBH3CN, THE  Me0 C 
OTBS O 
2 6-lutidine, 
OH TBSOTf, CH2Cl2 
90%  82% 
169  170 
,OTBS  LDA, Me2N=CH2
Me02C  OTBS  Me02C 
X
0=  Mel, Me0H; 
171  NaHCO3, CH2Cl2 
Scheme 32 
In an alternative route from 169 the aldehyde was oxidized to a 
carboxylic acid78 which was then treated with diazomethane to produce 
dimethyl ester 172 (Scheme 33). 
1) NaCIO2, t-BuOH, 
Me02C 
OTBS 
CHO 
(CH3)2C=CHCH3 
Me02C 
0=  2) CH2N2, Et20 
169  82% (from 168)  172 
Scheme 33 
Unexpectedly, the silyl ether of 169 was cleaved in the course of its 
oxidation to carboxylic acid with sodium chlorite.  It is likely that nucleophilic 
addition of chlorite ion to the carbonyl carbon in 169 produced an a-alkoxy 
anion 173, which then underwent a 1,2 -silyl shift to give 174. The oxygen-
chlorine bond would be broken in a radical process to give the silyl ester 175, 
which would be hydrolyzed to a-hydroxy acid 176 (Scheme 34). 50 
Me3C(Me2)Si
 
Me02C
 
es  0 
Me02C  H 
173 
CI 
O
 
,OH  0TBS 
Me02C  OTBS  Me02C 
0 
175  + HCIO  (CI 174  '0' 0 
1  H2O 
176 
Scheme 34 
Although the protecting group was easily replaced in 172, attempts to 
introduce an a-methylene function into this acyclic diester were again foiled by 
an intramolecular reaction of the ester enolate, in this case a facile Dieckmann 
condensation to a cyclopentenone. Reasoning that an exo methylene group 
might be more easily incorporated into a 5-lactone derived from 172, the latter 
was subjected to careful saponification with the result that the more exposed 
ester was cleaved with very high selectivity. The resultant 6-hydroxy acid 177 
was easily converted to lactone 178 using Mukaiyama's reagent89 (Scheme 
35). 9 Z`
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Mel, Me0H; 
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Do­
0 
CO2Me 
0  ''',, 
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Scheme 36 
It  is known that certain ketones such as cyclohexanone are rather 
unreactive toward Eschenmoser's reagent under conventional conditions.73 
The same situation obtains with 178, and therefore a more reactive reagent 
than Eschenmoser's salt is clearly required in order to introduce the exo 
methylene group into the 8-lactone.  In fact, formaldehyde is just such a reagent, 
and it was found that treatment of 178 with base and then with gaseous 
formaldehyde afforded the unstable 0-hydroxy lactone 179 in good yield. 
Exposure of 179 to methanesulfonyl chloride led directly to exo methylene 6­
lactone 180 in excellent yield (Scheme 37).91 
LDA, THF, -78 °C; 
CH2O, -35 °C  HO 
68%  0  --. 
CO2Me 
179  _ 
180 
Scheme 37 53 
Lactone 180 crystallized from diethyl ether-chloroform as well formed 
needles which proved to be suitable for X-ray crystallographic analysis (Figure 
3.1). The X-ray crystal structure fully confirmed the relative configuration of this 
lactone and thus proved that the tertiary alcohol resulting from vinylmagnesium 
bromide addition to ketone 164 has the stereochemistry shown in 167. 
Figure 3.1. ORTEP Diagram from X-ray Crystallographic Analysis of 180. 54 
Basic hydrolysis of 180 gave the unstable 2-epi-swazinecic acid (181) 
which was isolated and characterized as its dimethyl ester (-)-182 after 
exposure to diazomethane (Scheme 38). 
- _ 
0  KOH, Me0H/H20  OH 
0 °C, 80 min  HO2C 
0 
......0O2Me 
0  0 
CO2H 
180  2-epi-Swazinecic acid (181) 
CH2N2, Et20  Me02C 
37% (2 steps) 
182 
Scheme 38 
It is known from X-ray crystallographic analysis of its p-bromobenzoate 
that the spirodilactone 51 derived from natural (-)-swazine (2) upon treatment 
with hot sulfuric acid has the S configuration at the Spiro center. This implies 
retention of configuration in the opening of the epoxide.2  It was assumed that 
when dimethyl ester 182 was treated under the same reaction conditions as 2, 
spirodilactone 183 with the same S configuration at the spiro center as 51 
would result (Scheme 39). 55 
H2SO4 (3N), THF,  0_..\OH 
reflux, 24 h 
-..0  0 OiS 
(-)-Swazine (2)  51 
H2SO4 (3N), THF,
 
Me02C  reflux, 24 h
 
182  183 
Scheme 39 
Surprisingly, when 182 was exposed to refluxing sulfuric acid, the 
epoxide was opened with inversion of configuration, producing the crystalline 
spirodilactone 184 with R configuration at the Spiro center (Scheme 40). The 
stereochemistry of 184 was fully confirmed by an X-ray crystallographic 
analysis (Figure 3.2). 
H2SO4 (3N), THF, 
Me02C  reflux, 24 h 
43% 
182  184 
Scheme 40 56 
Figure 3.2. ORTEP Diagram from X-ray Crystallographic Analysis of 184. 57 
An explanation for the divergent behavior of swazinecic acid derived 
from acidic hydrolysis of the parent alkaloid and 2-epi-swazinecic acid derived 
from 182 probably lies in the nature of the ester groups. First, it is clear that the 
two spirodilactones 51 and 184 are the result of different reaction pathways 
rather than some fortuitous event which scrambles the epoxide configuration in 
route to the spirodilactones.  It is known that the primary ester linkage (at C-9) of 
pyrrolizidine alkaloids is normally the most susceptible to hydrolysis, especially 
if  it  is an allylic ester as in unsaturated pyrrolizidine alkaloids such  as 
swazine.3,6  In the case of swazine (2), the liberated carboxylic acid is able to 
attack the protonated epoxide at the less substituted terminus with consequent 
retention of configuration at the tertiary center and formation of a five-membered 
lactone. The liberated tertiary alcohol then reacts with the remaining ester 
carbonyl function to form spirodilactone 51 (Scheme 41). 
OH 0  H2SO4 (3N), THF, 
reflux, 24 h 
51 
(-)-Swazine (2) 
H+ 
H2O  ,SOH 
O r 0 
Scheme 41 58 
The ester functions of 182, on the other hand, are more resistant to 
acidic hydrolysis and a different reaction pathway to the spirodilactone 
intervenes.  If the epoxide is first protonated, Markownikoff addition by water to 
the epoxide results in inversion of the tertiary center and leads to diol 
intermediate 185.92 The spirodilactone 184 would then be formed by a 
double cyclization of the diol diesters (Scheme 42). 
H2SO4 (3N), THF, Me02C
 
reflux, 24 h
 
43%
 182  184 
H 
i 
OH 
Me02C Me02C  CO2Me 
..±1 
HO) 
185 
Scheme 42 
The configuration of the tertiary alcohol in 181 is epimeric with that of 
swazinecic acid (50).  In principle, a straightforward modification of the route to 
181 could reverse the configuration at C-2 and thus could lead to a synthesis of 
swazinecic acid (50). The tertiary C-2 stereocenter of 181 was generated in 
the chelation-controlled addition of vinylmagnesium bromide to methyl ketone 
(164), and it seemed plausible that the configuration of this stereocenter could 59 
be inverted by simply reversing the sequence of methyl and vinyl Grignard 
additions. 
HO2C  HO2C 
2-epi-Swazinecic acid
Swazinecic acid (50)  (181) 
The revised route towards swazinecic acid now required an initial 
Grignard reaction of aldehyde 162 with vinylmagnesium bromide. This gave 
allylic alcohol 186, which was oxidized to a,(3- unsaturated ketone 187 with 
Dess-Martin periodinane (Scheme 43).86 
CH2=CHMgBr 
THF, -78 °C 
72% 
CH2Cl2 
187 
100% 
Scheme 43 
The second Grignard reaction, a chelation-controlled addition of 
methylmagnesium bromide to the ketone 187 was expected to occur selectively 60 
at the re face of the carbonyl group as a result of the directing effect of the 
epoxide previously seen with Grignard addition to 164. However, this reaction 
was complicated by competition between  1,2- and  1,4-addition  of 
methylmagnesium bromide to 187.  It was found that this problem could be 
overcome by slow addition of a dilute solution of the Grignard reagent to 187 at 
low temperature, a protocol which led to the desired kinetically-controlled 1,2­
adduct 189 as the major product. The minor quantity of 1,4-addition product 
(188) formed in this reaction could be easily removed by flash chromatography 
(Scheme 44). 
+ 
MeMgBr, 
MeO THF, -78 °C 
0=  0­
187 
188 (6%) 
+ 
Scheme 44 
The alcohol 189 was converted to dimethyl ester 192 by the same 
reaction sequence used with 167. Thus, 189 was first protected as its tert­
butyldimethylsilyl ether 190 which was subjected to ozonolytic cleavage  as 61 
described by Schreiber.87 This gave the expected aldehyde ester 191, which 
was oxidized directly to the corresponding carboxylic acid. As before, the silyl 
ether was cleaved from 191 in the course of its oxidation with sodium chlorite. 
The resulting a-hydroxy carboxylic acid was immediately esterified with 
diazomethane to afford dimethyl ester 192 (Scheme 45). 
TBSOTf, 2,6-lutidine 
OH  OTBS MeO  MeO CH2Cl2, -35 °C 
76% 
1) NaCIO2, NaH2PO4, H2O,
03, Me0H-0H2012 (1:5);  (CH3)2C=CHCH3, t -BuOH; OTBS Ac20, Et3N, CH2Cl2;  Me02C  2) CH2N2, Et20
CHO 
65% (from 190) 
Me02C 
Scheme 45 
It was expected that selective hydrolysis of the more exposed ester 
function of 192 could be accomplished by the same protocol used for selective 
saponification of its C-2 epimer 172. However, all attempts at monohydrolysis 
of 192 resulted in immediate cleavage of both methyl esters (Scheme 46). 
Apparently, the steric hindrance due to the adjacent tertiary center in 172 which 
prevents saponification of the a-hydroxy ester is absent in the (R) stereoisomer 62 
192, resulting in relatively little difference in reactivity between the two ester 
groups towards basic reagents. 
KOH (0.5 M) 
Me0H/H20 (1:1) Me02C  HO2C 
193 192 
NaOH (0.5 M) 
Me0H/H20 (1:1) Me02C  HO2C 
192 
NaOH (0.05 M)
 
Me0H/H20 (1:1)
 Me02C 
193 192 
LiOH (0.05 M) 
Me0H/H20 (1:1)  HO2C 
192 
Scheme 46 
The failure to effect selective hydrolysis of dimethyl ester 192 required 
that differentiation of the ester termini be accomplished by some other means. 
Since a benzyl ester can be cleaved by hydrogenolysis under conditions which 
leave a methyl ester intact, a solution to this problem was available in principle 
through a mixed diester such as 202. The accepted mechanism of ozonolysis 63 
as carried out under Schreiber's conditions suggests that if benzyl alcohol is 
present during the reaction with 190, it should produce a benzyl ester at the 
more exposed cleavage site. 
The mechanism of ozonolysis of an unsymmetrical alkene is shown in 
Scheme 47. Ozone initially attacks the alkene 194 to form a five-membered 
(primary) ozonide 195. Due to the differing inductive effects of its substituents, 
cleavage of this ozonide occurs in a highly regioselective fashion to give a 
ketone 196 derived from the olefinic carbon bearing the stronger electron-
withdrawing group (CH2OR2), and a zwitterionic carbonyl oxide 197 arising 
from the carbon to which is bonded the more electron-donating group (R1) 
Nucleophilic attack on 197 by an alcohol yields an alkoxy hydroperoxide 198, 
which in the Schreiber modification is acetylated with acetic anhydride to 
produce 199. Base mediated elimination from 199 furnishes an ester 200.81 
/
R1  (0
03  0- ,-0 H
H,p,,,,,  0  +  0-0 Ri R20--7  H R20
R20-- H 194  196  197 195 
+  Ri  R1  Ac20 -0--0  HO-0-- Ac0-0  ,..  R1CO2R 
k--)  ORri  200 198 OR  199 197  ROH ROH 
Et3N 
Scheme 47
 
In accord with expectations based on this mechanism, ozonolysis of 
diene 190 in the presence of benzyl alcohol gave an intermediate benzyloxyl 64 
hydroperoxide, which upon treatment with acetic anhydride and triethylamine 
provided benzyl ester 201.  Without purification, the aldehyde 201 was 
oxidized to the corresponding carboxylic acid with sodium chlorite, and the acid 
was converted to its methyl ester 202. Hydrogenolysis of the benzyl ester was 
accomplished with 10% palladium on activated carbon under an hydrogen 
atmosphere and cleanly produced the monocarboxylic acid 203.93 The latter 
was lactonized under Mukaiyama's conditions89 to afford 8-lactone 204 in 
excellent overall yield from 202 (Scheme 48). 
Me0  OTBS 
03, BnOH- CH2Cl2; 
Ac20, Et3N, CH2Cl2  BnO2C 
OTBS 
CHO 
0 
201 
1) NaCI02, NaH2PO4, H2O, 
(CH3)2C=CHCH3, t-BuOH;  H2, 10% Pd/C, 
2) CH2N2, Et20  BnO2C  Me0H 
47% (from 190) 
202 
0 - N  CI 
HO2C  Me 
DMAP, CH3CN  CO2Me 
99% 203  204 
Scheme 48 
Thus far, lactone 204 has resisted all attempts at a-methylenation with 
Eschenmoser's reagent, and a synthesis of swazinecic acid has yet to be 
completed. Future work will focus on conversion of 204 to f3-hydroxy lactone 
205 by treatment of the enolate of 205 with gaseous formaldehyde (Scheme 65 
49).  Exposure of 205 to methanesulfonyl chloride and base should lead 
directly to exo methylene lactone 206 which should undergo basic hydrolysis to 
provide swazinecic acid (50).  The latter would first be characterized as its 
dimethyl ester 207 and then converted with hot sulfuric acid to a spirodilactone. 
Following the precedent established with 184, this spirodilactone should 
possess the structure 208. 
0	  LDA, THF, -78 °C;  MsCI, Et3N, 
CH20, -35 °C  CH2Cl2, 0 °C HO 
OHO/tr.° co2me 
204 
0 
KOH, Me0H/H20  HO2C 
OH 
CH2N2, Et20 
CO2H 
0  0  'CO2Me 
206  50 
3N H2SO4,  OH 
reflux 
0 0 
207  208 
Scheme 49 
Although this route to swazinecic acid remains unfinished,  it was 
possible to confirm the structure including absolute configuration of this necic 
acid independently.  An X-ray crystallographic analysis of natural swazine 
conclusively established its structure as 2 (Figure 3.3). The known absolute 66 
configuration85,94 of the necine portion (retronecine) of 2 mandates that 
swazinecic acid possesses 2R,3S,4S configuration. 
Figure 3.3. ORTEP Diagram from X-ray Crystallographic Analysis of 
(-)-Swazine (2). 
0 67 
In conclusion, this work accomplished the first asymmetric synthesis of 2­
epi-swazinecic acid (181) and significantly extended a general strategy for 
necic acid synthesis based on the monoterpene citronellal.  Although the 
configuration of the tertiary alcohol at C-2 of 181 is epimeric with that of natural 
swazinecic acid (50), it was shown that this center can be inverted by simply 
reversing the sequence of Grignard reactions with methyl and vinylmagnesium 
bromide. The different configuration at the Spiro center of 51 and 184 arising 
from acidic hydrolysis of the parent alkaloid (-)-swazine (2) and the dimethyl 
ester 182 is explained by different reaction mechanisms in each case.  Finally, 
an X-ray crystallographic analysis of natural swazine confirmed that its structure 
is correctly represented as 2. 68 
CHAPTER VI
 
EXPERIMENTAL SECTION
 
Starting materials and reagents were obtained from commercial sources 
and were used without further purification.  Solvents were dried by distillation 
from the appropriate drying agents immediately prior to use. Tetrahydrofuran 
and ether were distilled from sodium and benzophenone under an argon 
atmosphere. Diisopropylamine, triethylamine, acetonitrile and dichloromethane 
were distilled from calcium hydride under argon.  All solvents used for routine 
isolation of products and chromatography were reagent grade. Moisture and air 
sensitive reactions were carried out under an atmosphere of argon.  Reaction 
flasks were flame dried under a stream of argon gas, and glass syringes were 
oven dried at 120 °C and cooled in a desicator over anhydrous calcium sulfate 
prior to use. 
Unless otherwise stated, concentration under reduced pressure (or in 
vacuo) refers to a rotary evaporator at water aspirator pressure. 
Analytical thin layer chromatography (TLC) was performed using 
precoated aluminum E. Merck TLC plates (0.2 mm layer thickness of silica gel 60 
F-254). Compounds were visualized by ultraviolet light, and/or by heating the 
plate after dipping in a 1% solution of vanillin in 0.1M sulfuric acid in methanol or 
1°/0 solution of potassium permanganate in 2% 1N sodium hydroxide in water. 
Flash chromatography was carried out using E. Merck silica gel 60 (230-400 
mesh ASTM). Radial chromatography was carried out on individually prepared 
rotors with layer thicknesses of  1,  2, or 4 mm using a Chromatotron 
manufactured by Harrison Research, Palo Alto, California. 69 
Melting points were measured using a Buchi melting point apparatus, and 
are uncorrected. Infrared (IR) spectra were recorded with a Nicolet 5DXB FT-IR 
spectrometer. Proton and carbon nuclear magnetic resonance (NMR) spectra 
were obtained using either a Bruker AC-300 or a Bruker AM-400 spectrometer. 
All chemical shifts are reported in parts per million (ppm) downfield from 
tetramethylsilane using the 8 scale. 1H NMR spectral data are reported in the 
order: chemical shift, number of protons, multiplicity (s=singlet, d=doublet, 
t=triplet, q=quartet, m=multiplet and b=broad), and coupling constant (J) in Hertz 
(Hz). 
Chemical ionization (CI) high and low resolution mass spectroscopy 
(HRMS and MS) were obtained using a Kratos MS-50 spectrometer with a 
source temperature of 120 °C and methane gas as the ionizing source. 
Perfluorokerosene was used as a reference. Electron impact (El) mass spectra 
(HRMS and MS) were obtained using a Varian MAT311 or a Finnegan 4000 
spectrometer.  X-ray crystallographic data were collected on a Siemens P4 
spectrometer and these data were interpreted using the direct methods program 
contained in the SHELXTL (Silicon Graphics/Unix) software package. Elemental 
analyses were performed by Desert Analytics, Tucson, Arizona. 70 
CHO 
a,13-Unsaturated  Aldehyde  133.  To a stirred solution of 
diisopropylamine (3.60 mL, 25.6 mmol) in 15 mL of tetrahydrofuran at -78 °C 
was added n-butyllithium (16.1 mL, 24.5 mmol). After being stirred at 0 °C for 
15 min, the reaction mixture was cooled to -78 °C and a solution of (R)-(+)­
citronella! (102) (3.44 g, 22.3 mmol) in 15 mL of tetrahydrofuran was added 
dropwise over 45 min via cannula. The mixture was stirred at -78 °C for 1 h and 
was then added to a suspension of Eschenmoser's salt (11.6 g, 63.0 mmol) in 
30 mL of tetrahydrofuran at -78 °C.  After being stirred at -78 °C for 1  h, the 
suspension was allowed to warm to room temperature and was stirred at that 
temperature for 5 h. The solvent was removed and a solution of iodomethane 
(4.2 mL, 67.0 mmol) in 15 mL of methanol was added. After being stirred at 4 
°C for 12 h, the reaction mixture was allowed to warm to room temperature and 
was stirred at that temperature for 5 h. The methanol was removed in vacuo 
and 42 mL of 5% aqueous sodium bicarbonate and 50 mL of dichloromethane 
was added and the mixture was stirred at room temperature for 16 h.  The 
aqueous layer was separated and was extracted with dichloromethane (5 x 50 
mL).  The combined organic layers were washed with brine, dried over 
anhydrous magnesium sulfate, filtered and concentrated  in vacuo.  The residue 
was purified by chromatography on silica gel (5% ethyl acetate in hexanes as 
eluent) to give 3.49 g (94%) of 133: [a]p3 -9.4° (c 20.15, CHCI3); IR (neat) 2950, 
1690, 1440 cm-1; 1H NMR (CDCI3, 400 MHz) 8 1.07 (3H, d, J = 7 Hz), 1.40 (1H, 
m), 1.54 (1H, m), 1.57 (3H, s), 1.67 (3H, s), 1.93 (2H, m), 2.71 (1H, m), 5.08 (1H, 
m), 5.99 (1H, s), 6.23 (1H, s), 9.53 (1H, s); 13C NMR (CDCI3, 100 MHz) 6 17.6, 
19.6, 25.7, 25.8, 31.0, 35.6, 124.2, 131.6, 133.0, 155.5, 194.6; Anal. calcd. for 
Cii Hi 80; C, 79.46; H, 10.91. Found: C, 79.11; H, 10.72. 71 
OH 
(3R)-2-(Hydroxymethyl)-3,7-dimethylocta-1,6-diene  (134). To 
a stirred solution of 133 (3.44 g, 20.7 mmol) and cerium(III) chloride 
heptahydrate (7.73g, 20.7 mmol) in 50 mL of methanol at 0 °C was added 
portionwise sodium borohydride (1.02 g, 27.0 mmol). The reaction mixture was 
stirred for 15 min and was quenched with 50 mL of saturated aqueous 
ammonium chloride. After removal of methanol in vacuo, 150 mL of water was 
added and was extracted with ethyl acetate (5 x 100 mL).  The combined 
extracts were washed with brine, dried over anhydrous magnesium sulfate, 
filtered  and concentrated  in  vacuo.  The residue was purified by 
chromatography on silica gel (10% ethyl acetate in hexanes as eluent) to afford 
3.23 g (93%) of alcohol 134: [a]o3 -18.7° (c 3.66, CHCI3); IR (neat) 3300 
(broad), 2900 cm-1; 1H NMR (CDCI3, 400 MHz) 8 1.06 (3H, d, J = 7 Hz), 1.37 
(1H, m), 1.48 (2H, m), 1.59 (3H, s), 1.68 (3H, d, J = 1 Hz), 1.96 (2H, m), 2.16 (1H, 
m), 4.10 (2H, s, br), 4.89 (1H, s), 5.05 (1H, d, J = 1 Hz), 5.09 (1H, m); 13C NMR 
(CDCI3, 100 MHz) 8 17.7, 20.1, 25.7, 25.9, 35.8, 36.6, 64.5, 107.9, 124.5, 131.5, 
153.9; HRMS calcd. for Ci 1 H200 m/z 168.1514.  Found:168.1511.  This 
compound was converted to its 4-phenylbenzoate. Anal. calcd. for C241-12802: 
C, 82.71; H, 8.11. Found: C, 82.49; H, 8.25. 
OH 
SePh 
(3R)-2-(Hydroxymethyl)-3,7-dimethy1-7-methoxy-6-phenyl­
seleny1-1-octene (135). To a stirred solution of 134 (995.4 mg, 5.93 mmol) 
and sodium bicarbonate (2.84 g, 33.8 mmol) in 30 mL of methanol was added 72 
dropwise a solution of phenylselenenyl chloride (2.74 g, 14.2 mmol) in 30 mL of 
methanol via cannula. The reaction mixture was stirred at room temperature for 
2 h and the methanol was removed in vacuo. The resultant suspension was 
filtered through a small pad of silica gel which was eluted with diethyl ether. 
The combined filtrates were evaporated, and the residue was purified by 
chromatography on silica gel (25% ethyl acetate in hexanes as eluent) to 
provide 2.08 g (99%) of 135 as a diastereomeric mixture: IR (neat) 3396 
(broad), 3070, 2971, 1649, 1576, 1072 cm-1; 1H NMR (CDCI3, 400 MHz) 8 
1.02-1.04 (3H, m), 1.24-1.45 (8H, m), 1.76-2.15 (4H, m), 3.04-3.08 (1H, m), 3.14 
(3H, s), 4.03 (2H, s, br), 4.85 (1H, d, J = 7 Hz), 5.02-5.04 (1H, m), 7.21-7.26 (3H, 
m), 7.56-7.59 (2H, m); 13C NMR (CDCI3, 100 MHz) 8 14.0, 19.7, 20.7, 22.6, 
22.8, 23.9, 24.0, 28.8, 34.5, 34.7, 36.5, 36.8, 49.3, 49.4, 57.7, 57.8, 64.3, 78.4, 
108.0, 108.4, 126.9, 127.0, 128.9, 131.8, 133.8, 133.9; HRMS calcd. for 
C181-12802Se m/z 354.1262. Found: m/z 354.1261. 
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(3R)-2-(Hydroxymethyl)-3,7-dimethy1-7-methoxyocta-1,5­
diene (136). To a stirred solution of 135 (2.10 g, 5.94 mmol) and sodium 
bicarbonate (19.5 g, 0.232 mol) in 59 mL of tetrahydrofuran and 59 mL of water 
was added 59 mL of 30% aqueous hydrogen peroxide solution. The mixture 
was stirred at room temperature for 30 min and 80 mL of water was added. The 
mixture was extracted with diethyl ether (6 x 100 mL) and the combined organic 
layers were washed with brine, dried over anhydrous magnesium sulfate, 
filtered  and concentrated  in  vacuo.  The residue was purified by 
chromatography on silica gel (25% ethyl acetate in hexanes as eluent) to yield 73 
1.21 g (98%) of 136: [a]p3 -12.2° (c 3.66, CHCI3); IR (neat) 3417, 3248, 2978, 
1649, 1076 cm-1; 1H NMR (CDCI3, 400 MHz) 8 1.00 (3H, d, J . 7 Hz), 1.19 (6H, 
s), 2.00-2.24 (3H, m), 2.45 (1H, s, br), 3.08 (3H, s), 4.04 (2H, s), 4.82 (1H, s), 
5.02 (1H, s), 5.32-5.44 (2H, m); 13C NMR (CDCI3, 100 MHz) 6 19.3, 25.7, 36.5, 
38.5, 50.1, 64.6, 74.9, 108.2, 128.3, 136.6, 153.1; HRMS calcd. for C12H2202 
m/z 199.1698. Found: m/z 199.1698. 
Me0 
OH 
0 
(2R,3R)-3,7-Dimethy1-7-methoxy-2-oxirany1-5-octenol  (137). 
To a stirred suspension of 3A molecular sieves in 25 mL of dichioromethane at 
-15 °C was added titanium(IV) isopropoxide (2.49 mL, 8.35 mmol) and 
diisopropyl (-)-tartrate (1.77 mL, 8.35 mmol). The reaction mixture was stirred 
for 15 min at -15 °C.  tert-Butyl hydroperoxide (2.23 mL, 11.1 mmol) was added 
and stirring was continued for 30 min. To this mixture was added a solution of 
136 (1.10 g, 5.57 mmol) in 25 mL of dichloromethane via cannula. The mixture 
was allowed to stir for an additional 15 min at -15 °C and the reaction flask was 
placed in a -35 °C freezer for 20 h.  After addition of 16 mL of 10% aqueous 
tartaric acid, the reaction mixture was stirred at -15 °C for 30 min, allowed to 
warm to room temperature, and stirred for 1  h, during which time an additional 
50 mL of dichloromethane was added. The organic layer was separated and 
the aqueous layer was extracted with dichloromethane (2 x 50 mL).  The 
organic extracts were combined and the solvent was removed in vacuo. The 
residue was stirred with 16 mL of 1N aqueous sodium hydroxide in 50 mL of 
diethyl ether at 0 °C for 30 min. Organic phase was separated and the aqueous 
phase was washed once with 20 mL of dichioromethane.  The combined 74 
organic phases were dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo. The residue was purified by chromatography on silica 
gel (40% ethyl acetate in hexanes as eluent) to produce 1.02 g (86%) of 137 as 
12:1 mixture of oxiranes: [a]p3 +9.5° (c 2.19, CHCI3); IR (neat) 3416, 2978, 
2882, 1668 cm-1; 1H NMR (CDCI3, 400 MHz) 6 1.00 (3H, d, J = 7.9 Hz), 1.22 
(6H, s), 1.63-1.70 (1H, m), 1.82-2.02 (2H, m), 2.16-2.25 (1H, m), 2.61 (1H, d, J. 
4.7 Hz), 2.88 (1H, d, J = 4.7 Hz), 3.11 (3H, s), 3.66 (1H, dd, J = 12.3, 8.8 Hz), 
3.82 (1H, dd, J. 12.3, 3.7 Hz), 5.38-5.53 (1H, m); 13C NMR (CDCI3, 100 MHz) 
5 15.9, 25.8, 35.2, 36.5, 49.4, 50.1, 60.2, 62.0, 74.6, 127.7, 137.3; HRMS calcd. 
for C12H2203 m/z 213.1490. Found: m/z 213.1490. 
H 
(2R,3R)-3,7-Dimethy1-7-methoxy-2-oxirany1-5-octenal  (138). 
To a stirred solution of oxalyl chloride (624 !IL, 7.14 mmol) in 25 mL of 
dichloromethane at -78 °C was added dimethyl sulfoxide (1.0 mL, 14.3 mmol). 
The reaction mixture was stirred for 10 min and a solution of 137 (764 mg, 3.57 
mmol) in 20 mL of dichloromethane was added via cannula. An additional 5 mL 
of dichloromethane was used to ensure that all the alcohol was transferred to 
the reaction flask. The mixture was stirred for 10 min, triethylamine (3.0 mL, 
21.4 mmol) was added and stirring was continued for 1 h. The reaction mixture 
was diluted with 70 mL of diethyl ether and the solution was filtered through a 
small pad of silica gel.  The filtrate was concentrated, and the residue was 
purified by chromatography on silica gel (17% ethyl acetate in hexanes as 
eluent) to give 757 mg (100%) of 138: [4;3 -9.0° (c 2.18, CHCI3); IR (neat) 
3525, 2979, 1734, 1253, 1173, 1077 cm-1; 1H NMR (CDCI3, 400 MHz) 8 0.93 75 
(3H, d, J = 7 Hz), 1.23 (6H, s), 1.36 (3H, s), 1.80-2.06 (3H, m), 3.02 (1H, s), 3.13 
(3H, s), 3.79 (3H, s), 5.37-5.51 (2H, m); 13C NMR (CDCI3, 100 MHz) 8 2.30, 
12.6, 14.1, 23.6, 25.7, 25.9, 33.1, 34.9, 40.9, 50.2, 52.7, 74.7, 128.3, 137.3, 
188.9; HRMS calcd. for C1 2H2003 (M  Me0H)± m/z 212.1412. Found: m/z 
212.1412. Anal. Calcd. for C13H2404: C, 63.91; H, 9.90. Found: C, 64.01; H, 
10.00. 
0 Me0 
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Methyl Ester 141. To a stirred solution of 138 (757 mg, 3.57 mmol) 
and 2- methyl -2- butene (18 mL) in 70 mL of tert-butanol at 0 °C was added 
dropwise a solution of sodium chlorite (2.95 g, 32.6 mmol) and sodium 
phosphate monobasic monohydrate (3.00 g, 21.7 mmol) in 45 mL of water. The 
reaction mixture was stirred for 10 min and was diluted with 100 mL of water. 
The aqueous layer was separated and was acidified to pH 3 with 10% aqueous 
hydrochloric acid. The mixture was extracted with dichloromethane (5 x 70 mL), 
and the combined extracts were dried over anhydrous magnesium sulfate, 
filtered, and concentrated in vacuo to afford 730 mg (90%) of a carboxylic acid. 
To a stirred solution of the above acid (250 mg, 1.09 mmol) in 30 mL of 
tetrahydrofuran at room temperature was added portionwise lithium aluminum 
hydride (83 mg, 2.19 mmol). The reaction mixture was stirred for 3 h and was 
then quenched by careful addition of 10 mL of water followed by 10 mL of 1N 
aqueous sodium hydroxide. After being stirred at room temperature for 5 min, 
the mixture was acidified to pH 2 with 10% aqueous hydrochloric acid. The 
mixture was extracted with diethyl ether (5 x 20 mL), and the combined organic 76 
extracts were washed with brine, dried over anhydrous magnesium sulfate, 
filtered, and concentrated in vacuo. 
A stirred solution of the crude acid in 20 mL of diethyl ether was treated 
with an ethereal solution of diazomethane95 until the yellow color persisted. 
Stirring was continued for 30 min, the solvent was removed in vacuo, and the 
residue was purified by chromatography on silica gel (25% ethyl acetate in 
hexanes as eluent) to produce 121 mg (45%) of 141: [a]i2,3 -9.0° (c 2.18, 
CHCI3): IR (neat) 3525 (broad), 2979, 1734, 1253, 1173, 1077 cm-1; 1H NMR 
(CDCI3, 400 MHz) 5 0.93 (3H, d, J = 7 Hz), 1.23 (6H, s), 1.36 (3H, s), 1.80-2.06 
(3H, m), 3.02 (1H, s), 3.13 (3H, s), 3.79 (3H, s), 5.37-5.51 (2H, m); 13C NMR 
(CDCI3, 100 MHz) 5 2.30, 12.6, 14.1, 23.6, 25.7, 25.9, 33.1, 34.9, 40.9, 50.2, 
52.7, 74.7, 128.3, 137.3, 188.9; HRMS calcd. for Ci 2H2003 (M  Me0H)± m/z 
212.1412.  Found: m/z 212. 1412. Anal. Calcd. for Ci 3H2404: C, 63.91; H, 
9.90. Found: C, 64.01; H, 10.00. 
Silyloxy Ester 142. To a stirred solution of 141 (94 mg, 0.384 mmol) 
in 10 mL of dichloromethane at 0 °C was added triethylamine (534 [LL, 3.84 
mmol) and tert-butyldimethylsilyl trifluoromethanesulfonate (440 gL, 1.92 mmol). 
The reaction mixture was stirred at room temperature for 24 h and was 
quenched with 7.5 mL of saturated aqueous sodium bicarbonate. The organic 
layer was separated and  the aqueous layer was extracted  with 
dichloromethane (5 x10 mL). The combined organic layers were washed with 
brine, dried over anhydrous magnesium sulfate, filtered, and concentrated in 
vacuo. The residue was purified by chromatography on silica gel (5% ethyl 77 
acetate in hexanes as eluent) to yield 113 mg (82%) of 142: [a]p3 +18.0° (c 
1.07, CHCI3); IR (neat) 2932, 1750, 1126, 837 cm-1; 1H NMR (CDCI3, 400 
MHz) 8 0.06 (3H, s), 0.10 (3H, s), 0.85 (3H, d, J . 6 Hz), 0.89 (9H, s), 1.24 (6H, 
s), 1.36 (3H, s), 1.62-1.89 (2H, m), 2.09-2.15 (1H, m), 3.13 (3H, s), 3.70 (3H, s), 
5.34-5.52 (2H, m); 13C NMR (CDCI3, 100 MHz) 8 -3.3, -2.8, 12.9, 18.6, 23.5, 
25.9, 34.9, 42.4, 50.2, 51.7, 74.7, 80.1, 129.0, 136.9, 176.3; HRMS calcd. for 
Ci 4H2503Si (M - Me0H)-F m/z 269.1573. Found: m/z 269.1573. Anal. calcd. 
for Ci 9H3804Si: C, 63.64; H, 10.68; Si, 7.83. Found: C, 63.68; H, 10.70; Si, 
7.84. 
Aldehyde Ester 143. Ozone was passed through a stirred solution of 
142 (324 mg, 0.904 mmol) in 65 mL of dichioromethane at -78 °C until a 
persistent blue color remained. The solution was stirred at -78 °C for 10 min, 
after which argon was bubbled into the solution until the blue color had 
dissipated.  Methyl sulfide (1.3 mL, 18.1 mmol) was added, and the reaction 
mixture was allowed to warm to room temperature and was stirred for 1 h at that 
temperature.  Excess methyl sulfide was removed by bubbling argon through 
the solution for 15 min. The solvent was removed in vacuo and the residue was 
purified by chromatography on silica gel (10% ethyl acetate in hexanes as 
eluent) to provide 231 mg (89%) of 143: [a],2,3 +14.6° (c 1.59, CHCI3); IR (neat) 
2930, 2821, 1747, 1729, 1255, 1131 cm-1; 1H NMR (CDCI3, 400 MHz) 8 0.06 
(3H, s), 0.11 (3H, s), 0.88 (9H, s), 1.95 (3H, d, J = 7 Hz), 1.38 (3H, s), 2.20-2.30 
(1H, m), 2.43-2.53 (2H, m), 3.70 (3H, s), 9.72 (1H, t, J. 1 Hz); 13C NMR (CDCI3, 
100 MHz) 8 -3.5, -2.9, 14.3, 18.5, 22.9, 25.8, 37.10, 46.7, 52.0, 79.5, 175.6, 78 
201.9; LRMS m/z 229 (20), 203 (20), 171 (50), 113 (17), 89 (27), 75 (86), 73 
(100). 
0 
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Hydroxy Ester 144.  To a stirred solution of 143 (24.8 mg, 0.086 
mmol) in 10 mL of diethyl ether at -78 °C was added methylmagnesium bromide 
(144 pt,L, 3 M, 0.431 mmol). After being stirred for 10 min at -78 °C, the reaction 
mixture was quenched with 5 mL of water. The mixture was warmed to room 
temperature, acidified to pH 2 with 10% aqueous hydrochloric acid, and 
extracted with diethyl ether (3 x 10 mL). The combined organic extracts were 
washed with brine, dried over anhydrous magnesium sulfate, filtered, and 
concentrated in vacuo. The residue was purified by chromatography on silica 
gel (25% ethyl acetate in hexanes as eluent) to give 17.2 mg (66%) of 144 as a 
diastereomeric mixture and 3.6 mg (15%) of recovered 143. 144: IR (neat) 
3406 (broad), 2856, 1748, 1193, 1126 cm-1; 1H NMR (CDCI3, 400 MHz) 8 0.07 
(3H, s), 0.11 (3H, s), 0.89 (9H, s), 0.91 (3H, d, J= 7 Hz), 1.16 (3H, d, J= 11 Hz), 
1.36 (3H, d, J= 4 Hz), 1.25-1.46 (2H, m), 1.59 (1H, s, br), 1.87-2.08 (1H, m), 3.70 
(3H, s), 3.77-3.84 (1H, m); 13C NMR (CDCI3, 100 MHz) 8 -3.4, -2.8, 13.5, 14.4, 
18.5,  23.1, 23.2, 23.6, 24.6, 25.9, 29.7, 38.8, 39.4, 41.7,  42.0, 51.8, 65.9, 66.6, 
80.3, 80.4, 176.3; LRMS m/z 247 (M C4H9)+, 217 (36), 187 (82), 155 (20), 145 
(21),  119  (34), 113 (70), 95 (28), 89 (40), 75 (100); HRMS calcd. for 
Cii H23O4Si (M - C4H9)+ m/z 247.1366. Found: m/z 247.1365. 79 
O
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Keto Ester 145. To a stirred solution of oxalyl chloride (17 gt, 0.188 
mmol) in 10 mL of dichloromethane at -78 °C was added dimethyl sulfoxide (27 
4, 0.376 mmol). The mixture was stirred at -78 °C for 5 min, and a solution of 
144 (29 mg, 94.1 mmol) in 3 mL of dichloromethane was added. Stirring was 
continued for 10 min, after which triethylamine (79 gL, 0.565 mmol) was added. 
The solution was stirred for 30 min, and 10 mL of diethyl ether was added. The 
mixture was filtered through a small pad of silica gel and the solvent was 
removed in vacuo. The residue was purified by chromatography on silica gel 
(10% ethyl acetate in hexanes as eluent) to afford 28 mg (100%) of 145: [43 
+6.1° (c 2.45, CHCI3); IR (neat) 2955, 2858, 1743, 1720, 1253, 1192, 1130 cm­
1; 1H NMR (CDCI3, 400 MHz) 8 0.04 (3H, s), 0.10 (3H, s), 0.87 (3H, d, J.7 Hz), 
0.88 (9H, s), 1.35 (3H, s), 2.10 (3H, s), 2.20 (1H, dd, J. 16, 9 Hz), 2.37-2.46 (1H, 
m), 2.50 (1H, dd, J. 16, 3 Hz), 3.67 (3H, s); 13C NMR (CDCI3, 100 MHz) 8 -3.5, 
-2.9, 14.1, 18.5, 23.4, 25.9, 30.3, 37.8, 46.2, 51.9, 79.4, 175.8, 208.1; LRMS m/z 
245 [(M  C4H9)+, 30], 243 (40), 217 (75), 185 (100); HRMS calcd. for 
C11 H2104Si (M COM+ m/z 245.1209. Found: m/z 245.1210. Anal. calcd. 
for C15H3004Si: C, 59.59; H, 10.00. Found: C, 59.60; H, 9.96. 
EtO2C 
a,13- Unsaturated Ester 146.  To a stirred suspension of potassium 
hydride (83 mg, 0.729 mmol) in 3 mL of tetrahydrofuran at room temperature 
was added ethyl triethylphosphonoacetate (161 ptL, 0.810 mmol). The reaction 
mixture was stirred for 10 min and a solution of 145 (49 mg, 0.162 mmol) in 1 80 
mL of tetrahydrofuran was added via cannula.  An additional  1 mL of 
tetrahydrofuran was used to ensure that all the ketone was transferred to the 
reaction flask.  The reaction mixture was heated at reflux for 43 h and was 
quenched with 5 mL of water. The mixture was extracted with diethyl ether (3 x 
10 mL), and the combined extracts were washed with brine, dried over 
anhydrous magnesium sulfate, filtered, and concentrated in vacuo. The residue 
was purified by chromatography on silica gel (5% ethyl acetate in hexanes as 
eluent) to give 30 mg (50%) of 146 as a mixture of E- and Z- isomers (5.6 : 
ratio by 1H NMR). The two isomers were separated by chromatography to 
provide pure E- 146: [a],233 +14.8° (c 3.25, CHCI3); IR (neat) 2953, 2857, 1746, 
1717, 1254, 1223, 1192, 1045 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.81 (3H, s), 
0.83 (3H, s), 0.89 (3H, d, J . 1 Hz), 0.90 (9H, s), 1.28 (3H, t, J . 7 Hz), 1.37 (3H, 
s), 1.85-1.93 (1H, m), 2.11 (3H, d, J . 1 Hz), 2.03-2.36 (1H, m), 3.71 (3H, s), 4.14 
(2H, q, J = 7 Hz), 5.64 (1H, s); 13C NMR (CDCI3, 75 MHz) 8 -3.4, -2.8, 12.8, 
14.3, 18.4, 18.6, 23.5, 25.9, 29.7, 39.9, 43.5, 51.8, 59.5, 80.0, 117.4, 159.0, 
166.6, 176.0; LRMS m/z 373, 357, 328, 327 (100), 315; HRMS calcd. for 
C1 gH3705Si (M + H)+ m/z 373.2410. Found: m/z 373.2411. 
s''s.  0  'CO2Me  0 t02Me 
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Tetrahydrofurans 148 and 149. A from 146 and 147. To a stirred 
solution of a mixture of 146 and 147 (29.9 mg, 80.3 ilmol) in 5 mL of tetra-n­
hydrofuran was added tetra-n-butylammonium fluoride (803 gL, 0.803 mmol). 
After being stirred at room temperature for 1  h, the reaction mixture was 
concentrated in vacuo and the residue was purified by chromatography on 
1 81 
silica gel (17% ethyl acetate in hexanes as eluent) to provide 16 mg (77%) of a 
mixture of 148 and 149 (1  : 4.5 ratio by 1H NMR). 
B from 146. To a stirred solution of 146 (40 mg, 0.107 mmol) in 5 mL of 
tetrahydrofuran was added tetra-n-butylammonium fluoride (1.61 mL, 1.61 
mmol). After being stirred at room temperature for 1 h, the reaction mixture was 
concentrated in vacuo and the residue was purified by chromatography on 
silica gel (17% ethyl acetate in hexanes as eluent) to give 20.8 mg (75%) of a 
mixture of 148 and 149 (1  : 4.5 ratio). The two diastereomers were separated 
by preparative HPLC (250 x 4.6 mm silica column, 15:1 hexane-ethyl acetate, 3 
mL min-1). 
148: [a]p3 +11.7° (c 0.30, CHCI3); IR (neat) 2977, 1734, 1113 cm-1; 1H 
NMR (CDCI3, 400 MHz) 6 1.08 (3H, d, J. 7 Hz), 1.26 (3H, t, J. 7 Hz), 1.29 (3H, 
s), 1.43 (3H, s), 1.56 (1H, dd, J = 13, 13 Hz), 2.42 (1H, dd, J = 13, 7 Hz), 2.54 
(1H, d, J. 15 Hz), 2.65 (1H, d, J. 15 Hz), 2.63-2.73 (1H, m), 3.73 (3H, s), 4.12 
(2H, q, J = 7 Hz); 13C NMR (CDCI3, 100 MHz) 5 14.1, 20.6, 28.2, 40.0, 43.9, 
45.4, 52.2, 60.2, 81.5, 85.3, 171.0, 175.4. 
149: [42,3 +33.9° (c 1.59, CHC13); IR (neat) 2977, 1734, 1113 cm-1; 1H 
NMR (CDCI3, 400 MHz) 8 1.09 (3H, d, J = 7 Hz), 1.25 (3H, s), 1.26 (3H, t, J. 7 
Hz), 1.34 (3H, s), 1.92 (1H, dd, J. 12, 12 Hz), 2.05 (1H, dd, J. 13, 7 Hz), 2.56 
(1H, d, J. 14 Hz), 2.69 (1H, d, J. 14 Hz), 2.65-2.75 (1H, m), 3.73 (3H, s), 4.12 
(2H, q, J = 7 Hz); 13C NMR (CDCI3, 100 MHz) 6 14.1, 14.2, 20.3, 26.9, 39.9, 
43.9, 47.5, 52.2, 60.3, 81.2, 85.2, 170.8, 175.6; LRMS m/z 259, 199 (100), 171; 
HRMS calcd. for C13H2205 (M + H)± m/z 259.1546. Found: m/z 259.1545. 82 
0  "CO2H 
CO2H 
(+)-Nemorensic Acid (25). To a stirred solution of 148 (3 mg, 11.6 
grnol) in 1 mL of tetrahydrofuran was added 200 pi_ of lithium hydroxide (1M). 
After being stirred at room temperature for 3 h, the reaction mixture was 
quenched with 2 mL of water and was acidified to pH 2 with 10% aqueous 
hydrochloric acid. The mixture was extracted with diethyl ether (4 x 2 mL) and 
the combined extracts were washed with brine, dried over anhydrous 
magnesium sulfate, filtered, and concentrated in vacuo to produce 2.4 mg 
(91%) of 25 as a yellow crystalline solid which showed identical spectral 
properties to those reported for the natural product: [43 +87.2° (c 0.24, EtOH); 
m.p. 174-175 °C; IR (neat) 3550-3100 (broad), 2925, 2860, 1722, 1630, 1461, 
1383, 1124, 1085, 1038 cm-1; 1H NMR [(CD3)2S0, 400 MHz] 8 0.99 (3H, d, J = 
7 Hz), 1.13 (3H, s), 1.27 (3H, s), 1.50 (1H, dd, J = 12, 12 Hz), 2.10 (1H, dd, J 
13, 7 Hz), 2.30 (1H, d, J. 14 Hz), 2.46 (1H, d, J = 14 Hz), 2.45-2.55 (1H, m). 
O  "'CO2H 
CO2H 
(+)-Isonemorensic Acid (153). To a stirred solution of 149 (15 mg, 
58.1 mmol) in 2 mL of tetrahydrofuran was added 1 mL of lithium hydroxide 
(1M). After being stirred at room temperature for 3 h, the reaction mixture was 
quenched with 5 mL of water and was acidified to pH 2 with 10% aqueous 
hydrochloric acid. The mixture was extracted with diethyl ether (4 x 5 mL) and 
the combined extracts were washed with brine, dried over anhydrous 
magnesium sulfate, filtered, and concentrated in vacuo to produce 12.5 mg 83 
(94%) of 153: [a]2,3 +55.4° (c 0.99, CHCI3); IR (neat) 3640-3050 (broad), 2971, 
2919, 1713, 1378, 1121, 1054 cm-1; 1H NMR (CDCI3, 300 MHz) 5 1.16 (3H, d, 
J = 7 Hz), 1.26 (1H, s), 1.32 (3H, s), 1.43 (3H, s), 1.91 (1H, dd, J = 13, 13 Hz), 
2.14 (1H, dd, J = 13, 7 Hz), 2.65 (1H, d, J = 15 Hz), 2.74 (1H, d, J =15 Hz), 2.61­
2.78 (1H, m); 13C NMR (CDCI3, 75 MHz) 8 13.8, 19.6, 26.9, 40.0, 44.4, 47.1, 
81.6, 85.5, 175.8, 177.5. 
,s's.  0 CO2Me 
CO2Me 
Dimethyl Nemorensate (154). To a stirred solution of 25 (2.5 mg, 
0.012 mmol) in 0.5 mL of diethyl ether was added an ethereal solution of 
diazomethane95 until a yellow color persisted.  After being stirred at room 
temperature for 30 min, the reaction mixture was concentrated in vacuo to yield 
2.8 mg (100%) of 154: IR (neat) 2946, 2863, 1734, 1447, 1111 cm-1; 1H NMR 
(CDCI3, 400 MHz) 6 1.08 (3H, d, J. 7 Hz), 1.29 (3H, s), 1.43 (3H, s), 1.56 (1H, 
dd, J. 12, 12 Hz), 2.40 (1H, dd, J = 13, 7 Hz), 2.56 (1H, d, J. 14 Hz), 2.66 (1H, 
d, J. 15 Hz), 2.61-2.71 (1H, m), 3.66 (3H, s), 3.73 (3H, s). 
O .-"CO2Me 
CO2Me 
Dimethyl Isonemorensate (155). To a stirred solution of 153 (10 
mg, 0.046 mmol) in 1 mL of diethyl ether was added an ethereal solution of 
diazomethane95 until a yellow color persisted.  After being stirred at room 
temperature for 30 min, the reaction mixture was concentrated in vacuo to give 84 
11.3 mg (100%) of 155: [a]p3 +45.8° (c 0.28, CHCI3); IR (neat) 2956, 1733, 
1440, 1383, 1346, 1242, 1213, 1118, 1061 cm-1; 1H NMR (CDCI3, 300 MHz) 8 
1.09 (3H, d, J. 7 Hz), 1.24 (3H, s), 1.34 (3H, s), 1.92 (1H, dd, J. 13, 13 Hz), 
2.05 (1H, dd, J. 13, 7 Hz), 2.58 (1H, d, J. 14 Hz), 2.71 (1H, d, J. 14 Hz), 2.64­
2.77 (1H, m), 3.66 (3H, s), 3.74 (3H, s); 130 NMR (CDCI3, 75 MHz) 5 14.1, 20.3, 
27.0, 39.9, 43.8, 47.2, 51.5, 52.3, 81.2, 85.2, 171.3, 175.6; LRMS m/z 245, 185 
(100) 171; HRMS calcd. for Ci 2H2005 (M + H)+ m/z 245.1389. Found: m/z 
245.1389. 
a,(3- Unsaturated  Aldehyde  158.  To a stirred solution of 
diisopropylamine (2.09 mL, 14.9 mmol) in 15 mL of tetrahydrofuran at -78 °C 
was added n-butyllithium (8.92 mL, 14.3 mmol). After being stirred at 0 °C for 
15 min, the reaction mixture was cooled to -78 °C and a solution of (S)-(-)­
citronella! (157) (2.0 g, 13.0 mmol) in 15 mL of tetrahydrofuran was added 
dropwise over 30 min.  An additional 5 mL of tetrahydrofuran was used to 
ensure that all of the citronella! was transferred to the reaction flask.  The 
mixture was stirred at -78 °C for 1 h and was added to a stirred suspension of 
Eschenmoser's salt (3.60 g, 19.46 mmol) in 20 mL of tetrahydrofuran at -78 °C. 
The suspension was allowed to stir for 1  h at -78 °C and for 5 h at room 
temperature. After most of the solvent was removed, a solution of iodornethane 
(1.62 mL, 25.94 mmol) in 30 mL of methanol was added to the residue and the 
solution was stirred at room temperature for 12 h. The solvent was evaporated, 
and 26 mL of 5% aqueous sodium bicarbonate and 30 mL of dichloromethane 
was added to the residue. The mixture was stirred at room temperature for 5 h, 85 
the organic layer was separated, and the aqueous layer was extracted with 
dichloromethane (4 x 30 mL). The combined organic extracts were washed 
with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated 
in vacuo. The residue was purified by chromatography on silica gel (5% ethyl 
acetate in hexanes as eluent) to yield 1.93 g (90%) of 158: [a]3 +8.4° (c 11.8, 
CHCI3); IR (neat) 2968, 2924, 2859, 2697, 1701, 1458, 1382, 1257, 949 cm-1; 
1H NMR (CDCI3, 300 MHz) 8 1.07 (3H, d, J. 7 Hz), 1.26-1.60 (2H, m), 1.56 (3H, 
s), 1.67 (3H, d, J. 1 Hz), 1.86-1.97 (2H, m), 2.65-2.76 (1H, m), 5.05-5.10 (1H, 
m), 5.99 (1H, s), 6.23 (1H, s), 9.53 (1H, s); 13C NMR (CDCI3, 75 MHz) 5 17.5, 
19.4, 25.55, 25.65, 30.9, 35.5, 124.0, 131.5,  132.9, 155.4, 194.5; LRMS m/z 166 
(Mt 20), 151 (20), 123 (20),  109 (100), 95  (40), 93 (20), 84 (30), 81 (50), 79 
(20), 69 (80); HRMS calcd. for C11 H1 g0 m/z 166.1358. Found: m/z 166.1358. 
OH 
(3S)-2-(Hydroxymethyl)-3,7-dimethylocta-1,6-diene  (159). To 
a stirred solution of 158 (1.81  g,  10.9 mmol) and cerium(III) chloride 
heptahydrate (5.39 g, 14.5 mmol) in 50 mL of methanol at 0 °C was added 
portionwise sodium borohydride (549 mg, 14.2 mmol). The reaction mixture 
was stirred for 10 min and was quenched with 50 mL of saturated aqueous 
ammonium chloride solution.  After removal of the methanol, 150 mL of water 
was added and was extracted with ethyl acetate (4 x 50 mL). The combined 
extracts were washed with brine, dried over anhydrous magnesium sulfate, 
filtered,  and concentrated  in  vacuo.  The residue was purified by 
chromatography on silica gel (17% ethyl acetate in hexanes as eluent) to 
provide 1.70 g (93%) of 159: [at' +17.6° (c 13.09, CHCI3); IR (neat) 3350 86 
(broad), 2964, 2918, 2858, 1661, 1450, 1390, 1239, 1033, 912, 836, 761 cm-1; 
1H NMR (CDCI3, 300 MHz) 5 1.05 (3H, d, J= 7 Hz), 1.22-1.55 (2H, m), 1.58 (3H, 
s), 1.67 (3H, s), 1.91-2.03 (2H, m), 2.12-2.21 (1H, m), 2.52 (1H, s, broad), 4.06 
(2H, s), 4.87 (1H, s), 5.05-5.11 (2H, m); 13C NMR (CDCI3, 75 MHz) 8 17.5, 19.9, 
25.5,  25.7, 35.7, 36.4, 64.3, 107.6,  124.4, 131.2,  153.7; LRMS m/z 168 (20), 151 
(30),  150 (30), 149 (25), 137 (60), 135 (60), 109 (40), 107 (25), 95 (100); HRMS 
calcd. for C11 H200 m/z 168.1514. Found: m/z 168.1515. 
Me0 
OH 
(3S)-2-(Hydroxymethy1)-3,7-dimethy1-7-methoxyocta-1,5­
diene (160). A. Stepwise Procedure. To a stirred solution of 159 (978 
mg, 5.82 mmol) and sodium bicarbonate (2.93 g, 34.9 mmol) in 20 mL of 
methanol was added a solution of phenylselenenyl chloride (2.96 g, 15.5 mmol) 
in 50 mL of methanol dropwise via cannula.  After being stirred at room 
temperature for 1.5 h, the solution was concentracted and the residue was 
purified by chromatography on silica gel (25% ethyl acetate in hexanes as 
eluent) to yield 1.98 g (96%) of a stereoisomeric mixture of methoxyselenides: 
IR (neat) 3415 (broad), 3070, 2973, 2932, 2870, 2829, 1586, 1483, 1457, 1442, 
1380, 1360, 1226, 1129, 1067, 1031, 903, 744, 698 cm-1; 1H NMR (CDCI3, 300 
MHz) 5 1.03 (3H, d, J = 6.9 Hz), 1.24 (3H, s), 1.29 (3H, s), 1.39-1.44 (2H, m), 
1.92-1.99 (2H, m), 2.13-2.17 (2H, m), 3.07 (1H, d, J = 8.6 Hz), 3.14 (3H, s), 4.06 
(2H, s), 4.86 (1H, s), 5.04 (1H, d, J . 1.3 Hz), 7.21-7.27 (3H, m), 7.55-7.59 (2H, 
m); 13C NMR (CDCI3, 75 MHz) 8 20.6, 22.6, 24.0, 28.8, 34.5, 36.8, 49.3, 57.8, 
64.3, 78.5, 108.4, 126.9, 128.9. 133.8, 153.7; LRMS m/z 356 (M+, 60), 339 (60), 87 
284 (20), 167 (100), 149 (100), 123 (20 ), 111 (20), 107 (30 ), 95 (20), 93 (20); 
HRMS calcd. for C18H28O2Se m/z 356.1255. Found: m/z 356.1252. 
To a stirred suspension of the above methoxyselenides (1.98 g, 5.56 
mmol) and sodium bicarbonate (4.66g, 55.5 mmol) in 30 mL of tetrahydrofuran 
was added 1.26 mL of 30% aqueous hydrogen peroxide. After being stirred for 
30 min, the solution was concentracted and 100 mL of water was added. The 
mixture was extracted with diethyl ether (5 x 30 mL) and the combined extracts 
were washed with brine, dried over anhydrous magnesium sulfate, filtered, and 
concentrated in vacuo. The crude product was purified by chromatography on 
silica gel (25% ethyl acetate in hexanes as eluent) to give 864.9 mg (79%) of 
160: [a],2,3 +9.5° (c 9.03, CHCI3); IR (neat) 3389 (broad), 2974, 2935, 1459, 
1376, 1264, 1176, 1079, 981, 907 cm-1; 1H NMR (CDCI3, 300 MHz) 8 1.02 (3H, 
m), 1.19 (3H, s), 1.20 (3H, s), 1.78-2.16 (2H, m), 2.17-2.22 (2H, m), 2.22-2.51 
(1H, broad), 3.08 (3H, s), 4.05 (2H, s), 4.84 (1H, d, J = 1 Hz), 5.03 (1H, m), 5.34­
5.54 (2H, m); 13C NMR (CDCI3, 75 MHz) 8 19.3, 25.7, 36.5, 38.5, 50.1, 64.6, 
74.9, 108.2, 128.3, 136.6, 153.1; LRMS m/z 183 [(M - CH3)+, 20], 167 (40), 151 
(40), 149 (80), 123 (20), 113 (20), 111 (100), 109 (30), 107 (20), 93 (40); HRMS 
calcd. for C11 H1902 (M CH3)± m/z 183.1385. Found: m/z 183.1385. 
B. Single Step Procedure. To a stirred suspension of alcohol 159 
(3.51 g, 20.9 mmol) and sodium bicarbonate (10.52 g, 0.125 mol) in 100 mL of 
methanol at room temperature was added portionwise phenylselenenyl 
chloride (4.40 g, 23.0 mmol). After being stirred for 10 min, the reaction mixture 
was concentrated and 50 mL of tetrahydrofuran and 5.90 mL of 30% aqueous 
hydrogen peroxide was added. The mixture was stirred at room temperature for 
30 min and 80 mL of water was added. The mixture was extracted with ethyl 
acetate (5 x 30 mL) and the combined organic extracts were washed with brine, 
dried over anhydrous sodium sulfate, filtered, and concentrated. The residue 88 
was purified by chromatography on silica gel (25% ethyl acetate in hexanes as 
eluent) to give 3.46 g (84%) of 160. 
OH 
(2S,3S)- 3,7- Dimethyl -7- methoxy- 2- oxiranyl -5- octenol  (161). 
To a stirred suspension of 3A molecular sieve in 30 mL of dichloromethane at 
room temperature was added titanium(IV) isopropoxide (2.60 mL, 8.73 mmol). 
The mixture was cooled to -35 °C and diisopropyl (+)-tartrate (2.20 mL, 10.5 
mmol) was added. After 15 min, tert-butylhydroperoxide (5.24 mL, 26.2 mmol) 
was added to the stirred mixture and stirring was continued for 15 min. To this 
mixture was added a solution of 160 (3.46 g, 17.5 mmol) in 10 mL of 
dichloromethane.  An additional 5 mL of dichloromethane was used to ensure 
that all of the alcohol was transferred to the reaction flask, which was then 
placed in a -35 °C freezer for 20 h. To the mixture was added 30 mL of 10% 
aqueous tartaric acid and the mixture was stirred at -35 °C for 30 min and then 
at room temperature for 1 h. The organic layer was separated and the aqueous 
layer was extracted with dichloromethane (3 x 30 mL). The combined organic 
layers were dried over anhydrous magnesium sulfate, filtered, and concentrated 
in vacuo. The residue was purified by chromatography on silica gel (40% ethyl 
acetate in hexanes as eluent) to afford 3.27 g (87%) of 161 as a mixture of two 
diastereomers (13:1 ratio as shown by 13C NMR):  [a],!,3 -8.3° (c 3.46, CHCI3); 
IR (neat) 3433 (broad), 2976, 2930, 2824, 1463, 1382, 1179, 1153, 1082, 981 
cm-1; Major isomer: 1H NMR (CDCI3, 300 MHz) 8 1.03 (3H, d, J = 7 Hz), 1.24 
(6H, s), 1.64-1.77 (1H, m), 1.85-1.95 (1H, m), 2.20-2.28 (1H, m), 2.36-2.47 (1H, 
m), 2.64 (1H, d, J = 5 Hz), 2.90 (1H, d, J = 5 Hz), 3.14 (3H, s), 3.68 (1H, dd, J. 89 
12, 8 Hz), 3.84 (1H, dd, J = 12, 2 Hz), 5.39-5.56 (2H, m); 13C NMR (CDCI3, 75 
MHz) 5 15.8, 25.6, 25.7, 35.1, 36.3, 49.3,  50.1, 60.2, 62.0, 74.6,  127.7, 137.1; 
LRMS m/z 199 [(M - CH3)+, 20], 183 (30), 167 (20), 165 (20),  137 (20), 113 (20), 
109 (100); HRMS calcd. for Cii H1903 (M CH3)+ m/z 199.1334. Found: m/z 
199.1335. 
me0 
(2S,3S)-3,7-Dimethy1-7-methoxy-2-oxirany1-5-octenal  (162). 
To a stirred solution of oxalyl chloride (554 pt,L, 6.35 mmol) in 20 mL of 
dichloromethane at -78 °C was added dimethyl sulfoxide (900 gL, 12.7 mmol). 
The mixture was stirred for 15 min and a solution of 161 (680 mg, 3.18 mmol)in 
5 mL of dichloromethane was added via cannula.  An additional 5 mL of 
dichloromethane was used to ensure that all of 161 was transferred to the 
reaction flask.  The reaction mixture was stirred at -78 °C for 30 min and 
triethylamine (2.65 mL, 19.1 mmol) was added. After being stirred at -78 °C for 
1 h, the reaction mixture was diluted with 30 mL of diethyl ether and the solution 
was filtered through a small pad of silica gel, eluting with diethyl ether. The 
filtrate was concentrated  in  vacuo and the residue was purified by 
chromatography on silica gel (17% ethyl acetate in hexanes as eluent) to give 
673 mg (100%) of 162: [a],2,3 +22.3° (c 2.32, CHCI3); IR (neat) 2979, 2940, 
2823, 1733, 1465, 1386, 1181, 1084, 986, 859 cm-1; 1H NMR (CDCI3, 300 
MHz) 8 0.99 (3H, d, J = 7 Hz), 1.24 (6H, s), 2.01-2.36 (3H, m), 2.96 (1H, d, J = 5 
Hz), 3.04 (1H, d, J = 5 Hz), 3.13 (3H, s), 5.42-5.49 (2H, m), 8.87 (1H, s); 13C 
NMR (CDCI3, 75 MHz) 6 15.1, 25.7, 25.9, 32.0, 35.2, 48.7, 50.2, 63.7, 74.6, 
127.6, 137.7, 199.1; LRMS m/z 211 (M - H)±, 197 (100), 181 (60), 151 (20), 135 90 
(40), 123 (20), 113 (40), 107 (20), 95 (20); HRMS calcd. for Ci2H1903 (M  - H)+ 
m/z 211.1334, Ci1H1703 (M CH3)+ m/z 197.1178. Found: m/z 211.1334, m/z 
197.1178. 
OH 
MeO 
0= 
Alcohol 163. A. From 162. To a stirred solution of 162 (673.5 mg, 
3.18 mmol) in 30 mL of tetrahydrofuran at -78 °C was added dropwise a 
solution of methylmagnesium bromide (2.12 mL, 3M, 6.35 mmol) in 10 mL of 
tetrahydrofuran via cannula. The reaction mixture was stirred at -78 °C for 2 h 
and was quenched with 50 mL of water. The mixture was acidified to pH 2 with 
10% aqueous hydrochloric acid and was extracted with diethyl ether (4 x 30 
mL).  The combined organic extracts were washed with brine, dried over 
anhydrous magnesium sulfate, filtered, and concentrated in vacuo. The residue 
was purified by chromatography on silica gel (17% ethyl acetate in hexanes 
followed by 33% ethyl acetate in hexanes as eluent) to afford 451.5 mg (62%) of 
163 as a mixture of two diastereomers and183.9 mg (27%) of recovered 162. 
163: IR (neat) 3445 (broad), 2973, 2937, 1463, 1381, 1268, 1175, 1078, 985, 
939 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.99 (3H, d, J = 7 Hz), 1.25 (6H, s), 
1.25-1.28 (3H, m), 1.67-1.74 (2H, m), 1.90-2.02 (1H, m), 2.23-2.28 (1H, m), 2.64 
(1H, d, J = 5 Hz), 2.88 (1H, d, J = 5 Hz), 3.14 (3H, s), 3.88-3.97 (1H, m), 5.46­
5.52 (2H, m); 130 NMR (CDCI3, 75 MHz) 8 16.8, 19.1, 25.7, 25.9, 33.3, 34.5, 
47.6, 50.2, 64.7, 67.4, 74.7, 128.4, 137.1; LRMS m/z 213 [(M - CH3)+, 20], 197 
(50), 181 (80), 179 (60), 167 (20), 161 (20), 153 (30), 151 (50), 109 (100), 85 
(20), 73 (20); HRMS calcd. for C13H2503 (M + H)± m/z 229.1804, C12H2103 
(M CH3)+ m/z 213.1491. Found: m/z 229.1800, m/z 213.1480. 91 
B. From 161. To a stirred solution of 161 (1.02 g, 4.76 mmol) in 30 mL 
of dichloromethane was added Dess-Martin's periodinane (3.0 g, 7.14 mmol). 
After being stirred for 1 h, the reaction mixture was diluted with 100 mL of diethyl 
ether, and 40 mL of 1N aqueous sodium hydroxide was added. The mixture 
was stirred until both the organic and aqueous layers were clear and colorless. 
The layers were separated and the organic layer was washed with 20 mL of 1N 
aqueous sodium hydroxide followed by 20 mL of brine. The organic solution 
was dried over anhydrous magnesium sulfate, filtered, and concentrated in 
vacuo. 
To a stirred solution of the residue obtained above in 60 mL of 
tetrahydrofuran at -78 °C was added methylmagnesium bromide (5.3 mL, 3.0M, 
14.3 mmol). After being stirred at -78 °C for 30 min, the reaction mixture was 
allowed to slowly warm to room temperature over 30 min and was quenched 
with 100 mL of water. The mixture was acidified to pH 3 with 10% aqueous 
hydrochloric acid and was extracted with diethyl ether (4 x 30 mL).  The 
combined extracts were washed with brine, dried over anhydrous magnesium 
sulfate, filtered, and concentrated in vacuo.  The residue was purified by 
chromatography on silica gel (33% ethyl acetate in hexanes as eluent) to 
provide 859 mg (79%) of 163 as a mixture of two diastereomers and 105 mg 
(10%) of recovered 161. 
MeO 
0-= 
Ketone 164. To a stirred solution of 163 (847.2 mg, 3.72 mmol) in 50 
mL of dichloromethane at room temperature was added Dess-Martin's 
periodinane (3.15 g, 7.43 mmol). After being stirred for 3 h, the reaction mixture 92 
was diluted with 100 mL of diethyl ether, and 40 mL of 1N aqueous sodium 
hydroxide. The mixture was stirred until both the organic and aqueous phases 
were clear and colorless. The organic layer was separated and was washed 
with 20 mL of 1N aqueous sodium hydroxide followed by 20 mL of brine, dried 
over anhydrous magnesium sulfate, filtered, and concentrated in vacuo.  The 
residue was purified by chromatography on silica gel (14% ethyl acetate in 
hexanes as eluent) to give 797.7 mg (95%) of 164: [4233 +27.0° (c 3.18, 
CHCI3); IR (neat) 2978, 2932, 2824, 1715, 1463, 1365, 1263, 1175, 1073, 980, 
852 cm-1; 1H NMR (CDCI3, 300 MHz) 6 0.89 (3H, d, J = 7 Hz), 1.23 (6H, s), 2.0­
2.1 (1H, m), 2.03 (3H, s), 2.22-2.35 (2H, m), 2.82 (1H, d, J = 5 Hz), 2.92 (1H, d, J 
= 5 Hz), 3.13 (3H, s), 5.46-5.49 (2H, m);  13C NMR (CDCI3, 75 MHz) 5 14.6, 
24.6, 25.6, 25.9, 33.1, 36.0, 49.3, 50.1,  65.1, 74.6, 127.9, 137.3, 208.1; LRMS 
m/z 211 [(M  CH3)+, 100],  195 (100),  177 (90), 163 (40),  151 (20), 135 (80), 
119 (20), 109 (60), 99 (20), 93 (20), 85 (20), 73 (30); HRMS calcd. for 
Ci 3H21 03 (M  m/z 225.1491, Ci 2Hig03 (M  CH3)+ m/z 211.1334. 
Found: m/z 225.1491, 211.1334. 
,OH Me0 
0= 
Alcohol 167. To a stirred solution of 164 (797.7 mg, 3.53 mmol) in 60 
mL of tetrahydrofuran at -78 °C was added dropwise vinylmagnesium bromide 
(11.1 mL, 1M, 11.1 mmol). The reaction mixture was stirred at -78 °C for 1 h and 
was then quenched with 100 mL of water. The mixture was extracted with ethyl 
acetate (5 x 30 mL), and the combined extracts were washed with brine, dried 
over anhydrous magnesium sulfate, filtered, and concentrated  in vacuo.  The 
residue was purified by chromatography on silica gel (25% ethyl acetate in 93 
hexanes as eluent) to produce 791.8 mg (88%) of 167: [a],2,3 +3.3° (c 6.11, 
CHCI3); IR (neat) 3450 (broad), 2978, 2957, 1453, 1376, 1165, 1078, 929 cm-1; 
1H NMR (CDCI3, 300 MHz) 8 0.97 (3H, d, J = 7 Hz), 1.24 (6H, s), 1.34 (3H, s), 
1.59-1.68 (1H, m), 2.04-2.19 (2H, m), 2.34 (1H, s), 2.60 (1H, d, J. 5 Hz), 2.95 
(1H, d, J= 5 Hz), 3.13 (3H, s), 5.19 (1H, dd, J. 11, 1 Hz), 5.33 (1H, dd, J= 17, 1 
Hz), 5.37-5.55 (2H, m), 5.99 (1H, dd, J. 17, 11 Hz); 13C NMR (CDCI3, 75 MHz) 
5 19.8, 23.5, 26.3, 26.4, 32.2, 35.9,  47.0, 50.7, 67.3, 73.5, 75.3,  114.8, 129.3, 
137.4, 141.7; LRMS m/z 223 (40), 205 (20), 193 (20), 125  (30),  109 (100), 73 
(20); HRMS calcd. for C1 4H2303 (M  CH3)+ m/z 239.1647.  Found: m/z 
239.1648. 
sOTBS Me0 
0­
Silyl Ether 168. To a stirred solution of 167 (1.18 g, 4.64 mmol) in 35 
mL of dichloromethane at -40 °C was added 2,6-lutidine (1.10 mL, 9.28 mmol) 
and tert-butyldimethylsilyl trifluoromethanesulfonate (1.6 mL, 6.96 mmol). After 
being stirred at -40 °C for 1 h, the reaction mixture was allowed to warm to 4 °C. 
After stirring at this temperature for 14 h, the reaction mixture was quenched 
with 20 mL of saturated aqueous sodium bicarbonate. The organic phase was 
separated and the aqueous phase was extracted with dichloromethane (3 x 25 
mL).  The combined organic extracts were washed with brine, dried over 
anhydrous magnesium sulfate, filtered, and concentrated in vacuo. The residue 
was purified by chromatography on silica gel (9% ethyl acetate in hexanes as 
eluent) to give 1.41 g (83%) of 168: [a]p3 +5.1° (c 6.66, CHCI3); IR (neat) 2958, 
2939, 2896, 2858, 2827, 1469, 1369, 1251, 1208, 1177, 1146, 1084, 1047, 985, 
929, 836, 786, 699 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.09 (6H, d, J = 8 Hz), 94 
0.90 (9H, s), 0.92 (3H, d, J = 7 Hz), 1.24 (6H, s), 1.30 (3H, s), 1.53-1.57 (1H, m), 
2.13-2.21 (2H, m), 2.50 (1H, d, J = 5 Hz), 2.77 (1H, d, J = 5 Hz), 3.13 (3H, s), 
5.13 (1H, dd, J . 11, 1 Hz), 5.27 (1H, dd, J . 17, 1 Hz), 5.35-5.49 (2H, m), 5.88 
(1H, dd, J . 17, 11 Hz); 13C NMR (CDCI3, 75 MHz) 8 -2.2, -2.1, 18.4, 19.5, 22.7, 
25.8, 25.9, 26.0, 30.9, 35.3, 46.4, 50.2, 66.3, 74.7, 114.1, 129.2, 136.4, 142.4; 
LRMS m/z 353 [(M  CH3)+, 10], 337 (50), 307 (20), 279 (20), 225 (20), 197 (20), 
187 (20), 185 (100), 171 (20), 109 (60), 75 (40); HRMS calcd. for C20H37O3Si 
(M CH3)+ m/z 353.2512. Found: m/z 353.2511. 
OH 
Me0 C 
CO2Me 
0= 
Dimethyl Ester 172. Ozone was passed through a stirred suspension 
of 168 (331.8 mg, 0.898 mmol) and sodium bicarbonate (75.4 mg, 0.898 mmol) 
in 20 mL of dichloromethane and 4 mL of methanol at -78 °C until a blue color 
persisted.  After being stirred at -78 °C for 5 min, the reaction mixture was 
allowed to warm to room temperature while argon was passed through the 
solution until  it was clear and colorless. To the reaction mixture was added 
triethylamine (751 1AL, 5.39 mmol) and the acetic anhydride (508 IA, 5.39 
mmol), and the mixture was stirred at room temperature for 30 min. To this 
mixture was added 10 mL of saturated aqueous sodium bicarbonate, and the 
mixture was extracted with ethyl acetate (4 x 10 mL). The combined organic 
layers were washed with brine, dried over anhydrous magnesium sulfate, and 
concentrated in vacuo . 
To a stirred solution of the residue obtained above and 2-methy1-2­
butene (1.9 mL) in 10 mL of tert-butanol at 0 °C was added dropwise a solution 
of sodium chlorite (744 mg, 8.23 mmol) and sodium phosphate monobasic 95 
monohydrate (744 mg) in 4 mL of water. The reaction mixture was allowed to 
warm to room temperature and was stirred at that temperature for 30 min, after 
which 10 mL of brine was added and the organic layer was separated. The 
aqueous layer was washed once with 10 mL of hexane and was kept for further 
treatment. 
The combined organic layers were washed with brine, dried over 
anhydrous magnesium sulfate, filtered, and concentrated  in vacuo.  The residue 
was diluted with 10 mL of diethyl ether and an ethereal solution of 
diazomethane95 was added until a yellow color persisted. The reaction mixture 
was stirred at room temperature for 30 min and the solvent was removed in 
vacuo. The residue was purified by chromatography (50% ethyl acetate in 
hexanes as eluent) to provide 49.9 mg of 172. 
The aqueous layer obtained above was acidified to pH 3 with 10% 
aqueous hydrochloric acid and was extracted with ethyl acetate (5 x 10 mL). 
The combined extracts were washed with brine, dried over anhydrous 
magnesium sulfate, filtered, and concentrated in vacuo. The residue was 
diluted with diethyl ether and an ethereal solution of diazomethane95 was 
added until a yellow color persisted. The reaction mixture was stirred at room 
temperature for 30 min, and the solvent was removed in vacuo to give an 
additional 131.2 mg (total 181 mg, 82%) of 172: [a],2,3 -6.42° (c 1.87, CHCI3); IR 
(neat) 3481 (broad), 2952, 1740, 1442, 1370, 1263, 1160, 1098, 1006, 944 cm­
1; 1H NMR (CDCI3, 300 MHz) 5 1.01 (3H, d, J = 7 Hz), 1.44 (3H, s), 1.96-2.04 
(1H, m), 2.17-2.22 (1H, m), 2.60 (1H, d, J = 4 Hz), 2.77-2.88 (1H, m), 2.93 (1H, d, 
J = 4 Hz), 3.53 (1H, s), 3.66 (3H, s), 3.83 (3H, s); 13C NMR (CDCI3, 75 MHz) 8 
19.0, 21.3, 28.0, 36.7, 46.0, 51.6, 52.8,  64.4, 75.3, 173.0, 174.3; LRMS m/z 247 
[(M + H)+,  20], 229 (40), 215 (60), 211  (20),  197 (90), 187 (50), 185 (20), 169 96 
(40), 165 (100), 155 (70), 143 (80), 127 (30), 113 (70), 112 (20), 85 (20), 69 
(20); HRMS calcd for C11 H1906 (M + H)± m/z 247.1181. Found: m/z 247.1182. 
0 
Z.. 
0 0  CO2Me 
6-Lactone 178. To a stirred solution of 172 (98 mg, 0.398 mmol) in 1 
mL of methanol and 1 mL of water at room temperature was added 0.5M 
aqueous potassium hydroxide (796 p.L, 0.398 mmol). After being stirred at room 
temperature for 24 h, the reaction mixture was diluted with 2 mL of brine and 
was acidified to pH 3 with 3% aqueous phosphoric acid. The organic layer was 
separated and the aqueous layer was extracted with ethyl acetate (5 x 10 mL). 
The combined organic extracts were washed with brine, dried over anhydrous 
magnesium sulfate,  filtered, and concentrated in vacuo to afford crude 
carboxylic acid alcohol 177. 
To a stirred solution of 2-chloro-1-methylpyridinium iodide (276.7 mg, 
1.08 mmol) and 4-dimethylaminopyridine (220.5 mg, 1.81 mmol) in 4 mL of 
acetonitrile was added a solution of crude 177 in 2 mL of acetonitrile via 
cannula. An additional 2 mL of acetonitrile was used to ensure that all of the 
acid was transferred to the reaction flask. The resulting suspension was stirred 
for 24 h at room temperature and was filtered through a small pad of silica gel 
which was washed with diethyl ether. The combined filtrates were concentrated 
and the residue was purified by chromatography on silica gel (50% ethyl 
acetate in hexanes as eluent) to provide 72.3 mg (85%) of 178: [a]o' +71.8° (c 
4.81, CHCI3); IR (neat) 2969, 1753, 1450, 1264, 1237, 1119, 998, 948, 843, 741 
cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.84 (3H, d, J = 6 Hz), 1.44 (3H, s), 2.38­
2.46 (2H, m), 2.65-2.80 (1H, m), 2.99 (2H, m), 3.83 (3H, s); 13C NMR (CDCI3, 97 
75 MHz) 6 13.3, 18.7, 27.2, 35.9, 47.8,  53.4, 58.4, 85.3, 168.4, 171.3; LRMS m/z 
215 [(M + H)±, 20], 197 (20), 169 (80),  165  (20),  155 (100), 153 (20), 127 (20), 
113 (90); HRMS calcd. for C101-11505 (M + H)± m/z 215.0920. Found: m/z 
215.0919. 
Uu
0
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a-Methylene  8-Lactone  180.  To a  stirred  solution  of 
diisopropylamine (116 iaL, 0.885 mmol) in 1 mL of tetrahydrofuran at -78 °C was 
added n-butyllithium (731 A, 0.870 mmol). After warming to 0 °C for 30 min, 
the reaction mixture was recooled to -78 °C and a solution of 178 (62.1 mg, 
0.290 mmol) in 1.5 mL of tetrahydrofuran was added during 10 min.  An 
additional 1 mL of tetrahydrofuran was used to ensure that all the lactone was 
transferred to the reaction flask. The reaction mixture was stirred at -78 °C for 
45 min and was then stirred at -35 °C. Gaseous formaldehyde, produced by 
heating paraformaldehyde at 180 °C, was passed through the solution in a 
stream of argon for 5 min. The reaction mixture was stirred for an additional 5 
min at -35 °C and was quenched with 2 mL of saturated aqueous ammonium 
chloride. The mixture was extracted with ethyl acetate (3 x 10 mL), and the 
combined extracts were washed with brine, dried over anhydrous magnesium 
sulfate, filtered, and concentrated in vacuo.  The residue was purified by 
chromatography on silica gel (67% ethyl acetate in hexanes as eluent) to yield 
31.2 mg (44%) of 179 as a mixture of two diastereomers. 
To a stirred  solution  of 179  (8.4  mg, 34.4 mmol) and 4­
dimethylaminopyridine (6.3 mg, 51.6 mmol) in 1.5 mL of dichloromethane at 0 
°C was added triethylamine (57.6 JAL, 0.413 mmol) and methanesulfonyl 98 
chloride (16  0.206 mmol). After 30 min, 57.6 fiL of triethylamine was added 
to the mixture which was filtered through a small pad of silica gel, and eluting 
with diethyl ether. The combined filtrates were concentrated and the residue 
was purified by chromatography on silica gel (50% ethyl acetate in hexanes as 
eluent) to give 7.1 mg (91%) of 180: [a],233 +3.2° (c 0.71, CHCI3); IR (neat) 2917, 
1735, 1627, 1453, 1290, 1187, 1111, 943 cm-1; 1H NMR (CDCI3, 300 MHz) 8 
1.04 (3H, d, J.7 Hz), 1.46 (3H, s), 2.96 (2H, s), 3.05-3.15 (1H, m), 3.82 (3H, s), 
5.67 (1H, d, J. 2 Hz), 6.53 (1H, d, J. 2 Hz); 13C NMR (CDCI3, 75 MHz) 8 12.3, 
19.0, 33.2, 47.8, 53.4, 58.8, 84.4, 128.2, 137.1, 164.1, 171.3; LRMS m/z 227 [(M 
+ H)+, 20], 209 (20), 181 (60), 177 (20), 167 (60), 152 (30), 149 (20), 125 (100); 
HRMS calcd. for Cii H1505 (M + H)+ m/z 227.0920. Found: m/z 227.0919. 
,OH 
Me02C 
CO2Me 
Dimethyl Ester 182. To a stirred solution of 180 (5.7 mg, 25.0 gmol) 
in methanol-water (1mL 1:1) at 0 °C was added 0.5 mL of 1M aqueous 
potassium hydroxide. After being stirred for 80 min, the reaction mixture was 
acidified to pH 3 with 3% aqueous phosphoric acid and was saturated with solid 
sodium chloride. The mixture was extracted with ethyl acetate (4 x 10 mL), and 
the combined extracts were washed with brine, dried over anhydrous sodium 
sulfate, filtered, and concentrated in vacuo. The residue was diluted with 5 mL 
of diethyl ether and an ethereal solution of diazomethane95 was added until a 
yellow color persisted. The reaction mixture was stirred at room temperature for 
h and was dried over anhydrous magnesium sulfate,  filtered, and 
concentrated in vacuo. The residue was purified by chromatography on silica 
gel (33% ethyl acetate in hexanes as eluent) to give 2.8 mg (37%) of 182: [a]r 
1 99 
-44.1° (c 0.22, CHCI3); IR (neat) 3477 (broad), 2939, 1733, 1635, 1448, 1365, 
1151, 954 cm-1; 1H NMR (CDCI3, 300 MHz) 8 1.16 (3H, d, J = 7 Hz), 1.48 (3H, 
s), 2.45 (1H, d, J = 5 Hz), 2.86 (1H, d, J = 5 Hz), 3.59 (2H, m), 3.76 (3H, s), 3.83 
(3H, s), 5.54 (1H, s ), 6.18 (1H, s); 13C NMR (CDCI3, 75 MHz) 8 16.6, 21.9, 32.3, 
45.1, 52.0, 52.8, 63.9,  75.2,  123.6, 140.7,  167.8, 174.4; LRMS m/z 259 [(M + 
H)+, 30], 241  (20),  227 (30),  211  (10),  209 (100), 199 (50), 181 (30), 177 (50), 
167 (40),  155 (30),  149 (20),  139  (20),  125 (60); HRMS calcd. for Ci 2E11906 (M 
+ H)+ m/z 259.1182. Found: m/z 259.1181. 
H 
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Spirodilactone 184. To a stirred solution of 182 (6.0 mg, 23..2 [Lmol) 
in tetrahydrofuran (2 mL) was added 1 mL of 3N aqueous sulfuric acid. The 
mixture was heated to reflux for 24 h and after cooling was extracted with 
chloroform (5 x 10 mL). The combined extracts were washed with brine (2 mL), 
dried over anhydrous magnesium sulfate, filtered, and concentrated in vacuo. 
The residue was purified by chromatography on silica gel (5% ethanol in 
chloroform as eluent) to yield 2.1 mg (43%) of 184: [a]  +39.5° (c 0.21, EtOH); 
IR (neat) 3443 (broad), 2356, 1782, 1661, 1470, 1415, 1269, 1112, 1002 cm-1; 
1H NMR (CDCI3, 300 MHz) 8 1.45 (3H, d, J = 7 Hz), 1.60 (3H, s), 2.95 (1H, s), 
3.08-3.15 (1H, m), 4.24 (2H, s), 5.71 (1H, d, J = 2 Hz), 6.30 (1H, d, J = 2 Hz); 
13C NMR (CDCI3, 75 MHz) 5 16.1, 19.6, 38.4, 73.1, 74.2, 88.5, 123.0, 139.8, 
167.1, 176.1; LRMS m/z 213 [(M + H)+, 100], 195 (50), 185 (20), 167 (20), 151 
(20), 139 (10), 124 (30), 115 (80), 69 (10): HRMS calcd. for C101-11305 (M + H)+ 
m/z 213.0763. Found: m/z 213.0764. 100
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Alcohol 186. To a stirred solution of 162 (2.67 g, 12.6 mmol) in 50 mL 
of tetrahydrofuran at -78 °C was added vinyl magnesium bromide (18.9 mL, 
1.0M, 18.9 mmol). The reaction mixture was stirred at -78 °C for 1 h and was 
quenched with 20 mL of water. The mixture was extracted with ethyl acetate (4 
x 20 mL), and the combined extracts were washed with brine, dried over 
anhydrous magnesium sulfate, filtered, and concentrated in vacuo. The residue 
was purified by chromatography on silica gel (40% ethyl acetate in hexanes as 
eluent) to give 2.17 g (72%) of 186 as a mixture of two diastereomers: IR (neat) 
3422 (broad), 2977, 2922, 2823, 2355, 1458, 1376, 1255, 1167, 1073, 985, 924 
cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.97 (3H, dd, J = 7, 6 Hz), 1.25 (6H, d, J . 1 
Hz), 1.67-1.77 (1H, m), 1.85-2.00 (2H, m), 2.23-2.33 (1H, m), 2.67 (1H, m), 2.86 
(1H, m), 3.14 (3H, d, J . 1 Hz), 4.23-4.34 (1H, m), 5.20-5.56 (4H, m), 5.72-5.99 
(1H, m); 130 NMR (CDCI3, 75 MHz) 8 16.0, 16.6, 25.7, 25.9, 33.4, 34.4, 34.5, 
35.4, 47.0, 48.0, 50.2, 63.7, 70.7, 72.6, 74.7, 117.4, 118.4, 128.0, 128.3, 136.4, 
137.1, 137.4; LRMS m/z 241 [(M + H)±, 20], 197 (40), 181 (60), 163 (40), 151 
(30), 139 (30), 135 (40), 125 (30), 123 (40), 121 (40), 113 (40), 109 (100), 97 
(50), 95 (50), 85 (50), 83 (70), 81 (40), 73 (40), 71 (60), 69 (90), 67 (30); HRMS 
calcd. for C14H2503 (M + H)-1- m/z 241.1803. Found: m/z 241.1803. 
MeO 
0= 
a,(3- Unsaturated Ketone 187. To a stirred solution of 186 (2.00 g, 
8.33 mmol) in water (300 ilL, 16.7 mmol) and dichloromethane (50 mL) was 
added Dess-Martin's periodinane (7.06 g, 16.7 mmol). After being stirred for 1 101 
h, the reaction mixture was diluted with 50 mL of diethyl ether and was filtered 
through a small pad of silica gel, eluting with diethyl ether (4 x 50 mL). The 
combined filtrates were concentrated and the residue was purified by 
chromatography on silica gel (14% ethyl acetate in hexanes as eluent) to 
provide 1.98 g (100%) of 187: [a]o3 +22.1° (c 1.65, CHCI3); IR (neat) 2975, 
2934, 2821, 1696, 1607, 1465, 1406, 1257, 1157, 1074, 985, 855, 790 cm-1; 
1H NMR (CDCI3, 300 MHz) 8 0.92 (3H, d, J = 7 Hz), 1.22 (6H, s), 2.02-2.12 (1H, 
m), 2.24-2.33 (1H, m), 2.37-2.48 (1H, m), 2.80 (1H, d, J = 5 Hz), 2.97 (1H, d, J = 
5 Hz), 3.12 (3H, s), 5.40-5.55 (2H, m), 5.74 (1H, dd, J = 10, 2 Hz), 6.43 (1H, dd, J 
= 17, 2 Hz), 6.63 (1H, dd, J = 17, 10 Hz);  13C NMR (CDCI3, 75 MHz) 6 14.7, 
25.6, 25.9, 33.1, 36.0, 49.1, 50.2, 64.7, 74.7, 128.0, 129.1, 130.5, 137.3, 198.0; 
LRMS m/z 239 (M + H)±, 237 (60), 223 (30), 207 (60), 191 (20), 189 (60), 175 
(20), 161 (20), 151 (20), 135 (40), 125 (20), 123 (40), 113 (40), 109 (100), 107 
(20), 91 (20), 81 (20), 76 (20); HRMS calcd. for Ci 4H21 03 (M  m/z 
237.1491, Ci 3H-1903 (M  CH3)-F m/z 223.1334.  Found: m/z 237.1491, 
223.1334. 
OH MeO 
0= 
Alcohol 189. To a stirred solution of 187 (760 mg, 3.19 mmol) in 10 
mL of tetrahydrofuran at -78 °C was added dropwise a pre-cooled solution (-78 
°C) of methylmagnesium bromide (1.60 mL, 3.0M, 4.79 mmol) in 27 mL of 
tetrahydrofuran during 20 min.  After addition was completed, the reaction 
mixture was immediately quenched with 10 mL of saturated aqueous 
ammonium chloride and was allowed to warm to room temperature.  The 
mixture was diluted with 10 mL of water, the organic layer was separated, and 102
 
the aqueous layer was extracted with ethyl acetate (3 x 20 mL). The combined 
organic extracts were washed with brine, dried over anhydrous magnesium 
sulfate, filtered, and concentrated in vacuo.  The residue was purified by 
chromatography on silica gel (14% ethyl acetate in hexanes followed by 25% 
ethyl acetate in hexane as eluent) to afford 489 mg (60%) of 189 as a single 
diastereomer along with 253.7 mg (33%) of recovered 187. 189:  [a],2,3 +12.9° 
(c 6.65, CHCI3); IR (neat) 3444 (broad), 2980, 2931, 2825, 1465, 1379, 1163, 
996, 921, 841 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.94 (3H, d, J = 7 Hz), 1.25 
(6H, s), 1.38 (3H, s), 1.60-170 (1H, m), 2.02-2.19 (2H, m), 2.31 (1H, s), 2.59 (1H, 
d, J = 5 Hz), 2.99 (1H, d, J = 5 Hz), 3.14 (3H, s), 5.20 (1H, dd, J = 11, 1 Hz), 5.36 
(1H, dd, J = 17, 1 Hz), 5.39-5.53 (2H, m), 5.92 (1H, dd, J = 17, 11 Hz); 13C NMR 
(CDCI3, 75 MHz) 8 19.3, 23.4, 25.7, 25.8, 31.9, 35.2, 46.7, 50.1, 66.6, 72.8, 74.6, 
114.8, 128.8, 136.8, 140.4; LRMS m/z 239 (20), 237 (20), 223 (90), 209 (40), 
205 (80), 193 (30), 109 (100); HRMS calcd. for C1 4H2303 (M  CH3)-F m/z 
239.1647, C1 5H2502 (M  OH)± m/z 237.1855.  Found: m/z 239.1648, 
237.1854. 
OTBS Me0 
Siloxy Ether 190. To a stirred solution of 189 (238.0 mg, 0.936 mmol) 
in 6 mL of dichloromethane was added 2,6-lutidine (327 111_, 2.81 mmol) and 
tert-butyldimethylsilyl trifluoromethanesulfonate (322.4 pt, 1.40 mmol) at -78 °C. 
The reaction mixture was allowed to stir for 2 h at -78 °C and for 22 h at 4 °C, 
then was quenched with 10 mL of saturated aqueous sodium bicarbonate and 
the organic layer was separated. The aqueous layer was extracted with ethyl 
acetate (3 x 20 mL), and the combined organic extracts were washed with brine, 103 
dried over anhydrous magnesium sulfate, filtered, and concentrated  in vacuo. 
The residue was purified by chromatography on silica gel (5% ethyl acetate in 
hexanes as eluent) to give 231 mg (67%) of 190: [a]p3 -1.1° (c 5.02, CHCI3); IR 
(neat) 2963, 2942, 2896, 2865, 2814, 1468, 1412, 1381, 1252, 1083, 1052, 
985, 944, 847, 780 cm-1 ; 1H NMR (CDCI3, 300 MHz) 6 0.06 (6H, s), 0.88 (9H, 
s), 0.90 (3H, d, J = 8 Hz), 1.23 (6H, s), 1.34 (3H, s), 1.55-1.65 (1H, m), 2.11-2.25 
(2H, m), 2.49 (1H, d, J= 5 Hz), 2.75 (1H, d, J = 5 Hz), 3.12 (3H, s), 5.12 (1H, dd, 
J=11, 1 Hz), 5.21 (1H, dd, J. 18, 1 Hz), 5.35-5.56 (2H, m), 5.93 (1H, dd, J=18, 
11 Hz); 13C NMR (CDCI3, 75 MHz) 8 -2.2, -2.1, 18.4, 19.5, 22.4, 25.82, 25.85, 
25.92, 31.0, 35.6, 46.3, 50.2,  66.6, 74.7,  114.2, 129.3, 136.4, 142.1; LRMS m/z 
369 (M + H)±,  353 (10),  337 (100),  321  (20), 307 (60), 279 (30), 239 (20), 225 
(40), 205 (30),  187 (20),  185 (60); HRMS calcd. for C21 H41 03Si (M + H)± m/z 
369.2825, C20H37Si (M  CH3)± m/z 353.2512.  Found: m/z 369.2825, 
353.2511. 
Dimethyl Ester 192. Ozone was passed through a stirred suspension 
of 190 (350 mg, 0.950 mmol) and sodium bicarbonate (80 mg, 0.950 mmol) in 
10 mL of dichloromethane and 2 mL of methanol at -78 °C until a blue color 
persisted.  The reaction mixture was stirred at -78 °C for 20 min and was 
allowed to warm to room temperature while a stream of argon was passed 
through the solution until it was clear and colorless. To the mixture was added 
triethylamine (795 ilL, 5.70 mmol) and acetic anhydride (538 JAL, 5.70 mmol) 
and the mixture was stirred at room temperature for 30 min. The mixture was 
filtered and concentrated in vacuo, and the residue was passed through a short 104 
column of silica gel (14% ethyl acetate in hexanes as eluent). The solvent was 
removed, and the residue was taken up in 2-methyl-2-butene (4.0 mL) and 15 
mL of tert-butanol. To this solution at 0 °C was added dropwise a solution of 
sodium chlorite (787 mg, 8.70 mmol) and sodium phosphate monobasic, 
monohydrate (744 mg) in 6 mL of water. The reaction mixture was stirred at 
room temperature for 1.5 h and the organic layer was separated. The aqueous 
layer was washed once with hexane (10 mL) and was kept for further treatment. 
The combined organic layers were washed with brine, dried over anhydrous 
sodium sulfate, filtered, and concentrated in vacuo. The residue was diluted 
with diethyl ether and an ethereal solution of diazomethane95 was added until 
a yellow color persisted. The reaction mixture was stirred at room temperature 
overnight, dried over anhydrous magnesium sulfate, filtered, and concentrated 
in vacuo. The residue was purified by chromatography on silica gel (50% ethyl 
acetate in hexanes as eluent) to give 113.9 mg of 192. 
The aqueous layer obtained above was acidified to pH 3 with 3% 
aqueous phosphoric acid and was extracted with ethyl acetate (5 x 10 mL). The 
combined extracts were washed with brine, dried over anhydrous sodium 
sulfate, filtered, and concentrated in vacuo. The residue was diluted with diethyl 
ether and an ethereal solution of diazomethane95 was added until a yellow 
color persisted.  The reaction mixture was stirred overnight, dried over 
anhydrous magnesium sulfate, filtered, and concentrated in vacuo to give an 
additional 38.4 mg (total 152.3 mg, 65%) of 192: [at3 -3.2° (c 3.39, CHCI3); IR 
(neat) 3488 (broad), 2993, 2960, 1750, 1447, 1381, 1266, 1227, 1161, 1106, 
1013, 935, 853 cm-1; 1H NMR (CDCI3, 300 MHz) 8 1.06 (3H, d, J= 7 Hz), 1.44 
(3H, s), 1.98-2.23 (2H, m), 2.60 (1H, d, J = 4 Hz), 2.77-2.89 (1H, m), 2.98 (1H, d, 
J= 4 Hz), 3.67 (3H, s), 3.72 (1H, s), 3.81 (3H, s); 13C NMR (CDCI3, 75 MHz) 6 
19.3, 21.9, 28.5, 36.6, 46.1, 51.6, 52.9, 63.6, 77.0, 173.2, 174.4; LRMS m/z 247 105 
[(M + H)±, 20], 215 (30),  197  (100),  187 (30),  185  (20),  169 (40), 165 (90), 155 
(90), 143 (20),  141  (20),  137  (20),  127 (30),  113  (80),  85 (20), 69 (20); HRMS 
calcd. for Ci 1H1906 (M + H)± m/z 247.1182. Found: m/z 247.1182. 
BnO2C 
Benzyl Methyl Ester 202. To a stirred suspension of 190 (139 mg, 
0.377 mmol) and sodium bicarbonate (31.7 mg, 0.377 mmol) in 5 mL of 
dichloromethane at room temperature was added benzyl alcohol (390  3.77 
mmol). The reaction mixture was stirred at -78 °C and ozone was passed 
through the mixture for 5 min. The reaction mixture was stirred for an additional 
10 min and was allowed to warm to room temperature while a stream of argon 
was passed through the solution until it was clear and colorless. To the reaction 
mixture was added triethylamine (525 1.11, 3.77 mmol) and acetic anhydride 
(356 1.11_, 3.77 mmol), and the solution was stirred at room temperature for 30 
min, filtered, and concentrated in vacuo. The residue was passed through a 
short column of silica gel (33% of ethyl acetate in hexanes as eluent) to remove 
the residual benzyl alcohol. 
To a stirred solution of the crude aldehyde and 2- methyl -2- butene (1.6 
mL) in 10 mL of tert-butanol at room temperature was added dropwise a 
solution of sodium chlorite (313.7 mg, 3.47 mmol) and sodium phosphate 
monobasic, monohydrate (313.7 mg) in 5 mL of water. The reaction mixture 
was stirred at room temperature for 3 h and the organic layer was separated. 
The aqueous layer was acidified to pH 3 with 3% aqueous phosphoric acid and 
was extracted with ethyl acetate (3 x 20 mL). The combined organic extracts 
were washed with brine, dried over anhydrous sodium sulfate, filtered, and 106
 
concentrated  in vacuo.  The residue was diluted with 5 mL of diethyl ether and 
an ethereal solution of diazomethane was added until a yellow color persisted. 
The solution was stirred overnight and was dried over anhydrous magnesium 
sulfate, filtered, and concentrated  in vacuo.  The residue was purified by 
chromatography on silica ge (50% ethyl acetate in hexanes as eluent) to give 
57 mg (47%) of 202: [o]o3 +1.37° (c 1.82, CHCI3); IR (neat) 3492 (broad), 2950, 
1732, 1493, 1453, 1384, 1350, 1260, 1214, 1159, 1103, 984, 928, 751, 699 cm­
1; 1H NMR (CDCI3, 300 MHz) 6 1.05 (3H, d, J = 7 Hz), 1.43 (3H, s), 2.07 (1H, 
dd, J = 17, 6 Hz), 2.25 (1H, dd, J =  17, 9 Hz), 2.60 (1H, d, J = 4 Hz), 2.80-2.93 
(1H, m), 2.98 (1H, d, J = 4 Hz), 3.70 (1H, s, broad), 3.78 (3H, s), 5.12 (2H, d, J = 
3 Hz), 7.32-7.36 (5H, m); 13C NMR (CDCI3, 75 MHz) 8 19.3, 21.9, 28.6, 36.9, 
46.1, 52.9, 63.6, 66.3, 128.2, 128.3, 128.5, 136.0, 172.6, 174.4; LRMS m/z 323 
[(M + H)+, 50], 305 (40), 275 (20), 263 (20), 215 (80), 197 (50), 185 (40), 181 
(20), 169 (40), 165 (20), 155 (100), 139 (40), 129 (30), 119 (60), 113 (70), 107 
(20), 91 (100); HRMS calcd. for C17H2306 (M + H)-F m/z 323.1495. Found: m/z 
323.1495. 
O 
OOCO2Me 
6-Lactone 204. A mixture of 202 (41.6 mg, 0.129 mmol) and 10% 
palladium on activated carbon (20 mg) in 3 mL of methanol was stirred under 
an hydrogen atmosphere at room temperature for 20 h. The mixture was diluted 
with ethyl acetate, filtered through a small pad of Celite, and concentracted in 
vacuo to yield crude 203. 
To a stirred mixture of 2-chloro-1-methylpyridinium iodide (98.9 mg, 
0.387 mmol) and 4-dimethylaminopyridine (78.9 mg 0.646 mmol) in 2 mL of 107 
acetonitrile was added the crude 203 obtained above in 2 mL of acetonitrile via 
cannula. An additional 2 mL of acetonitrile was used to ensure that all of the 
alcohol was transferred to the reaction flask.  After stirring for 24 h at room 
temperature, 5 mL of diethyl ether was added to the solution which was filtered 
through a small pad of silica gel, eluting with diethyl ether. The eluent was 
concentrated and the residue was purified by chromatography on silica gel 
(55% ethyl acetate in hexanes as eluent) to give 27.3 mg (99%) of 204: [a]p 
+52.8° (c 2.32, CHCI3); IR (neat) 2949, 1744, 1453, 1442, 1381, 1260, 1194, 
1117, 1002, 947 cm-1; 1H NMR (CDCI3, 300 MHz) 5 0.85 (3H, d J = 6 Hz), 1.71 
(3H, s), 2.43-2.70 (3H, m), 2.99 (2H, dd, J = 6, 4 Hz), 3.75 (3H, s); 13C NMR 
(CDCI3, 75 MHz) 8 12.2, 23.1, 26.3, 35.6, 48.3, 53.0, 59.9,  85.8, 168.7,  169.4; 
LRMS m/z 215 [(M +  30],  197 (30), 185 (20), 169 (70),  165 (30), 155 (100), 
153 (20), 127 (30), 113 (70), 69 (20); HRMS calcd. for C10111505 (M + H)± m/z 
215.0920. Found: m/z 215.0919. 108 
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Table 1. Crystal Data and Structure Refinement for Nemorensine (1) 
Empirical Formula 
Formula Weight 
Temperature 
Wavelength 
Crystal Color, Habit 
Crystal System 
Space Group 
Unit Cell Dimensions: 
Volume 
Z 
Density (calculated) 
F(000) 
Crystal Size 
Diffractometer 
Reflections Collected 
Independent Reflections 
No. Observations [I <4.00sig(I)] 
No. Variables 
Reflection/Parameter Ratio 
Residuals: R; Rw 
Goodness- of-Fit on F2 
Max Shift/Error in Final Cycle 
Largest Diff. Peak and Hole 
C18H27N05 
337.4 
296 (2) K 
1.54178 A 
Yellow, plate 
Orthorhombic 
P2(1)2(1)2(1) 
a = 6.721(1) A  a = 90° 
b = 10.819(2) A  (3 = 90° 
c = 25.003(5) A  y = 90° 
1818.65 A3 
4 
1.233 Mg/m3 
728.00 
0.01 x 0.070 x 0.050 mm3 
Simens P4 
2002 
1823 [R(int) = 0.0442] 
1641 
217 
7.6:1 
0.0549; 0.0680 
1.41 
0.00 
0.27 and -0.22 e.A-3 121 
Table 2. Atomic Coordinates (x 104) and Equivalent Isotropic Displacement
 
Parameters (A2 x 103) for Nemorensine (1)
 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
 
Atom  x 
N  -20(8) 
0(1)  -1406(7) 
0(2)  -1798(13) 
0(3)  -2058(10) 
0(4)  -1912(7) 
0(5)  -4818(10) 
C(1)  -2143(11) 
C(2)  -2754(10) 
C(3)  -4834(10) 
C(4)  -4637(12) 
C(5)  -2431(13) 
C(6)  -1962(15) 
C(7)  -3103(15) 
C(8)  -2895(11) 
C(9)  -2975(12) 
C(10)  -831(11) 
C(12)  1825(11) 
C(13)  1482(11) 
C(14)  -375(11) 
C(15)  -1560(10) 
C(16)  -1457(14) 
C(17)  -2567(14) 
C18)  -6619(12) 
C(19)  -1503(15) 
y 
-7023(5) 
-2782(4) 
-1407(4) 
-3376(4) 
-5630(4) 
-5724(5) 
-2212(6) 
-2061(5) 
-2632(7) 
-3018(7) 
-3392(6) 
-4791(6) 
-5430(6) 
-6181(5) 
-7589(6) 
-7988(7) 
-6412(6) 
-5008(7) 
-4908(6) 
-6073(6) 
-3686(6) 
-697(6) 
-1826(8) 
-2937(7) 
z 
-4568(2) 
-3202(2) 
-4398(2) 
-4239(2) 
-3690(2) 
-3239(2) 
-4099(3) 
-3513(3) 
-3411(3) 
-2823(3) 
-2763(3) 
-2816(3) 
-3258(3) 
-4148(3) 
-4078(3) 
-4213(3) 
-4376(3) 
-4424(3) 
-4779(3) 
-4645(2) 
-4783(3) 
-3349(3) 
-3544(3) 
-2236(3) 
U(eq) 
39(2) 
42(2) 
91(3) 
66(2) 
36(1) 
69(2) 
40(2) 
37(2) 
45(2) 
53(3) 
48(3) 
54(3) 
51(3) 
37(2) 
49(2) 
52(3) 
54(3) 
54(3) 
43(2) 
37(2) 
58(3) 
64(3) 
75(3) 
73(3) 122 
Table 3. Bond Lengths [A] for Nemorensine (1) 
Atom 1  Atom 2 
0(1)  C(5) 
0(1)  C(2) 
0(4)  C(7) 
0(4)  C(8) 
0(3)  C(1) 
C(4)  C(5) 
C(4)  C(3) 
0(5)  C(7) 
0(2)  C(1) 
C(2)  C(1) 
C(6)  C(5) 
C(8)  C(9) 
C(3)  C(2) 
C(7)  C(6) 
Distance 
1.455(8) 
1.427(8) 
1.360(9) 
1.450(7) 
1.309(8) 
1.544(11) 
1.534(10) 
1.197(12) 
1.171(8) 
1.529(9) 
1.551(9) 
1.535(8) 
1.550(10) 
1.513(11) 
Atom 1 
N 
N 
N 
C(5) 
C(3) 
0(3) 
C(14) 
C(14) 
C(14) 
C(15) 
C(12) 
C(17) 
C(10) 
Atom2 
C(15) 
C(12) 
C(10) 
C(19) 
C(18) 
C(16) 
C(15) 
C(16) 
C(13) 
C(8) 
C(13) 
C(2) 
C(9) 
Distance 
1.471(9) 
1.486(9) 
1.475(9) 
1.537(10) 
1.520(11) 
1.458(8) 
1.528(9) 
1.508(10) 
1.536(10) 
1.538(9) 
1.540(10) 
1.538(9) 
1.541(11) 123 
Table 4. Bond Angles [°] for Nemorensine (1) 
Atoms (1-2-3)  Angle 
C(5)-0(1)-C(2)  111.1(5) 
C(7)-0(4)-C(8)  115.1(6) 
0(4)-C(7)-0(5)  123.8(7) 
0(4)-C(7)-C(6)  110.7(8) 
0(5)-C(7)-C(6)  125.4(7) 
C(5)-C(4)-C(3)  104.3(6) 
C(7)-C(6)-C(5)  113.9(6) 
0(4)-C(8)-C(9)  109.5(5) 
0(1)-C(5)-C(4)  105.2(5) 
0(1)-C(5)-C(6)  106.4(5) 
C(4)-C(5)-C(6)  116.3(7) 
C(4)-C(3)-C(2)  100.9(5) 
0(1)-C(2)-C(3)  105.4(5) 
0(1)-C(2)-C(1)  107.1(5) 
C(3)-C(2)-C(1)  111.0(5) 
0(3)-C(1)-0(2)  122.4(6) 
0(3)-C(1)-C(2)  111.8(5) 
0(2)-C(1)-C(2)  125.8(6) 
C(15)-N-C(12)  108.6(5) 
C(15)-N-C(10)  108.2(5) 
C(12)-N-C(10)  115.4(5) 
N-C(15)-C(14)  103.8(5) 
Atoms (1-2-3)  Angle 
N-C(12)-C(13)  106.8(6) 
N-C(15)-C(8)  104.6(5) 
N-C(10)-C(9)  106.2(5) 
C(17)-C(2)-C(1)  109.6(5) 
C(16)-0(3)-C(1)  118.9(5) 
C(8)-C(9)-C(10)  102.7(6) 
0(4)-C(8)-C(15)  110.0(5) 
C(15)-C(8)-C(9)  100.8(5) 
0(1)-C(5)-C(19)  107.9(6) 
C(4)-C(5)-C(19)  112.9(6) 
C(6)-C(5)-C(19)  107.7(6) 
C(4)-C(3)-C(18)  115.7(6) 
C(2)-C(3)-C(18)  116.6(6) 
0(1)-C(2)-C(17)  109.1(5) 
C(3)-C(2)-C(17)  114.4(6) 
C(14)-C(15)-C(8)  122.9(5) 
0(3)-C(16)-C(14)  109.2(5) 
C(14)-C(13)-C(12)  103.7(6) 
C(15)-C(14)-C(16)  118.2(6) 
C(15)-C(14)-C(13)  103.8(5) 
C(16)-C(14)-C(13)  117.2(6) 124 
Table 5. Anisotropic Displacement Parameters (A2 x 103) for 
Nemorensine (1) 
The anisotropic displacement factor exponent takes the form: 
-2 7r2 [ h2a*2U11 +  + 2 h K a* b* U12] 
Atom  U11  U22  U33  U12  U13  U23 
0(1)  40(3)  42(3)  44(3)  0(3)  -4(2)  5(2) 
0(2)  181(7)  41(3)  52(3)  1(5)  15(5)  12(3) 
0(3)  115(5)  33(3)  52(3)  3(3)  47(4)  2(2) 
0(4)  44(3)  35(2)  29(2)  -7(3)  1(2)  -2(2) 
0(5)  76(4)  62(4)  71(4)  -34(4)  38(4)  -17(3) 
N  38(3)  41(3)  40(3)  4(3)  1(3)  -8(3) 
C(1)  40(4)  34(4)  45(4)  1(4)  4(4)  4(3) 
C(2)  41(4)  27(3)  45(4)  -1(4)  -1(4)  -7(3) 
C(3)  36(4)  50(4)  48(4)  2(4)  8(4)  -11(4) 
C(4)  56(5)  53(5)  49(4)  -4(5)  18(4)  -10(4) 
C(5)  73(6)  41(4)  31(4)  2(4)  -4(4)  -9(3) 
C(6)  93(6)  42(4)  28(3)  3(5)  -3(4)  2(3) 
C(7)  87(6)  25(4)  41(4)  -5(5)  10(5)  3(3) 
C(8)  37(4)  35(3)  39(4)  -6(4)  4(4)  -6(3) 
C(9)  57(5)  35(4)  54(4)  -13(4)  1(4)  -5(3) 
C(10)  57(5)  42(4)  57(5)  10(4)  0(4)  3(4) 
C(12)  39(4)  60(5)  61(5)  2(4)  -2(4)  -16(4) 
C(13)  45(4)  55(5)  60(5)  -16(4)  13(4)  -10(4) 
C(14)  51(5)  43(4)  34(4)  2(4)  12(4)  0(3) 
C(15)  42(4)  42(4)  29(3)  3(4)  -2(3)  -6(3) 
C(16)  87(6)  45(4)  42(4)  3(5)  29(5)  4(3) 
C(17)  84(7)  34(4)  72(5)  -4(5)  -2(5)  -11(4) 
C(18)  46(5)  106(7)  73(5)  24(6)  5(5)  -9(6) 
C(19)  108(8)  66(5)  44(4)  7(6)  -14(5)  -17(4) 125 
Table 6. Hydrogen Coordinates (x 104) and Isotropic Displacement 
Parameters (A2 x 103) for Nemorensine (1) 
x  y z  U(eq) 
H(3A)  4934  3372  3621  80
 
H(4A)  5500  3697  2737
  80 
H(4B)  4942  2335  2592  80 
H(6A)  2265  5190  2483  80 
H(6B)  564  4891  2882  80 
H(8A)  4198  5843  4206  80 
H(9A)  3288  7800  3715  80 
H(9B)  3919  7981  4311  80 
H(10A)  832  8776  4389  80 
H(10B)  37  8049  3895  80 
H(12A)  -2072  6637  4011  80 
H(12B)  -2946  6656  4589  80 
H(13A)  -2603  4600  4583  80 
H(13B)  -1225  4646  4080  80 
H(14A)  -114  5032  5135  80 
H(15A)  2318  6295  4956  80 
H(16A)  2609  3747  5008  80 
H(16B)  608  3047  4920  80 
H(17A)  1246  397  3417  80 
H(17B)  2860  620  2975  80 
H(17C)  3506  220  3552  80 
H(18A)  7827  2270  3471  80 
H(18B)  6581  1597  3914  80 
H(18C)  6572  1096  3326  80 
H(19A)  1771  2071  2193  80 
H(19B)  91  3068  2247  80 
H(19C)  2063  3386  1942  80 126 
Table 7. Torsion Angles [°] for Nemorensine (1) 
Atoms (1-2-3-4) 
N-C(15)-C(8)-0(4) 
N-C(15)-C(8)-C(9) 
N-C(10)-C(9)-C(8) 
C(15)-N-C(10)-C(9) 
C(12)-N-C(10)-C(9) 
C(5)-C(4)-C(3)-C(2) 
C(8)-0(4)-C(7)-0(5) 
C(8)-0(4)-C(7)-C(6) 
C(12)-N-C(15)-C(8) 
0(4)-C(7)-C(6)-C(5) 
0(5)-C(7)-C(6)-C(5) 
C(7)- O(4)- C(8) -C(9) 
C(10)-N-C(15)-C(8) 
C(2)-0(1)-C(5)-C(4) 
C(2)-0(1)-C(5)-C(6) 
0(1)-C(2)-C(1)-0(3) 
0(1)-C(2)-C(1)-0(2) 
C(3)-C(2)-C(1)-0(3) 
C(3)-C(2)-C(1)-0(2) 
C(3)-C(4)-C(5)-0(1) 
C(3)-C(4)-C(5)-C(6) 
C(7)-C(6)-C(5)-0(1) 
C(7)-C(6)-C(5)-C(4) 
C(5)-0(1)-C(2)-C(3) 
C(5)-0(1)-C(2)-C(1) 
C(4)-C(3)-C(2)-0(1) 
C(4)-C(3)-C(2)-C(1) 
C(18)-C(3)-C(2)-0(1) 
C(2)-0(1)-C(5)-C(19) 
C(3)-C(4)-C(5)-C(19) 
Angle 
-75.8 
39.8 
25.5 
-0.6 
-122.5 
33.6
 
-3.0
 
176.8 
101.2 
-103.5 
76.4 
83.7 
-24.7 
-1.2 
-125.0 
-54.4 
126.2 
60.0 
-119.3 
-21.3 
96.0 
75.6 
-41.1 
23.0 
141.3 
-34.9 
-150.4 
-161.0 
119.6 
-138.8 
Atoms (1-2-3-4)  Angle 
C(7)-C(6)-C(5)-C(19)  -168.9 
C(5)-C(4)-C(3)-C(18)  160.4 
C(12)-N-C(15)-C(14)  -28.7 
C(16)-C(14)-C(15)-N  168.8 
C(13)-C(14)-C(15)-N  36.9 
C(10)-N-C(15)-C(14)  -154.6 
C(15)-N-C(12)-C(13)  9.1 
C(10)-N-C(12)-C(13)  130.8 
C(7)-0(4)-C(8)-C(15)  -166.4 
C(5)-0(1)-C(2)-C(17)  -100.2 
C(18)-C(3)-C(2)-C(1)  83.4 
C(16)-0(3)-C(1)-0(2)  -1.8 
C(16)-0(3)-C(1)-C(2)  178.8 
C(4)-C(3)-C(2)-C(17)  84.9 
N-C(12)-C(13)-C(14)  14.1 
0(4)-C(8)-C(9)-C(10)  76.7 
C(17)-C(2)-C(1)-0(3)  -172.7 
C(17)-C(2)-C(1)-0(2)  8.0 
C(15)-C(8)-C(9)-C(10)  -39.3 
C(14)-C(15)-C(8)-0(4)  41.7 
C(14)-C(15)-C(8)-C(9)  157.2 
C(1)-0(3)-C(16)-C(14)  -148.3 
C(18)-C(3)-C(2)-C(17)  -41.2 
C(16)-C(14)-C(15)-C(8)  50.9 
C(13)-C(14)-C(15)-C(8)  -80.9 
C(15)-C(14)-C(16)-0(3)  -67.8 
C(13)-C(14)-C(16)-0(3)  57.7 
C(15)-C(14)-C(13)-C(12)  -31.0 
C(16)-C(14)-C(13)-C(12)  -163.4 127 
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Table 1.  Crystal Data and Structure Refinement for a-Methylene 
Lactone 180
 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(000) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected / unique 
Completeness to 2theta = 57.08 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Extinction coefficient 
Largest diff. peak and hole 
STR3 
C11H1405 
226.22 
293(2) K 
1.54178 A 
Orthorhombic 
P212121 
a = 6.464(1) A  a = 90° 
b = 12.331(1) A  13 = 90° 
c = 14.434(1) A  y = 90° 
1150.43(14) A3 
4 
1.306 Mg/m3 
0.876 mm-1 
480 
0.3 x 0.3 x 0.02 mm3 
4.72 to 57.08 °
 
-7<=h<=4, -13<=k<=9, -15<=1<=10
 
1436 / 1236 [R(int) = 0.0482]
 
98.1%
 
Empirical (psi-scans)
 
0.998 and 0.616 
Full-matrix least-squares on F2 
1236 / 0 / 164 
1.055 
R1 = 0.0411, wR2 = 0.1140
 
R1 = 0.0437, wR2 = 0.1181
 
0.0(4)
 
0.019(2)
 
0.134 and -0.151 e.A-3 129 
Table 2.  Atomic Coordinates (x 104) and Equivalent Isotropic 
Displacement Parameters (A2 x 103) for a-Methylene Lactone 180 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
Atom  x  y  z  U(eq) 
0(1)  6778(3)  2133(2)  7548(2)  74(1) 
C(2)  6982(4)  3188(2)  7114(2)  59(1) 
C(21)  4874(5)  3418(4)  6692(3)  94(1) 
C(22)  8626(5)  3086(2)  6364(2)  54(1) 
0(21)  9662(4)  2311(2)  6229(2)  88(1) 
0(22)  8734(4)  3989(2)  5883(1)  74(1) 
C(23)  10315(8)  4042(3)  5159(2)  90(1) 
C(3)  7693(4)  3984(2)  7851(2)  58(1) 
0(3)  6096(4)  4257(2)  8501(2)  94(1) 
C(31)  6864(7)  5081(3)  7876(4)  87(1) 
C(4)  9765(5)  3703(2)  8258(2)  60(1) 
C(42)  10357(8)  4381(3)  9096(3)  107(1) 
C(5)  9868(5)  2495(3)  8462(2)  69(1) 
C(51)  11440(9)  2050(4)  8877(4)  137(2) 
C(6)  8221(6)  1761(3)  8130(3)  77(1) 
0(6)  8026(6)  830(2)  8380(3)  129(1) 130 
Table 3.  Bond Lengths [A]  for a-Methylene Lactone 180 
Atom 1  Atom 2  Distance  Atom 1  Atom 2  Distance 
0(1)  C(6)  1.336(4)  0(3)  C(31)  1.446(5) 
0(1)  C(2)  1.450(4)  C(4)  C(42)  1.519(5) 
C(2)  C(3)  1.517(4)  C(5)  C(51)  1.301(6) 
C(3)  0(3)  1.435(4)  C(2)  C(21)  1.519(5) 
C(3)  C(4)  1.504(4)  C(2)  C(22)  1.523(4) 
C(4)  C(5)  1.520(4)  C(22)  0(21)  1.182(3) 
C(5)  C(6)  1.477(5)  C(22)  0(22)  1.314(3) 
C(6)  0(6)  1.210(4)  0(22)  C(23)  1.463(5) 
C(3)  C(31)  1.455(5) 
Table 4.  Bond Angles [0] for a-Methylene Lactone 180 
Atoms (1-2-3)  Angle  Atoms (1-2-3)  Angle 
C(6)-0(1)-C(2)  121.0(2)  0(3)-C(3)-C(31)  60.0(2) 
0(1)-C(2)-C(3)  107.8(3)  C(3)-0(3)-C(31)  60.7(2) 
0(3)-C(3)-C(4)  116.1(3)  0(3)-C(31)-C(3)  59.3(2) 
0(3)-C(3)-C(2)  113.1(2)  C(31)-C(3)-C(4)  122.2(3) 
C(4)-C(3)-C(2)  113.2(2)  C(31)-C(3)-C(2)  120.5(3) 
C(3)-C(4)-C(5)  109.9(3)  C(3)-C(4)-C(42)  114.1(3) 
C(6)-C(5)-C(4)  120.4(3)  C(42)-C(4)-C(5)  112.0(3) 
0(6)-C(6)-0(1)  116.1(3)  C(51)-C(5)-C(6)  117.0(3) 
0(6)-C(6)-C(5)  124.0(4)  C(51)-C(5)-C(4)  122.4(3) 
0(1)-C(6)-C(5)  119.8(3)  C(21)-C(2)-C(22)  110.8(3) 
0(1)-C(2)-C(21)  105.0(2)  0(22)-C(22)-C(2)  110.0(2) 
C(3)-C(2)-C(21)  115.6(3)  0(21)-C(22)-C(2)  125.4(3) 
0(1)-C(2)-C(22)  107.2(2)  0(21)-C(22)-0(22)  124.6(3) 
C(3)-C(2)-C(22)  109.9(2)  C(22)-0(22)-C(23)  116.9(3) 131 
Table 5.  Anisotropic Displacement Parameters (A2 x 103) for 
a-Methylene Lactone 180 
The anisotropic displacement factor exponent takes the form: 
-27c2[ h2 a*2 Ull  + ... + 2 h k a* b* U12] 
Atom  U11  U22  U33  U23  U13  U12 
0(1)  65(1)  60(1)  96(2)  4(1)  -1(1)  -19(1) 
C(2)  49(2)  46(2)  82(2)  -6(1)  0(1)  -1(1) 
C(21)  53(2)  104(3)  125(3)  -13(2)  -17(2)  6(2) 
C(22)  59(2)  45(1)  59(2)  -7(1)  -9(1)  4(2) 
0(21)  113(2)  57(1)  93(2)  1(1)  22(2)  31(1) 
0(22)  92(2)  57(1)  72(1)  8(1)  -1(1)  11(1) 
C(23)  122(3)  93(3)  55(2)  11(2)  11(2)  5(2) 
C(3)  52(2)  52(2)  69(2)  -8(1)  10(1)  0(1) 
0(3)  88(2)  92(2)  101(2)  -20(2)  41(1)  5(1) 
C(31)  92(3)  59(2)  109(3)  -20(2)  8(3)  21(2) 
C(4)  64(2)  52(2)  65(2)  -4(1)  1(2)  -9(2) 
C(42)  139(4)  83(3)  100(3)  -16(2)  -36(3)  -21(3) 
C(5)  74(2)  60(2)  75(2)  4(2)  -6(2)  1(2) 
C(51)  141(4)  78(3)  190(6)  20(3)  -82(5)  -3(3) 
C(6)  83(2)  58(2)  90(2)  10(2)  2(2)  -16(2) 
0(6)  160(3)  69(2)  160(3)  44(2)  -40(2)  -43(2) ,  132 
Table 6.  Hydrogen Coordinates (x 104) and Isotropic Displacement 
Parameters (A2 x 103) for a-Methylene Lactone 180 
Atom  x  y  z  U(eq) 
H(21A)  4460(2)  2824(18)  6337(18)  126(5) 
H(21B)  4957(11)  4030(2)  6316(19)  126(5) 
H(21C)  3910(3)  3540(2)  7164(12)  126(5) 
H (23A)  10160(15)  4730(6)  4810(7)  126(5) 
H(23B)  10140(15)  3420(7)  4730(6)  126(5) 
H (23C)  11720(4)  4010(12)  5448(10)  126(5) 
H(23D)  11190(15)  3370(6)  5180(7)  126(5) 
H(23E)  11210(15)  4690(7)  5260(6)  126(5) 
H (23F)  9632(18)  4100(12)  4540(18)  126(5) 
H(31A)  7710(6)  5610(3)  8210(3)  87(11) 
H(31B)  6030(8)  5370(4)  7420(3)  116(16) 
H(4)  10810(5)  3851(8)  7770(2)  126(5) 
H (42A)  10340(4)  5150(2)  8928(8)  126(5) 
H(42B)  11750(4)  4178(16)  9303(13)  126(5) 
H(42C)  9360(4)  4250(18)  9599(15)  126(5) 
H(51A)  11495(10)  1240(3)  8960(5)  126(5) 
H(51B)  12610(4)  2518(15)  9117(9)  126(5) 133 
Table 7.  Torsion Angles [°] for a-Methylene Lactone 180 
Atoms (1-2-3-4) 
C(6)-0(1)-C(2)-C(3) 
0(1)-C(2)-C(3)-0(3) 
0(1)-C(2)-C(3)-C(4) 
0(3)-C(3)-C(4)-C(5) 
C(2)-C(3)-C(4)-C(5) 
C(3)-C(4)-C(5)-C(6) 
C(4)-C(5)-C(6)-0(1) 
C(2)-0(1)-C(6)-C(5) 
C(4)-C(5)-C(6)-0(6) 
C(2)-0(1)-C(6)-0(6) 
C(31)-C(3)-C(4)-C(5) 
C(6)-0(1)-C(2)-C(21) 
C(6)-0(1)-C(2)-C(22) 
C(21)-C(2)-C(3)-0(3) 
C(22)-C(2)-C(3)-0(3) 
0(1)-C(2)-C(3)-C(31) 
C(21)-C(2)-C(3)-C(4) 
C(22)-C(2)-C(3)-C(4) 
C(4)-C(3)-0(3)-C(31) 
C(2)-C(3)-0(3)-C(31) 
Angle 
-44.0(3) 
-73.0(3) 
61.7(3) 
89.0(3) 
-44.2(3) 
9.4(4) 
8.6(5) 
10.4(4) 
-168.3(4) 
-172.5(3) 
158.6(3) 
-167.7(3) 
74.3(3) 
44.1(4) 
170.5(2) 
-140.7(3) 
178.8(3) 
-54.9(3) 
113.7(3) 
-113.0(4) 
Atoms (1-2-3-4)  Angle 
C(4)-C(3)-C(31)-0(3)  -103.7(3) 
C(2)-C(3)-C(31)-0(3)  100.7(3) 
0(3)-C(3)-C(4)-C(42)  -37.7(4) 
C(2)-C(3)-C(4)-C(42)  -171.0(3) 
C(42)-C(4)-C(5)-C(6)  137.3(4) 
C(51)-C(5)-C(6)-0(6)  15.9(6) 
C(51)-C(5)-C(6)-0(1)  -167.1(4) 
C(3)-C(4)-C(5)-C(51)  -175.1(4) 
0(1)-C(2)-C(22)-0(22)  173.7(2) 
C(3)-C(2)-C(22)-0(22)  -69.4(3) 
C(21)-C(2)-C(3)-C(31)  -23.6(4) 
C(22)-C(2)-C(3)-C(31)  102.8(3) 
C(31)-C(3)-C(4)-C(42)  31.8(5) 
C(42)-C(4)-C(5)-C(51)  -47.2(6) 
0(1)-C(2)-C(22)-0(21)  -6.4(4) 
C(3)-C(2)-C(22)-0(21)  110.5(3) 
C(21)-C(2)-C(22)-0(22)  59.6(3) 
C(2)-C(22)-0(22)-C(23)  177.2(3) 
C(21)-C(2)-C(22)-0(21)  -120.5(4) 
0(21)-C(22)-0(22)-C(23)  -2.7(5)
 134 
APPENDIX C
 
SUPPLEMENTARY CRYSTALLOGRAPHIC INFORMATION ON
 
SPIRODILACTONE 184
 135 
Table 1.  Crystal Data and Structure Refinement for 
Spirodilactone 184
 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(000) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Extinction coefficient 
Largest diff. peak and hole 
STR4 
C10I-11205 
212.20 
298(2) K 
1.54178 A 
Monoclinic 
P21 
a = 6.928(1) A  = 90° 
b = 6.503(1) A  f3 = 91.222(6)° 
c = 11.336(1) A  y = 90° 
510.67(6) A3 
2 
1.380 Mg/m3 
0.950 mm-1 
224 
0.60 x 0.10 x 0.05 mm3 
6.39 to 57.43 ° 
-7<=h<=5, -7<=k<=5, -12<=1<=12 
1340 
1100 [R(int) = 0.0235] 
Empirical (Psi scans) 
0.9540 and 0.5994 
Full-matrix least-squares on F2 
1100 / 1 / 149 
1.073 
R1 = 0.0337, wR2 = 0.0879 
R1 = 0.0354, wR2 = 0.0896 
0.0(4) 
0.023(2) 
0.109 and -0.102 e.A-3 136 
Table 2.  Atomic Coordinates (x 104) and Equivalent Isotropic
 
Displacement Parameters (A2 x 103) for Spirodilactone 184
 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
 
Atom  x  y  z  U(eq) 
0(9)  4794(2)  9209(3)  8582(2)  54(1) 
0(2)  2865(3)  5803(3)  7797(2)  63(1) 
0(8)  4737(5)  9078(4)  10527(2)  101(1) 
0(4)  5858(3)  9152(4)  6190(2)  76(1) 
C(1)  3434(3)  9535(5)  7578(2)  47(1) 
C(2)  3261(4)  7392(5)  7011(2)  48(1) 
0(3)  6210(3)  5749(5)  6306(2)  84(1) 
C(3)  5259(4)  7245(7)  6482(2)  62(1) 
C(5)  4563(5)  10683(7)  6676(3)  70(1) 
C(8)  3914(5)  9445(5)  9613(3)  64(1) 
C(6)  1734(4)  10690(6)  8111(3)  61(1) 
C(7)  1928(5)  10160(4)  9386(3)  70(1) 
C(22)  1807(5)  7185(6)  5977(3)  74(1) 
C(62)  -278(5)  10398(9)  7575(5)  117(2) 
C(72)  635(8)  10189(6)  10240(5)  119(2) 137 
Table 3.  Bond Lengths [A] for Spirodilactone 184 
Atom 1  Atom 2  Distance  Atom 1  Atom 2  Distance 
0(9)  C(8)  1.339(3)  C(1)  C(2)  1.538(4) 
0(9)  C(1)  1.477(3)  C(2)  C(3)  1.523(4) 
0(2)  C(2)  1.395(3)  0(3)  C(3)  1.194(4) 
0(8)  C(8)  1.196(4)  C(8)  C(7)  1.470(5) 
0(4)  C(3)  1.351(4)  C(6)  C(7)  1.489(5) 
0(4)  C(5)  1.456(4)  C(2)  C(22)  1.535(4) 
C(1)  C(5)  1.500(4)  C(6)  C(62)  1.521(4) 
C(1)  C(6)  1.532(4)  C(7)  C(72)  1.333(6) 
Table 4.  Bond Angles [O] for Spirodilactone 184 
Atoms (1-2-3)  Angle  Atoms (1-2-3)  Angle 
C(3)-C(2)-C(1)  99.1(2)  0(4)-C(5)-C(1)  104.6(3) 
C(8)-0(9)-C(1)  111.2(2)  0(8)-C(8)-0(9)  121.1(3) 
C(3)-0(4)-C(5)  109.9(2)  0(8)-C(8)-C(7)  129.9(3) 
0(9)-C(1)-C(5)  105.3(2)  0(9)-C(8)-C(7)  109.0(3) 
0(9)-C(1)-C(6)  104.4(2)  C(7)-C(6)-C(1)  102.4(2) 
C(5)-C(1)-C(6)  116.2(3)  C(8)-C(7)-C(6)  108.0(3) 
0(9)-C(1)-C(2)  103.5(2)  0(2)-C(2)-C(22)  106.7(2) 
C(5)-C(1)-C(2)  101.7(2)  C(3)-C(2)-C(22)  106.3(2) 
C(6)-C(1)-C(2)  123.7(2)  C(22)-C(2)-C(1)  116.2(2) 
0(2)-C (2)-C (3)  113.5(3)  C(7)-C(6)-C(62)  115.0(4) 
0(2)-C(2)-C(1)  114.8(2)  C(62)-C(6)-C(1)  119.1(3) 
0(3)- C(3) -0(4)  122.3(3)  C(72)-C(7)-C(8)  121.2(4) 
0(3)-C(3)-C(2)  128.7(3)  C(72)- C(7) -C(6)  130.8(4) 
0(4)-C(3)-C(2)  109.0(3) 138 
Table 5.  Anisotropic Displacement Parameters (A2 x 103) for 
Spirodilactone 184 
The anisotropic displacement factor exponent takes the form: 
-2 7E2  [  h2a*2U1 1  + 2 h k a* b* U12] 
Atom  U11  U22  U33  U23  U13  U12 
0(9)  52(1)  65(1)  44(1)  -5(1)  -6(1)  -4(1) 
0(2)  67(1)  57(1)  64(1)  1(1)  5(1)  -10(1) 
0(8)  183(3)  74(2)  44(1)  -8(1)  -24(2)  9(2) 
0(4)  66(1)  104(2)  58(1)  11(1)  20(1)  -15(2) 
C(1)  44(1)  54(2)  42(1)  4(1)  -4(1)  -7(1) 
C(2)  49(1)  55(2)  40(1)  -2(1)  0(1)  -6(2) 
0(3)  69(1)  109(2)  74(2)  -20(2)  10(1)  15(2) 
C(3)  56(2)  90(3)  41(1)  -6(2)  2(1)  1(2) 
C(5)  71(2)  75(2)  64(2)  16(2)  6(2)  -7(2) 
C(8)  99(2)  47(2)  47(2)  -10(2)  6(2)  -2(2) 
C(6)  51(2)  54(2)  77(2)  -9(2)  0(1)  2(2) 
C(7)  96(2)  42(2)  73(2)  -9(2)  37(2)  -3(2) 
C(22)  69(2)  87(3)  64(2)  -20(2)  -14(2)  -4(2) 
C(62)  55(2)  126(4)  170(5)  -59(3)  -16(2)  20(2) 
C(72)  160(4)  63(3)  137(4)  -1(2)  90(4)  9(3) 139
 
Table 6.  Hydrogen Coordinates (x 104) and Isotropic Displacement 
Parameters (A2 x 103) for Spirodilactone 184 
Atom  x  y  z  U(eq) 
H(2)  3829(4)  5630(5)  8280(3)  47(8) 
H (5A)  3710(3)  11246(19)  6060(18)  84 
H(5B)  5290(2)  11810(4)  7042(11)  84 
H(6)  2030(13)  12160(6)  8046(4)  73 
H (22A)  540(3)  7060(5)  6274(7)  110 
H(22B)  2110(3)  6000(4)  5527(19)  110 
H (22C)  1870(3)  8370(3)  5488(17)  110 
H (62A)  -1220(3)  11320(6)  8000(3)  176 
H (62B)  -690(3)  8910(5)  7670(3)  176 
H(62C)  -268(14)  10770(6)  6700(3)  176 
H (72A)  1010(4)  9719(18)  11060(3)  142 
H(72B)  -710(5)  10683(18)  10068(8)  142 140 
Table 7.  Torsion Angles [°] for Spirodilactone 184 
Atoms (1-2-3-4) 
C(8)-0(9)-C(1)-C(5) 
C(8)-0(9)-C(1)-C(6) 
C(8)-0(9)-C(1)-C(2) 
0(9)-C(1)-C(2)-0(2) 
C(5)-C(1)-C(2)-0(2) 
C(6)-C(1)-C(2)-0(2) 
0(9)-C(1)-C(2)-C(3) 
C(5)-C(1)-C(2)-C(3) 
C(6)-C(1)-C(2)-C(3) 
C(5)- O(4)- C(3) -O(3) 
C(5)- O(4)- C(3) -C(2) 
O(2)- C(2)- C(3) -O(3) 
C(1)-C(2)-C(3)-0(3) 
O(2)- C(2)- C(3) -O(4) 
C(1)-C(2)-C(3)-0(4) 
C(3)- O(4)- C(5) -C(1) 
0(9)-C(1)-C(5)-0(4) 
C(6)-C(1)-C(5)-0(4) 
C(2)-C(1)-C(5)-0(4) 
C(1)-0(9)-C(8)-0(8) 
Angle 
140.8(3) 
17.9(3) 
-112.8(2) 
50.2(3) 
159.3(2) 
-67.8(3) 
-71.0(2) 
38.1(2) 
171.0(3) 
-170.9(3) 
10.3(3) 
28.4(4) 
150.6(3) 
-152.9(2) 
-30.7(3) 
15.5(3) 
73.7(3) 
-171.3(2) 
-34.0(3) 
173.8(3) 
Atoms (1-2-3-4)  Angle 
C(1)-0(9)-C(8)-C(7)  -5.8(3) 
0(9)-C(1)-C(6)-C(7)  -21.9(3) 
C(5)-C(1)-C(6)-C(7)  -137.3(3) 
C(2)-C(1)-C(6)-C(7)  95.7(3) 
O(8)- C(8)- C(7) -C(6)  171.2(4) 
O(9)- C(8)- C(7) -C(6)  -9.3(4) 
C(1)-C(6)-C(7)-C(8)  19.3(3) 
0(9)-C(1)-C(2)-C(22)  175.7(2) 
C(5)-C(1)-C(2)-C(22)  -75.3(3) 
C(6)-C(1)-C(2)-C(22)  57.7(3) 
C(22)- C(2)- C(3) -O(3)  -88.5(4) 
C(22) -C (2) -C (3) -O(4)  90.1(3) 
0(9)-C(1)-C(6)-C(62)  -150.0(4) 
C(5)-C(1)-C(6)-C(62)  94.5(5) 
C(2)-C(1)-C(6)-C(62)  -32.5(5) 
O(8)- C(8)- C(7) -C(72)  -10.9(6) 
O(9)- C(8)- C(7) -C(72)  168.6(3) 
C(1)-C(6)-C(7)-C(72)  -158.4(4) 
C(62)-C(6)-C(7)-C(8)  150.0(3) 
C(62)-C(6)-C(7)-C(72)  -27.6(6) 141 
APPENDIX D
 
SUPPLEMENTARY CRYSTALLOGRAPHIC INFORMATION ON
 
(-)-SWAZINE (2)
 
C(26) 
0(261)  0(262) 
C(18) 
C(15) 142 
Table 1. Crystal Data and Structure Refinement for Swazine (2) 
Empirical formula 
Formula Weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(000) 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Extinction coefficient 
Largest diff. peak and hole 
C18H23N06 
349.37 
293 (2) K 
1.54178 A 
Orthorhombic 
P212121 
a = 8.9400(10) A  a = 90° 
b = 12.2290(10) A  [3 = 90° 
c = 16.7060(10) A  y= 90° 
1826.4(3) A3 
4 
1.271 Mg/m3 
0.795 mm-1 
744 
4.48 to 56.73 ° 
-1<=h<=9, -1<=k<=13, -1<=1<=18 
1936 
1775 [R(int) = 0.0335] 
Full-matrix least-squares on F2 
1775 / 0 / 251 
1.050 
R1 = 0.0360, wR2 = 0.0971
 
R1 = 0.0365, wR2 = 0.0979
 
0.4(3)
 
0.0226(12)
 
0.131 and -0.151 eA-3 143 
Table 2. Atomic Coordinates (x 104) and Equivalent Isotropic Displacement
 
Parameters (A2 x 103) for Swazine (2)
 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
 
Atom  x 
N  8894(2) 
C(11)  10450(4) 
C(12)  10469(4) 
C(13)  9390(3) 
C(14)  8161(3) 
C(15)  7307(3) 
C(16)  7573(4) 
C(17)  8647(4) 
C(18)  6230(3) 
C(21)  11053(3) 
0(211)  10047(2) 
0(212)  11485(3) 
C(22)  11573(3) 
C(222)  12986(4) 
C(23)  10439(3) 
C(232)  11157(4) 
C(24)  9339(3) 
0(24)  9254(2) 
C(242)  9942(4) 
C(25)  7817(3) 
0(25)  8142(2) 
C(252)  6724(4) 
C(26)  7088(3) 
0(261)  6969(2) 
0(262)  6646(3) 
y 
4086(2) 
4319(3) 
5533(3) 
5986(2) 
5141(2) 
4865(2) 
3844(2) 
3291(2) 
5623(2) 
6767(2) 
5978(1) 
7410(2) 
6696(2) 
6929(3) 
6373(2) 
6002(2) 
7320(2) 
8092(1) 
8424(2) 
7032(2) 
6672(2) 
7993(3) 
6118(2) 
6394(1) 
5274(2) 
z 
5320(1) 
5523(2) 
5696(2) 
5084(2) 
5096(1) 
4345(1) 
4135(2) 
4675(2) 
3953(2) 
4127(2) 
4289(1) 
4623(1) 
3281(2) 
3145(2) 
2655(2) 
1877(2) 
2526(1) 
3171(1) 
2431(2) 
2156(1) 
1379(1) 
2143(2) 
2647(1) 
3416(1) 
2368(1) 
U(eq) 
47(1) 
67(1) 
62(1) 
46(1) 
42(1) 
42(1) 
53(1) 
60(1) 
51(1) 
49(1) 
43(1) 
75(1) 
49(1) 
80(1) 
41(1) 
58(1) 
38(1) 
52(1) 
53(1) 
44(1) 
62(1) 
67(1) 
44(1) 
45(1) 
74(1) 144 
Table 3. Bond Lengths [A] for Swazine (2) 
Atom 1  Atom 2  Distance  Atom 1  Atom 2  Distance 
N  C(11)  1.459(4)  C(242)  H(1)  0.97(4) 
N  C(17)  1.469(3)  C(242)  H(2)  1.00(4) 
N  C(14)  1.495(3)  0(25)  H(25)  0.91(4) 
C(11)  C(12)  1.513(5)  C(25)  C(26)  1.531(4) 
C(12)  C(13)  1.512(4)  C(18)  0(261)  1.460(3) 
C(21)  C(22)  1.490(4)  C(21)  0(212)  1.206(3) 
C(22)  C(23)  1.509(4)  C(21)  0(211)  1.346(3) 
C(23)  C(24)  1.534(3)  C(13)  0(211)  1.452(3) 
C(24)  0(24)  1.435(3)  C(22)  C(222)  1.315(4) 
C(13)  C(14)  1.508(4)  C(23)  C(232)  1.520(4) 
C(14)  C(15)  1.507(3)  C(24)  C(242)  1.462(4) 
C(15)  C(16)  1.319(4)  0(24)  C(242)  1.438(4) 
C(15)  C(18)  1.489(4)  C(25)  C(252)  1.529(4) 
C(16)  C(17)  1.481(4)  C(26)  0(262)  1.200(3) 
C(24)  C(25)  1.535(4)  C(26)  0(261)  1.333(3) 
C(25)  0(25)  1.401(3) 145 
Table 4. Bond Angles [°] for Swazine (2) 
Atoms (1-2-3)  Angle  Atoms (1-2-3)  Angle 
C(11)-N-C(17)  116.2(3)  H(1)- C(242) -H(2)  119(3) 
C(11)-N-C(14)  107.9(2)  H(1)-C(242)-C(24)  118(2) 
N-C(17)-C(16)  104.0(2)  C(22)-C(23)-C(232)  112.8(2) 
N-C(11)-C(12)  104.3(3)  C(232)-C(23)-C(24)  112.1(2) 
N-C(14)-C(13)  106.0(2)  0(261)-C(18)-C(15)  112.3(2) 
C(17)-N-C(14)  108.78(19)  C(24)-0(24)-C(242)  61.18(16) 
N-C(14)-C(15)  103.71(19)  0(212)- C(21) -C(22)  126.1(2) 
C(14)-C(13)-C(12)  101.8(2)  0(211)-C(21)-C(22)  111.0(2) 
C(13)-C(12)-C(11)  102.9(2)  C(222)-C(22)-C(21)  116.9(3) 
C(13)-C(14)-C(15)  120.8(2)  C(222)-C(22)-C(23)  125.5(3) 
C(16)-C(15)-C(18)  126.1(3)  C(242)-C(24)-C(23)  118.4(2) 
C(16)-C(15)-C(14)  110.1(2)  0(211)-C(13)-C(12)  111.0(2) 
C(18)-C(15)-C(14)  123.6(2)  C(242)-C(24)-C(25)  119.7(2) 
C(15)-C(16)-C(17)  112.7(3)  0(25)-C(25)-C(252)  111.1(2) 
C(21)-C(22)-C(23)  117.6(2)  0(262)-C(26)-C(25)  124.0(2) 
C(22)-C(23)-C(24)  109.3(2)  0(261)-C(26)-C(25)  111.4(2) 
0(24)-C(24)-C(23)  115.2(2)  C(26)-0(261)-C(18)  117.7(2) 
0(24)-C(24)-C(25)  114.0(2)  C(252)-C(25)-C(26)  107.2(2) 
H(1)-C(242)-0(24)  116(2)  C(252)-C(25)-C(24)  113.3(2) 
0(25)-C(25)-C(26)  110.8(2)  0(24)-C(242)-C(24)  59.30(16) 
0(25)-C(25)-C(24)  105.2(2)  0(24)-C(24)-C(242)  59.52(17) 
C(26)-C(25)-C(24)  109.2(2)  C(21)-0(211)-C(13)  116.70(19) 
H(25)-0(25)-C(25)  116(2)  0(211)-C(13)-C(14)  107.60(19) 
H(2)-C(242)-C(24)  114(2)  0(212)-C(21)-0(211)  122.9(2) 
H(2)-C(242)-0(24)  116(2)  0(262)-C(26)-0(261)  124.5(2) 
C(23)-C(24)-C(25)  116.84(19) 146 
Table 5. Anisotropic Displacement Parameters (A2 x 103) for Swazine (2) 
The anisotropic displacement factor exponent takes the form: 
-2 7t2 [ h2a*2U11 + ... + 2 h k a* b* U12 ] 
Atom  U11  U22  U33  U23  U13  U12 
N  57(1)  46(1)  39(1)  4(1)  -1(1)  4(1) 
C(11)  60(2)  71(2)  71(2)  22(2)  -3(2)  9(2) 
C(12)  59(2)  84(2)  44(1)  3(2)  -9(1)  -15(2) 
C(13)  51(1)  49(1)  39(1)  -6(1)  1(1)  -2(1) 
C(14)  47(1)  43(1)  35(1)  0(1)  2(1)  1(1) 
C(15)  44(1)  48(1)  34(1)  3(1)  3(1)  -9(1) 
C(16)  67(2)  51(2)  40(1)  -7(1)  4(1)  -13(1) 
C(17)  84(2)  47(1)  48(1)  -2(1)  7(2)  6(2) 
C(18)  43(1)  64(2)  45(1)  13(1)  2(1)  -6(1) 
C(21)  45(1)  47(1)  54(2)  4(1)  -9(1)  -7(1) 
0(211)  46(1)  41(1)  41(1)  -1(1)  2(1)  -8(1) 
0(212)  89(2)  70(1)  67(1)  -7(1)  -15(1)  -37(1) 
C(22)  41(1)  46(1)  60(2)  10(1)  2(1)  -3(1) 
C(222)  47(2)  113(3)  79(2)  17(2)  0(2)  -17(2) 
C(23)  45(1)  30(1)  47(1)  3(1)  8(1)  0(1) 
C(232)  70(2)  45(1)  58(2)  2(1)  21(2)  12(1) 
C(24)  50(1)  27(1)  39(1)  -2(1)  6(1)  0(1) 
0(24)  64(1)  40(1)  53(1)  -16(1)  6(1)  0(1) 
C(242)  68(2)  31(1)  60(2)  1(1)  8(2)  -2(1) 
C(25)  50(1)  45(1)  37(1)  1(1)  1(1)  1(1) 
0(25)  65(1)  86(1)  35(1)  -7(1)  0(1)  -14(1) 
C(252)  58(2)  65(2)  79(2)  24(2)  -1(2)  16(2) 
C(26)  46(1)  46(1)  41(1)  -1(1)  -6(1)  -1(1) 
0(261)  52(1)  47(1)  38(1)  4(1)  1(1)  -5(1) 
0(262)  104(2)  63(1)  54(1)  -7(1)  -3(1)  -34(1) 147 
Table 6. Hydrogen Coordinates (x 104) and Isotropic Displacement 
Parameters (A2 x 103) for Swazine (2) 
Atom  x  y  z  U (eq) 
H(11A)  11073(17)  4152(5)  5102(11)  72(2) 
H(11B)  10744(9)  3924(11)  5966(11)  73(2) 
H(12A)  10146(9)  5677(5)  6213(14)  73(2) 
H(12B)  11420(3)  5822(8)  5628(2)  73(2) 
H(13)  9009(13)  6740(3)  5239(5)  73(2) 
H(14)  7380(3)  5354(8)  5552(16)  73(2) 
H(16)  7122(18)  3498(13)  3683(17)  73(2) 
H(17A)  8220(11)  2602(18)  4888(6)  73(2) 
H(17B)  9590(2)  3124(5)  4393(7)  73(2) 
H(18A)  5518(19)  5208(11)  3657(8)  73(2) 
H(18B)  5703(14)  6020(10)  4355(10)  73(2) 
H (22A)  13666(18)  7144(7)  3605(11)  73(2) 
H (22B)  13396(11)  6894(3)  2578(14)  73(2) 
H(23)  9880(2)  5770(2)  2863(8)  73(2) 
H (23A)  11630(2)  6625(12)  1615(8)  73(2) 
H (23B)  10391(15)  5697(16)  1525(8)  73(2) 
H (23C)  11910(2)  5444(16)  1990(3)  73(2) 
H(1)  9370(4)  8950(3)  2114(19)  73(2) 
H(2)  11060(5)  8470(3)  2440(2)  73(2) 
H(25)  7360(5)  6390(3)  1100(2)  73(2) 
H (25A)  6586(17)  8286(12)  2711(11)  73(2) 
H(25B)  5720(2)  7737(6)  1924(11)  73(2) 
H (25C)  7139(13)  8598(13)  1785(11)  73(2) 148 
Table 7. Torsion Angles [O] for Swazine (2) 
Atoms (1-2-3-4)  Angle 
C(17)-N-C(11)-C(12)  141.8(2) 
C(14)-N-C(11)-C(12)  19.4(3) 
N-C(11)-C(12)-C(13)  -37.6(3) 
C(11)-N-C(17)-C(16)  -130.3(3) 
C(14)-N-C(17)-C(16)  -8.3(3) 
C(15)-C(16)-C(17)-N  6.3(3) 
C(11)-N-C(14)-C(13)  6.2(3) 
C(17)-N-C(14)-C(13)  -120.7(2) 
C(11)-N-C(14)-C(15)  134.4(2) 
C(17)-N-C(14)-C(15)  7.4(3) 
N-C(14)-C(15)-C(18)  171.7(2) 
N-C(14)-C(15)-C(16)  -3.6(3) 
C(12)-C(13)-C(14)-N  -29.1(2) 
0(211)-C(13)-C(14)-N  87.7(2) 
C(21)-C(22)-C(23)-C(24)  71.7(3) 
C(22)-C(23)-C(24)-0(24)  -21.0(3) 
C(12)-C(13)-C(14)-C(15)  -146.3(2) 
C(13)-C(14)-C(15)-C(16)  114.8(3) 
C(13)-C(14)-C(15)-C(18)  -70.0(3) 
C(18)-C(15)-C(16)-C(17)  -176.8(2) 
C(14)-C(15)-C(16)-C(17)  -1.6(3) 
C(22)-C(23)-C(24)-C(25)  -158.8(2) 
C(24)-0(24)-C (242)-H (1)  109(2) 
C(24)-0(24)-C (242)-H (2)  -104(2) 
0(24)- C(24)- C(242) -H(1)  -104(2) 
C(23)-C (24)-C(242)-H (1)  151(2) 
C(25)- C(24)- C(242) -H(1)  -2(2) 
0(24)-C (24)-C (242) -H(2)  107(2) 
C(23)-C(24)-C (242)-H (2)  3(2) 
C(25)- C(24)- C(242) -H(2)  -151(2) 149 
Table 7. Torsion Angles [0] for Swazine (2) (continued) 
Atoms (1-2-3-4) 
C(23)-C(24)-C(25)-0(25) 
O(24)- C(24)- C(25) -C(26) 
C (23)-C (24)-C(25)-C (26) 
C(11)-C(12)-C(13)-C(14) 
C(26)-C (25)-0(25)-H (25) 
C(24)-C (25)-0(25)-H (25) 
0(24)-C(24)-C(25)-0(25) 
C(22)-C(21)-0(211)-C(13) 
C(14)-C(13)-0(211)-C(21) 
C(12)-C(13)-0(211)-C(21) 
0(211)-C(13)-C(14)-C(15) 
C(16)-C(15)-C(18)-0(261) 
C(14)-C(15)-C(18)-0(261) 
0(212)-C(21)-C(22)-C(23) 
0(211)-C(21)-C(22)-C(23) 
C(21)-C(22)-C(23)-C(232) 
C(222)-C (22)-C (23)-C(24) 
C(232)- C(23) -C(24) -0(24) 
C(22)-C(23)-C(24)-C(242) 
C(232)-C(23)-C (24)-C (25) 
C(23)-C(24)-0(24)-C(242) 
C(25)-C(24)-0(24)-C(242) 
C(23)-C(24)-C(242)-0(24) 
C(25)-C(24)-C(242)-0(24) 
C(242)-C (24)-C (25)-0(25) 
0(24)-C(24)-C(25)-C(252) 
C(23)-C(24)-C(25)-C(252) 
C(242)-C(24)-C(25)-C(26) 
0(25)-C(25)-C(26)-0(262) 
C(24)-C(25)-C(26)-0(262) 
Angle 
-65.5(3) 
-84.8(2) 
53.5(3) 
40.7(3) 
55(2) 
173(2) 
156.20(19) 
-177.0(2) 
172.5(2) 
-76.9(3) 
-29.5(3) 
-101.0(3) 
84.5(3) 
-145.3(3) 
36.8(3) 
-162.9(2) 
-107.9(3) 
-146.8(2) 
46.5(3) 
75.4(3) 
109.5(3) 
-111.5(3) 
-104.0(2) 
102.0(2) 
88.9(3) 
34.7(3) 
173.0(2) 
-152.1(2) 
-10.7(4) 
-126.1(3) 150 
Table 7. Torsion Angles [O] for Swazine (2) (continued) 
Atom (1-2-3-4) 
O(25)- C(25)- C(26)- O(261) 
C(24)-C(25)-C(26)-0(261) 
C(25)-C(26)-0(261)-C(18) 
C(15)-C(18)-0(261)-C(26) 
C(252)-C(25)-0(25)-H(25) 
C(11)-C(12)-C(13)-0(211) 
C(242)-C(24)-C(25)-C(252) 
C(232)-C(23)-C(24)-C(242) 
0(212)-C(21)-C(22)-C(222) 
0(211)-C(21)-C(22)-C(222) 
0(212)-C(21)-0(211)-C(13) 
C(222)- C(22)- C(23)- C(232) 
0(262)-C(26)-0(261)-C(18) 
C(252)-C(25)-C(26)-0(261) 
C(252)- C(25)- C(26)- 0(262) 
Angle 
171.0(2) 
55.6(3) 
177.2(2) 
92.7(3) 
-64(2) 
-73.6(3) 
-32.6(3) 
-79.3(3) 
34.3(5) 
-143.6(3) 
5.1(4) 
17.5(4) 
-1.0(4) 
-67.6(3) 
110.7(3) 